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ABSTRACT 
 
The polymerization of nucleotides into nucleic acids is catalyzed by polymerases and is the 
supporting process for the survival and reproduction of all living organisms. In recent 
decennia analogues of nucleoside triphosphates ((d)NTPs), precursors of nucleic acids, have 
been synthesized in order to study the polymerization mechanism. Hereto, synthetic 
modifications can be introduced on different parts of the precursors. For instance, polymerase 
recognition of (d)NTP analogues where pyrophosphate has been replaced by various 
candidate leaving groups informs us about the mode of action of DNA polymerization 
enzymes. In addition, efficient leaving groups differing form pyrophosphate could be used for 
the development of new antivirals or serve for the orthogonalization of nucleic acid synthesis. 
More importantly, such leaving groups could support an orthogonal genetic system that 
cannot interfere with the natural cellular system. 
In the second chapter various chemical groups are investigated as mimics for 
pyrophosphate in the polymerization of DNA by HIV-1 reverse transcriptase. Diverse 
aliphatic and aromatic structures carrying one or two carboxylic acid functions are able to 
replace pyrophosphate during the nucleic acid synthesis process, albeit at the expense of DNA 
extension efficiency. During the nucleotide incorporation step phosphoramidate analogues 
seem to be less easily cleaved by the polymerase than their phosphodiester counterparts. 
Structures carrying only one carboxylic acid function can mimic pyrophosphate only when 
they are connected to the nucleoside via a phosphodiester linkage. 
In the third chapter the influence of the nature of this linkage is further investigated. 
Replacing the phosphoramidate linkage with a phosphodiester leads to better single nucleotide 
incorporation results. Longer DNA extension seems to be invariably impaired by the presence 
of a modified leaving group. We demonstrate that the nature of the linkage is not responsible 
for DNA synthesis pausing. 
The fourth chapter introduces a different leaving group mimic, iminodiacetic acid 
(IDA). IDA-deoxyadenosine monophosphate is a better substrate for single nucleotide 
incorporation and primer elongation than previous analogues. The reasons for DNA synthesis 
pausing are further explored. Computer modelling of ground state interactions during the 
chemical step of the process seems to support the hypothesis that IDA-dAMP binds to the 
polymerase active site in a similar way as compared to the natural substrate. Metabolic 
accessibility of this alternative DNA building block starting from naturally occurring 
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cyclotriphosphate is explored and shows that such DNA building blocks could potentially be 
biosynthesized. Directed evolution of polymerases is needed to develop enzymes capable of 
efficiently and exclusively using IDA-dNMPs as substrates. 
Metabolic availability of IDA-dNMPs is further explored in chapter five. IDA 
substituted adenosine triphosphate is synthesized and the ability of a human kinase to use it as 
a phosphate donor is tested. Deoxycytidine kinase cannot catalyze the transfer of IDA-
phosphoryl onto its natural substrates, showing the need for bacterial or engineered enzymes 
endowed with broader substrate specificity. Finally a bacterial enzyme capable of degrading 
the released leaving group is identified, bringing us a step closer to an orthogonal nucleic acid 
machinery.  
We could conclude that the pyrophosphate moiety of nucleotide triphosphates can be 
replaced by various leaving groups during the enzymatic synthesis of DNA. The efficiency of 
this synthesis depends on the structure of the group and on the nature of the linkage between 
the leaving group and the nucleotide to be incorporated. Further enzymatic studies are needed 
to understand the mechanisms of recognition and processing of polymerases. Directed 
evolution of polymerases is the following and necessary step in the development of 
polymerases that can use IDA-deoxynucleoside monophosphates as substrates in an efficient 
and exclusive manner.  
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SAMENVATTING 
 
De polymerisatie van nucleotiden tot nucleïnezuur wordt gekatalyseerd door polymerasen en 
dit proces is essentieel voor de overleving en reproductie van alle levende organismen. De 
laatste decennia werden tal van synthetische analogen van nucleoside-trifosfaten getest als 
substraat voor verschillende polymerasen met als doel het polymerisatiemechanisme te 
bestuderen. Chemische synthesemethoden maken het ons mogelijk om elk gedeelte van een 
nucleoside trifosfaat te modificeren en zo kan het pyrofosfaatgedeelte van een nucleoside 
trifosfaat vervangen worden door een andere uittredende groep. Een dergelijke studie kan ons 
veel leren over het mechanisme van enzymatische DNA synthese. Daarnaast kan deze 
technologie ook toegepast worden voor de ontwikkeling van een nieuw type van antivirale 
middelen of voor nucleïnezuursynthese. Tenslotte zijn zulke gemodificeerde nucleotiden ook 
geschikt om nieuwe genetische systemen te ontwikkelen die orthogonaal zijn aan het 
natuurlijke cellulaire systeem en er dus niet mee kunnen interfereren. 
In het eerste experimentele hoofdstuk worden verschillende chemische groepen 
onderzocht als ‘mimics’ voor pyrofosfaat in de polymerisatie van dAMP tot DNA door HIV-1 
reverse transcriptase (RT). Diverse alifatische of aromatische groepen die één of twee 
carbonzuurfuncties dragen, kunnen pyrofosfaat vervangen in het nucleïnezuursyntheseproces, 
ook al is de efficiëntie lager dan bij het gebruik van natuurlijke trifosfaten. Het inbouwen van 
nucleotiden lijkt minder efficiënt te verlopen met een fosforamidaatanaloog dan met zijn 
fosfodiëstertegenhanger. Structuren met slechts één carbonzuurfunctie werken enkel als 
pyrofosfaat-‘mimics’ als de binding die doorbroken wordt tijdens de polymerisatie een 
fosfodiëster is. 
In het tweede experimentele hoofdstuk wordt de invloed van de aard van de binding 
tussen de uittredende groep en het nucleotide verder onderzocht. Het vervangen van een 
fosforamidaatbinding door een fosfodiësterbinding vertaalt zich in een efficiëntere inbouw 
van het nucleotide in DNA. De synthese van langere DNA-ketens waarbij gebruik gemaakt 
wordt van deze gemodificeerde uittredende groepen wordt echter moeilijk. Een interessante 
waarneming is dat de ketenverlenging niet afhankelijk is van de aard van de binding tussen de 
fosfaatgroep en de uittredende groep. 
Het derde experimentele hoofdstuk beschrijft de synthese en eigenschappen van een 
nieuwe uittredende groep, het iminodiazijnzuur (IDA). IDA-deoxyadenosine-monofosfaat is 
een beter substraat voor de enzymatische synthese van DNA (verlenging van DNA-primers 
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met één of meerdere nucleotiden) dan de vroegere onderzochte analogen. De reden voor de 
vroegtijdige onderbreking van DNA-synthese werd verder onderzocht. Computermodelling 
van de binding van IDA-dAMP in de actieve plaats van HIV-1 RT lijkt de hypothese te 
ondersteunen dat IDA-dAMP zich aan het enzym bindt op een gelijkaardige manier als het 
natuurlijke substraat. Daarna werd de metabole toegankelijkheid van deze alternatieve DNA-
bouwsteen bestudeerd. We hebben aanwijzigingen dat natuurlijk voorkomend cyclisch 
trifosfaat een belangrijke rol kan spelen in zijn biosynthese. Een verdere stap in het onderzoek 
is de gestuurde evolutie van polymerasen die efficiënt en exclusief IDA-dNMPs als substraat 
kunnen gebruiken. 
De metabole toegankelijkheid van IDA-dNMPs werd verder onderzocht in het 
experimentele hoofdstuk vier. Hierbij werd IDA-gesubstitueerde adenosine-trifosfaat 
chemisch gesynthetiseerd. Het vermogen van een eoxycytidine kinase van menselijke 
oorsprong om IDA-ATP als fosfaatbron te gebruiken werd onderzocht. Helaas kan dit 
deoxycytidine-kinase de overdracht van IDA-monofosfaat naar hun natuurlijke substraten (dA 
of dC) niet katalyseren. Verder onderzoek dient uit te maken of bacteriële (of gemodificeerde) 
enzymen een bredere substraatspecificiteit hebben. Uiteindelijk werd ook één bacterieel 
enzym geïdentificeerd dat wel in staat bleek de afbraak van IDA te katalyseren waardoor het 
polymerisatieproces irreversibel wordt. 
We kunnen besluiten dat het pyrofosfaatgedeelte van nucleoside-trifosfaten kan 
vervangen worden door verschillende andere uittredende groepen tijdens het enzymatisch 
syntheseproces van DNA. De efficiëntie van deze synthese is afhankelijk van de structuur en 
van de aard van de binding tussen de uittredende groep en het nucleotide dat in het DNA 
wordt ingebouwd. Dit onderzoek is slechts een begin en nog vele functionele enzymstudies 
zijn nodig om dit proces van herkenning en verwerking bij polymerasen te begrijpen. 
Gestuurde evolutie van polymerasen is nodig om enzymen te ontwikkelen die op een 
efficiënte manier uitsluitend IDA-deoxynucleoside-monofosfaten kunnen gebruiken als 
substraten. 
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Chapter I – Introduction 
 
I.1 Nucleic acids 
 
The term ‘nucleic acid’ refers to informational polymers containing genetic material. It 
includes deoxyribonucleic acids (DNA) and ribonucleic acids (RNA). The monomer units, 
respectively deoxynucleotides (for DNA) or nucleotides (for RNA), are composed of a β-D-
2′-deoxyribose (DNA) or β-D-ribose (RNA) sugar covalently bound to a) a phosphate moiety 
at the 5′-C and b) to a heterocyclic base bound at the 1′-position through a β-glycosidic C1-N 
linkage (Figure I.1). The term ‘(deoxy)nucleoside’ is used to refer to a (deoxy)nucleotide 
deprived of the phosphate group. The heterocyclic bases have either a purine (adenine or 
guanine in the case of adenosine and guanosine nucleosides, rspectively) or a pyrimidine 
(cytosine, thymine and uracile in the case of cytosine, thymidine and uridine nucleosides, 
respectively) structure.  
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Figure I.1: Left: general structure of (deox)nucleotides and conventional numbering of the 
sugar backbone; Right: chemical structures of the five heterocyclic bases of DNA/RNA: 
adenine, guanine, cytosine, uracil and thymine and conventional numbering of the cyclic 
atoms. 
 
A DNA strand is made of nucleotides connected via 5′-3′ phosphodiester bonds. The 
resulting sugar-phosphate chain is referred to as the backbone of nucleic acids. In living 
organisms, RNA occurs as a single-stranded molecule, whereas DNA mostly occurs as a 
O
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double-stranded helix. This double helix is stabilized by hydrogen-bonding interactions 
between the bases of opposite strands. In the classical ‘complementary base pairing’ system 
unravelled by Watson and Crick in 1953, adenine pairs with thymine via two hydrogen-
bonds, while guanine pairs with cytosine via three hydrogen-bonds (Figure I.2) (1).  
N
N
O
O
Adenine Thymine
N
N
N
N
O
N
H
H
N
N
O
N
H
H
Guanine Cytosine
N
N
N
N
N
H
H
H
H
 
Figure I.2: Classical Watson-Crick complementary base pairs. 
 
In a nucleic acid chain the five-membered sugar ring of a nucleotide adopts a non-planar 
conformation resembling a half-chair (Figure I.3). As a consequence, and depending on 
nucleotide sequence, osmotic conditions or replication stage, a DNA helix can adopt three 
conformations that differ in geometry and dimensions (Figure I.4) (2). 
 
O
HO
Base
HO
O
HO
Base
HO
2'-endo 3'-endo
 
Figure I.3: Spatial representation of possible conformations adopted by deoxyribonucleosides 
in nucleic acids. 
 
Due to the 2′-endo ribose conformation, DNA usually forms a B-helix. The A-type helix 
conformation is adopted by dsRNA and DNA/RNA hybrids and is a consequence of the 3′-
endo conformation found in RNA. Both forms of helix are right-handed and anti-parallel 
(opposite ‘reading’ direction) and present a minor and a major groove to the environment. In 
the A double helix the major groove is very deep and narrow and the minor groove is wide 
and shallow. In the B-double helix both grooves have a similar depth, but their widths differ 
as the major groove is wide while the minor groove is narrow. A third type of helix called Z-
DNA is less common and can arise in the case of alternating purine-pyrimidine sequences. 
The purine nucleotides then adopt a 2′-endo conformation, while the pyrimidine nucleotides 
adopt a 3′-endo conformation, resulting in a left-handed helix presenting a deep minor groove 
and no discernible major groove (2). 
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Figure I.4: Three-dimensional structures of A- (left), B- (middle) and Z- (right) DNA. Orange bonds 
highlight the spatial arrangement of phosphate groups and do not represent chemical bonds. 
http://www.mun.ca/biology/scarr/A_B_Z_DNA.html (May 2010) 
 
During various life-cycles, hereditary information is replicated and transmitted via 
meiosis and mitosis. In accordance with Watson and Crick’s central dogma the genetic 
information (genotype) of any living organism is either stored as DNA replicated by specific 
enzymes into a complementary strand or is transcribed by other enzymes into RNA (mRNA 
or the ‘messenger’ RNA).  RNA is further processed by ribosomes that translate a succession 
of three nucleotides (or ‘codon’) into an amino acid, according to a universal genetic code. In 
this way, whole nucleotide sequences are translated into amino-acid sequences (peptide and 
proteins) that form the molecular phenotype of each individual.  
I.2 DNA precursors in vivo 
In all organisms the in vivo precursors of DNA are deoxyribonucleoside triphosphates 
(dNTPs) and are derived in situ from their corresponding ribonucleoside triphosphates 
(NTPs). A NTP is typically composed of the corresponding ribonucleoside monophosphate 
linked via the 5′-phosphate group to a pyrophosphate moiety. Three consecutive phosphate 
groups are referred as α-, β- and γ-phosphates, as represented in Figure I.5. 
 
O
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O
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O- O-
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Figure I.5: Molecular structure of nucleoside triphosphates with conventional nomenclature 
of phosphate groups. 
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The biosynthesis of NTPs starts with the assembly of simple fragment molecules that undergo 
successive biochemical transformations carried out by specific enzymes (3). Such process 
consists in a series of discrete/individual steps that differ whether a purine or a pyrimidine 
species is being synthesized. De novo synthetic purine and pyrimidine pathways respectively 
yield inosine and uridine monophosphates (I- and U-MP). Base differentiation towards the 
monophosphate species of adenosine (AMP) or guanosine (GMP) on one side, and cytidine 
(CMP) or thymidine (TMP) on the other side occurs via specific enzymes.  Once the 
corresponding nucleoside diphosphates are formed with the help of specific kinases, they are 
further reduced to deoxynucleoside diphosphates by ribonucleoside diphosphate reductase. 
Finally, base-specific kinases phosphorylate the diphosphates, resulting in the series of 
triphosphates dATP, dGTP, dCMP and dTTP (Figure I.6). 
IMP
(inosinate)
AMP
(adenylate)
ADP dADP dATP
GMP
(guanidylate)
GDP dGDP dGTP
UMP
(uridylate)
CMP
(cytidylate)
dCDP dCTP
dTMP
(thymidylate)
dTTP
CDP
dTDPUMP
k k
k k
k k
k k
 
Figure I.6: Biosynthesis of deoxyribonucleosides triphosphates: a cascade of enzymatically 
catalyzed transformations yielding four DNA building blocks. Kinases are symbolized by ‘k’.  
 
DNA building blocks can also be regenerated from their successive metabolites, although not 
in all growing cells, according to what is called the salvage pathway (3). 
 
I.3 Polymerization enzymes 
 
The transmission of the genetic information is crucial for both survival and evolution of all 
living species. Polymerases were identified as the enzymes endowed with replication activity 
and have been therefore the subject of intense studies (4;5). 
I.3.1 History and classification 
Since the discovery of DNA polymerase I of Escherichia coli by Kornberg in 1955 (5), 
several polymerases have been identified in prokaryotes and eukaryotes. Traditionally 
polymerases are classified according to their substrate or template specificity. In this 
classification two major groups of polymerases can be distinguished: the DNA and the RNA 
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polymerases. Both groups can then be subdivided into a template-dependent and a template-
independent class. A further distinction can be made between DNA-dependent (such as 
Klenow fragment and Vent polymerase) and RNA-dependent polymerases (reverse 
transcriptases (RT) such as HIV-1 RT and AMV-RT and eukaryotic telomerases). Similarly, 
RNA polymerases can either be template-dependent, such as T7 bacteriophage polymerase 
and or NS5B polymerase from hepatitis C virus) or template independent (e.g. poly(A) 
polymerase). 
 
A second classification which is most commonly used distinguishes polymerases on the 
basis of their amino acid sequence homology. This allows their subdivision into seven 
different families (A, B, C, D, X, Y and RT, Table I.1). Family A is also referred to as the 
DNA polymerase I (pol I) family and includes the Klenow fragment, Taq polymerase, 
mitochondrial γ and polymerases from odd-numbered phages (T3, T5 and T7). It is probably 
the most studied polymerase family. The B family includes all eukaryotic replicating DNA 
polymerases, the archeon Vent polymerase, Pfu polymerases and the polymerases form the 
phages T4, 46 and RB69. The DNA polymerases that duplicate bacterial chromosomes are 
members of the C family of polymerases. These particular polymerases share no sequence 
homology with any of the other families (6). Family D contains most of the archeon 
polymerases. Family X is also called the terminal transferase family and gathers the 
polymerases β, λ and µ. These enzymes are not directly involved in replication but are 
specialized in tasks such as DNA repair or RNA maturation. Polymerases involved in 
mutagenesis such as the mammalian polymerases η, ι, and κ are members of the polymerase 
Y family. They lack 3′-5′ proofreading activity. As a consequence they replicate DNA with 
low fidelity in vitro or play a role in the by-passing of damaged bases in the replication 
process. Finally, the reverse transcriptase (RT) family includes the eukaryotic telomerases and 
the viral reverse transcriptases. Viral RTs also lack 3′-5′ proofreading activity (7-9), and 
replicate DNA with low fidelity, endowing corresponding viruses with high mutation rates.  
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Table I.1: Classification of polymerases according to their amino acid sequence homology 
Family A Klenow, Taq, γ, T3, T5 and T7 DNA polymerases 
Family B α, δ, ε, Vent, Pfu, T4, T6 and RB69 polymerases 
Family C α subunit of DNA pol III 
Family D Archeon polymerases 
Family X β, λ and µ polymerases 
Family Y η, ι, and κ polymerases 
Family RT HIV-1, HIV-2, MLV and AMV RT, telomerases 
 
In the process of enzymatic DNA synthesis, DNA polymerases are confronted to a pool 
of four structurally similar dNTPs from which they must select the correct substrate for 
incorporation into the DNA duplex. Every second, several hundreds of dNMP are inserted 
with a fidelity varying among polymerases. Error rates for the replication process vary from 1 
in 1,000,000 bases for the high fidelity polymerases (eukaryotic DNA replication), to 1 in 
1,000 for lower fidelity polymerases involved in viral DNA replication. Polymerases that by-
pass DNA lesions go down to making 1 error in 10 insertions (4). 
 
I.3.2 Structure and mechanism 
In spite of their fundamental role, DNA polymerases are different among diverse life 
forms. Nevertheless, important functional regions are highly conserved among different 
classes (10) and the overall shape of all polymerases is similar. Their three-dimensional 
structure resembles a right-hand, consisting in ‘fingers’, ‘palm’ and ‘thumb’ domains (Figure 
I.7). Although significant sequence variations are observed among the fingers and thumb 
domains of different polymerases, the respective functions of these domains remain universal. 
The fingers are crucial for nucleotide accommodation, insertion fidelity, and for dsDNA-
enzyme complex stability. The thumb is responsible for the positioning of the replicating 
duplex, the processivity of the synthesis and plays an important role in the translocation 
process. The residues of this domain form extensive interactions with the phosphate backbone 
along the minor groove of the DNA duplex. The palm domain is the most conserved region 
and contains the active site responsible for the chemical step of nucleotide incorporation into 
DNA. A catalytic pocket accommodates the sugar moiety and allows steric discrimination 
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between deoxyribo- and ribo-nucleoside. Three conserved carboxylate residues play a crucial 
coordinating role towards the triphosphate moiety.  
 
Figure I.7: Schematic representation of the ‘palm’, ‘fingers’ and ‘thumb’ domains of HIV-1 
reverse transcriptase (reproduced from (11)). 
 
Polymerases catalyse DNA synthesis in a template-dependent manner. A DNA duplex 
made of a short primer DNA hydridized to a longer DNA template is recognized by the 
polymerase. At the active site, upon accommodation of a dNTP, the DNA polymerase 
promotes the nucleophilic attack of the 3′-hydroxyl group of the primer on the α-phosphate of 
the incoming dNTP. This reaction called the ‘phosphoryl transfer reaction’ is 
thermodynamically driven by the dissolution of the phosphate bond, the formation of a more 
stable phosphodiester bond, and the subsequent hydrolysis of the pyrophosphate moiety. In 
the transition state, the α-phosphorous is thought to be pentacoordinated (Figure I.8) (12). 
Furthermore, two magnesium ions (A and B) are thought to be tightly bound to three 
carboxylate functions belonging to the active site of the enzyme. Two of those residues 
consist of aspartic acids and are widely conserved in the polymerases. Magnesium ions A and 
B are also interacting with all three phosphate groups. The catalytic ion A is thought to 
activate the 3′-hydroxyl group for the attack, acting as a Lewis base. The second catalytic ion 
complexes the β and γ phosphate groups and is therefore thought to neutralize the negative 
charges of the dNTP in the initial state and during the transition state. In the final state, the 
released pyrophosphate moiety is likely to be leaving the active site together with catalytic 
metal B. Hydrolysis of the released pyrophosphate, by inorganic pyrophosphatase recruited 
by eukaryotic and viral polymerases (3) or by the pyrophosphatase domain of archeon 
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polymerases (13), is thought to provide an additional driving force for polymerization and 
makes the reaction irreversible.  
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Figure I.8: The two-metal ion mechanism of the phosphoryl-transfer reaction catalyzed by E. 
Coli DNA polymerase I (adapted from (12)). The carboxylate residues are shown in orange 
the coordination bonds of the magnesium ions in grey, and the bond in formation in purple. 
 
Extensive kinetic studies and numerous structural studies of polymerase complexes have 
helped in understanding the accuracy of DNA replication. Mechanistic and structural features 
that are common to almost all polymerases allow to control the fidelity of nucleotide insertion 
during five discrete steps. At first the dsDNA binds to the polymerase. Immediately after, the 
dNTP binds to the dsDNA:enzyme complex forming a ternary complex. A conformational 
change follows from an ‘open’ conformation to a ‘closed’ conformation (14).  Finally the 
chemical step of phosphodiester bond formation occurs and results in the release of 
pyrophosphate. A subsequent conformational change allows opening of the active site and 
translocation of the enzyme to the new 3′- hydroxyl primer terminus.  
Five interaction sites of importance were identified during the course of the nucleotide 
insertion process. The template base starts its journey at a ‘pre insertion site’ of the 
polymerase. During a conformational change that allows the enzyme to go into a ‘closed’ 
conformation, the template base is positioned in the ‘insertion site’. As a consequence a 
hydrophobic pocket forms around the deoxyribose and the base of the dNTP and the 
negatively charged phosphate residues are positioned between hydrophilic residues of the 
enzyme. At the ‘insertion site’ the dNTP base forms hydrogen bonds with the opposite 
template base. In the open conformation the template base is occluded by the aromatic side 
chain of a residue of the enzyme, often a tyrosine, that stacks with the template base. In the 
subsequent ‘closed’ conformation the residue is displaced, giving place to the dNTP base and 
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allowing base pairing. Following formation of the new phosphodiester bond, the newly 
formed base pair moves to the ‘post insertion site’ while the pyrophosphate leaving group is 
released and the enzyme changes back from the ‘closed’ to the ‘open’ conformation. In the 
case of a processive enzyme, the ternary complex remains in place and the following 
nucleotide insertion proceeds. Otherwise, the polymerase is said to be distributive and the 
ternary complex can be disrupted and a new ternary complex has to form, resulting in 
substantial slowing down of the DNA synthesis (5;15;16). 
1.3.3 HIV-1 reverse transcriptase 
Due to the fact that the viral enzyme HIV-1 reverse transcriptase is a drugable target for anti 
HIV-1 therapies, it has been the subject of many investigations. Thanks to the availability of 
crystal structures in various liganded states, a lot of information is available about structure-
activity relationships. HIV-1 RT is a heterodimeric enzyme composed of a 66 kDa unit (p66) 
endowed with polymerase activity and of a 51 kDa unit (p51) possessing RNase H activity 
(Figure I.9). HIV-1 RT belongs to the RNA-dependant DNA polymerases. This polymerase 
features the typical right-hand overall 3D structure (Figure I.7) and, as for all its congeners, 
the active site for nucleotide incorporation is situated in the palm domain. Both the fingers 
and the RNase H domain are responsible for primer:template (P:T) positioning. The three 
carboxylate functions essential for catalytic activity are situated at residues Asp110, Asp185 
and Asp186. HIV-1 RT preferentially functions in the presence of magnesium ions (17).  
HIV-1 RT (referred to as RT as from this section of the text) lacks a proof-reading 
function and is therefore known to be error-prone, making one misincorporation every 1000 
incorporations. As a consequence, it has a high mutation rate (18). It also has broad substrate 
specificity and is therefore able to incorporate many dNTP analogues into DNA. Current 
highly active antiretroviral therapies (HAART) include at least two compounds that inhibit 
the polymerase function of RT and thus interfere with the synthesis of viral DNA. The three-
dimensional structure of RT bound to dsDNA and diverse 3’-deoxynucleotides was elucidated 
by X-ray crystallography (17). The tremendous amount of data gathered since its first 
characterization and the low substrate specificity make it a very good tool to study the 
mechanism of dNTP incorporation and to test new dNTP analogue candidates as substrates. 
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Figure I.9: The structure of the HIV-1 RT catalytic complex with the polymerase active site 
on the left and the RNase H domain on the right. The domains of p66 are in colour: fingers 
(red), palm (yellow), thumb (orange), connection (cyan), and RNase H (blue); p51 is in gray. 
In the two chains, the domains have very different relative orientations. The DNA template 
strand (light green) contains 25 nucleotides, and the primer strand (dark green), 21 
nucleotides. The dNTP is in gold. This picture was reproduced from (17). 
I.4 In vitro chemical synthesis of nucleic acids 
I.4.1 Oligonucleotide synthesis 
With the aim to studying DNA and RNA secondary structures and conformations and their 
biophysical properties, chemists have developed synthetic procedures for the small scale 
production of oligonucleotides of variable lengths. In the 1960s, oligonucleotide (ON) 
synthesis was carried out in solution. Chain elongation resulted from block-synthesis 
following the phosphotriester method. This method suffered a lack of reproducibility and 
sequence precision; in addition, the process was strenuous, implicating silica gel column 
chromatography purification after each coupling. In order to overcome those problems, solid-
phase synthesis was developed (19). Nowadays the solid support consists mostly in a glass 
carrier functionalized with primary amines, namely controlled pore glass (CPG). A succinate 
group serves as linkage between CPG and the first building block. Using this method 
oligonucleotide synthesis is fast, reliable, reproducible and allows automation. Three 
synthetic strategies are available for solid-phase synthesis. The phosphite triester or 
phosphoramidite method adapted to solid support by Matteucci and Caruthers is the most 
  Chapter I – Introduction   
  11 
employed (20) and is represented in Figure I.10. The key step of this water sensitive PIII 
chemistry is a coupling between a tetrazole activated dN phosphoramidite and the 3′-hydroxyl 
group of the starting oligonucleotide which offers the major advantage to be very high 
yielded. Oxidation is usually carried out with the use of iodine in the presence of aqueous 
pyridine. Alternative methods are available for non aqueous and/or non-alkaline oxidation 
(21;22). 
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Figure I.10: Schematic representation of the synthesis cycle for oligonucleotide synthesis 
following the phosphite triester method: 1) The 3ʹ-end nucleotide carrying base B1 is linked to 
the CPG via a succinyl linker (both represented by a disk) and protected by a dimethoxytrityl 
(DMTr) group, 2) the phosphite triester carrying base B2 is activated and coupled to the pre-
existing oligonucleotide, 3) unreacted oligonucleotide are capped via acetylation, 4) the 
phosphorous in oxidation state +III is oxidized towards oxidation state +V, yielding a 
phosphotriester, 5) the full length ON is deprotected and cleaved from CPG by strong basic 
treatment. 
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 The H-phosphonate method, represented on figure I.11, also involves PIII chemistry. It 
proceeds via pivaloyl chloride activation of the building block’s phosphate function and offers 
a shorter coupling time. Since the oxidation step is carried out after completion of strand 
synthesis, it is possible to introduce phosphate modifications during this step (for example, 
sulphur oxidation yields a fully phosphorothioated ON).  
B1(protected)
O
O
P
DMTrO
O
H
O-
B2(protected)
O
O
OH
ON-CPG
O
CltBu
Py, CH3CN
B1(protected)
O
O
P
DMTrO
O
H B2(protected)
O
O
O
ON-CPG
4) Oxidation
3) Detritylation
B1(protected)
O
O
P
DMTrO
O
X B2(protected)
O
O
O
ON-CPG
1)
2)
B1
O
O
P
DMTrO
OX B2
O
O
O
ON
5) Deprotection
X=O, S, NHR...
Figure I.11: Schematic representation of the synthesis cycle for oligonucleotide (ON) 
construction following the H-phosphonate method: 1) The 5′-end nucleotide carrying base B2 
is linked to CPG, 2) the H-phosphonate carrying base B1 (protected by a DMTr in 5′ position) 
is activated and coupled to the pre-existing oligonucleotide, 3) the 5′ end of the ON is 
deprotected via acidic treatment and re-enters the synthesis cycle, or 4) the backbone 
phosphorous in oxidation state +III is oxidized by iodine towards oxidation state +V, yielding 
a phosphodiester or a phosphate modified backbone 5) the full length ON is deprotected via 
basic treatment. 
 
 Finally, the phosphotriester method uses a sulfonyl chloride species in combination with 
methylimidazole as activating agent of a protected 3′-phosphorylated dN building block, 
allowing subsequent attack of the phosphate by the 5′-hydroxyl group of the pre-existing 
oligonucleotide. Regardless of the synthetic method used, the resulting oligonucleotide is 
purified via a combination of preparative reverse phase (RP) and/or ion exchange (IE) 
chromatography. 
I.4.1 Synthesis of DNA building blocks 
Methods which rely on a similar chemistry to the one presented in the previous paragraph can 
also be used to synthesize nucleotide triphosphates (dNTPs) and their analogues (an overview 
is given in Figure I.12). Among those, Ludwig and Yoshikawa’s one pot synthesis is the most 
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straightforward method. A deoxynucleoside is first phosphitylated by phosphorous 
oxychloride (23). Subsequent coupling to pyrophosphate tributylammonium yields a dNTP 
(24). Another powerful method consists in activating the phosphate group of a dNMP.  Smith 
and Korana reported the synthesis of dNTP from dNMP and pyrophosphoric acid using 
dicyclohexylcarbodiimide (DCC) as coupling agent (25). Abraham et al. also used DCC 
activation to couple dNMPs to amino acids (26). DCC activation allows the high yielded 
synthesis of more stable activated species like (2-methyl) imidazole-dAMP (27) or 
morpholine-dAMP (28) and subsequent coupling via nucleophilic substitution by dNMPs and 
alcohols (29;30). Deoxynucleotide imidazolates can be stored and are therefore very 
convenient to use.  
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Figure I. 12: Overview of principal synthetic routes towards dNTPs and their analogues. 
‘Act’ symbolizes an activation group.  
 
The Mukayiama oxidation-reduction condensation (Figure I.13) offers an efficient alternative 
(31). In this method dipyridinium disulfide (DPDS) is used as a condensing agent and 
triphenylphosphine (PPh3) serves as reducing agent. 
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Figure I.13: Synthetic scheme of the Mukayiama oxidation-reduction condensation. 
 
Alternatively, the H-phosphonate approach consists in forming the H-phosphonate monoester 
of a deoxynucleoside via transesterification of diaryl H-phosphonate (e.g. diphenyl H-
phosphonate (32)) with subsequent hydrolysis of the second aryl group, or directly via 
reaction with phosphonic acid (33). Amines can be phosphorylated by diaryl or dialkyl 
phosphonates in the presence of carbon tetrachloride as reported by Atherton et al. (34). 
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Subsequent addition of hydroxylic compound to the H-phosphonate monoester, followed by 
activation with pivaloyl chloride (35), yields a H-phosphonate that can be oxidized with 
iodine (36) or other strong oxidants (37;38). An overview of these methods is given in Figure 
I.14. 
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Figure I.14: Overview of principal H-phosphonate synthetic routes towards dNTP analogues. 
 
Finally, in the phosphoramidite or phosphite triester method, phosphorous trichloride is 
derived in multiple steps into a deoxynucleoside phosphoramidate (Figure I.15). Subsequent 
activation by a large choice of activating agents (reviewed in (39)), followed by coupling to 
diverse nucleophilic species (using tetrazoles or triazoles as coupling agents) and final 
oxidation in appropriate conditions yields the desired dNTP analogues. This method involves 
extremely reactive chemicals and necessitates anhydrous synthetic conditions. It is therefore 
the least bench-friendly. 
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Figure I.15: General scheme for synthesis of dNTP analogues via phosphite triester method. 
 
I.5 Applications of nucleic acids 
 
Oligonucleotides are widely investigated for their use as pharmaceuticals. Diverse backbone 
modified oligonucleotides have been developed for the purpose of a therapeutic method later 
called the antisense approach (40), where a defined sequence binds to a pathogenic mRNA 
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and in this way inactivates it. The most realistic antisense therapeutic applications of 
oligonucleotides for antiviral purposes were reviewed by Van Aerschot in 2006 (41). The first 
generation of antisense oligonucleotides (AS-ONs) was modified at the phosphate position 
exclusively and the most successful were found to be phosphorothioate oligonucleotides (PS-
ONs) (Figure I.16).  
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Figure I.16: Fully phosphorothioated oligonucleotide. 
 
The second and third generations of AS-ONs consist in sugar modified oligonucleotides (e.g. 
peptide nucleic acid, or PNA (42), cyclohexenyl nucleic acid, or CeNA (43), 
phosphorodiamidate morpholino oligonucleotides or PMOs (Figure I.17).  
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Figure I.17: Molecular structure of the backbone of peptide, cyclohexenyl and 
phosphorodiamidate morpholino nucleic acids. 
 
Other therapeutic applications include RNA interference, aptamers technology (44) or 
immunostimulatory strategies (45). Nucleic acids have also found many applications in 
biochemical research. They are used as ‘primers’ and ‘probes’ in the polymerase chain 
reaction (PCR) technology (46) (involving biotinylated and fluorescent probes), DNA 
sequencing (47;48), and high-throughput screening (49;50) (using oligonucleotides in 
microarrays). In addition, site specific mutagenesis is used to study structure-activity 
relationships of proteins. Finally, nucleic acids may be used in nanotechnologies as 
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components for the construction of nanostructured systems by virtue of the structural 
properties and conformational dynamics of the self-assembling double helix (51;52), or of the 
electrostatic status of the backbone (53). An example of many possible geometric structures 
which could be generated is shown in Figure I.18. 
 
Figure I.18: A nanoscale shape (in red) composed of parallel double helices joined by 
periodic crossovers (in blue) (reproduced from (52)). 
 
The advances that have followed the control of nucleic acid synthesis have led to the 
proliferation of genetically modified organisms (GMOs) for research and industrial purposes, 
which possess synthetic nucleic acid constructs in their genome, endowing them with unusual 
properties or functions. Ten years ago, a lot of hope was given to the developing world at the 
presentation of the so-called ‘golden rice’ which had been engineered with additional 
nutritional properties in order to fight malnutrition issues (54). Until now, only intensive 
agriculture has benefited of engineered crops with enhanced resistance to viruses, fungus or 
drought. The agro-industrial giant Monsanto has been successful in manipulating corn 
genome and growing it at an industrial scale. There is good hope that some plant species 
could be modified so as to produce drugs or vaccines (55). However, since the genetic 
alphabet and genetic code are uniform and universal, it has become a major topic of debate 
that one cannot avert pollution of wild ecosystems by those genetically modified species. In 
this regard, GMOs might be threatening biodiversity on the long run. In fact, ‘polluted’ 
ecosystems were detected around GMOs fields, showing the lack of control of engineered 
nucleic acid dissemination. So far, experts have been unable to develop GMOs that do not 
disseminate their unusual genetic material in their environment. Therefore, there is an urge to 
develop safe genetically modified organisms whose hereditary information cannot interfere 
with the one of wild species. It could be envisaged that an independent molecular factory is 
introduced in natural organisms and participates in this manner in resistance mechanisms or in 
the production of exogenous molecules. In this regard, the notion of ‘xenonucleic acids’ 
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(XNA) that differ, in both their base alphabet and their backbone structure, from natural 
nucleic acids (DNA and RNA), has been introduced recently by Herdewijn and Marlière as 
part of an ‘orthogonal episome’ (56). 
I.6 Orthogonal DNA synthesis in vivo 
I.6.1 Presentation of the concept 
The ubiquity of (deoxy)nucleoside triphosphates as nucleic acid precursors and of DNA/RNA 
polymerases as polymerization enzymes implies that, if a precursor analogue is substrate for 
one given polymerase, stakes are high that it will also function as substrate for foreign 
polymerases (different cell type, different organism) with various efficiencies. For example it 
is a major concern that nucleoside-like RT inhibitors (NRTIs) also disrupt mitochondrial 
DNA synthesis and that their therapeutic effect is concomitant with many undesirable side 
effects (57;58). In addition, artificial DNA synthesis and DNA manipulation as technologies 
for engineering of genetically modified organisms often raise concerns of interference with 
natural systems. The term ‘orthogonality’ suggests that two systems are mutually exclusive. 
Thus, ‘orthogonal’ DNA synthesis in vivo aims at segregating the artificial synthesis from that 
of natural organisms. In the frame of a synthetic biology project of genetic enclave (56), as 
shown in Figure I.19, the use of alternative building blocks (modified sugar, base and leaving 
group) and of a specific polymerase (mutated and selected for its specificity towards the new 
building blocks) could allow the segregation from the natural deoxynucleoside triphosphates 
and avoid interference with natural genetic systems. In order to modify one single parameter 
at a time, all three chemical approaches (sugar, base or leaving group modification) need to be 
investigated separately. Polymerases specific for each modified unit may be mutated towards 
recognition of each modified unit separately. Directed evolution could then culminate with 
the final selection of a polymerase specific for the fully modified nucleic acid precursors.  
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Figure I.19: Schematic representation of orthogonal DNA synthesis based on 5′,6′-modified 
hexose building block (adapted from (56)). PM= pyrophosphate mimic, DG= delivery group. 
I.6.2 Monomer diversification 
During the last ten years the search for an alternative phosphate-sugar backbone offering 
identical stability and replication machinery has led to the discovery of diverse dNTP 
analogues containing a modified sugar moiety. Among others, cyclohexenyl nucleic acids 
analogues (CedNTP) (59) and hexitol nucleic acids (HNA) (60) are possible alternatives. In 
their molecular structure the (2′-deoxy)ribose sugar unit of the backbone is replaced by a 
cyclohexenyl moiety or an hexitol sugar, respectively. CeNA and HNA are able to form stable 
single- and double-stranded structures with DNA. The corresponding triphosphates (Figure 
I.20) are processed by usual DNA enzymes. They are, therefore, not orthogonal on their own. 
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Figure I.20: Cyclohexenyl nucleoside triphosphate, hexitol nucleoside triphosphate. 
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Expanding the genetic alphabet by creating novel base pairs is becoming a great 
challenge since various properties like specific base pairing, stacking, specificity, and 
selectivity are required for replication fidelity. In addition, extra bases should not be able to 
form base pairs with the natural ones. In this context, the Romersberg group introduced 
several heteropairs of bases, whose pairing is based on complementary hydrophobicity (61) 
and could successfully employ some of them (Figure I.21) for PCR (62) and transcription 
(63). 
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Figure I.21: Molecular structure and base pairing between the 1-thioisocarbostiryl moiety as 
a base substitute and methylmethoxyphenyl (left) or 2-methoxynaphtalene (right) as its 
complementary base. 
 
Remarkably, Neumann et al. recently extended the orthogonalization concept to the 
translation step by 'expanding the genetic code’. An engineered orthogonal ribosome was able 
to encode 4-base codons into unnatural amino acids (64). 
 
I.6.3 Enzyme evolution 
The issue of orthogonality, in particular enzyme specificity and fidelity, can be addressed 
simultaneously by developing appropriate DNA enzymes. Several in vitro directed evolution 
methods such as DNA shuffling/recombination (65) using affinity selection techniques such 
as phage-display (66) and compartmentalized self-replication (CSR (67), depicted in Figure 
I.22), are now available to direct the evolution of a given enzyme towards enhanced substrate 
specificity (68). The generated mutant will therefore segregate natural DNA precursors and 
process non-natural nucleic acids (‘xenonucleic acids’, XNA) precursors in exclusivity. 
Subsequent use of bacteria like Escherichia Coli as host for an orthogonal machinery 
dedicated to synthesis of informational polymers could provide a direct and unlimited access 
to tailor-made XNA for diverse therapeutic or analytic applications. 
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Figure I.22: Schematic representation of compartmentalized self-replication. 1) A repertoire 
of polymerase genes is cloned and expressed in E. coli. Spheres represent active polymerase 
molecules. 2) Bacterial cells (white rectangular unit) containing the polymerase and encoding 
genes are suspended in reaction buffer containing flanking primers and dNTPs and segregated 
into aqueous compartments (in grey). 3) The polymerase enzyme and encoding gene are 
released from the cell, allowing self-replication to proceed. Poorly active polymerases (white 
hexagons) fail to replicate their encoding gene. The offspring polymerase genes of active 
polymerases are released and cloned for another cycle of CSR (reproduced from (69)).  
 
I.6.4 Modification of the leaving group 
An unprecedented approach in the search for orthogonality consists in replacing the chemical 
moiety of nucleic acid building blocks which serves as leaving group in the polymerization 
mechanism by a mimicking group. The leaving group of natural DNA precursors is a 
pyrophosphate (PPi) and consists in the β- and γ-phosphate moiety of the nucleoside 
triphosphate (the universal denomination of these phosphate groups is illustrated in Figures 
I.5 and I.8). Pyrophosphate serves as universal biochemical energy storage and is therefore 
ubiquitous in living organisms. The tremendous amount of data available on DNA 
polymerases and their polymerization mechanism enabled to characterize the major 
characteristics and the structure-function relationship of PPi in this process (12;17), setting 
some of the requirements for rational design of potentially successful pyrophosphate mimic 
candidates endowed with similar efficiency. For example, in the laboratory of Goodmann 
modifications have been introduced on the bridging oxygen between the phosphorous atoms 
in α and β positions. Such modifications affected the polymerization rate (kpol) and replication 
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fidelity. Interestingly, variations in kpol could be correlated to the corresponding variations in 
the pKa of the departing biphosphonic acid (70;71). 
In order to function as leaving group during the polymerization process, a candidate 
should be able to behave chemically and biochemically in a similar way to pyrophosphate. 
Molecular models, based on crystal structures of various liganded states of polymerase, 
suggest that a leaving group should fit into the active site pocket, therefore limiting the steric 
size of the leaving group. They also imply that the leaving group should be able to form 
hydrogen bonding (triphosphate and sugar moiety) and Van der Waals interactions (base and 
sugar moiety) with the enzyme’s residues and with the catalytic ions. From a strict chemical 
point of view, the leaving group’s structure should promote the nucleophilic attack on the α-
phosphate (Figure I.8).  Therefore it should be linked to the phosphate via a highly polarisable 
bond. The released molecule should also be basic enough to be readily protonated after 
departure.  
A first possibility is to replace the linking oxygen atom with various heteroatoms that 
would generate good departing anions upon cleavage from the α-phosphorous. Some 
bioisosteres of oxygen that could fulfil these requirements are nitrogen and sulphur (72). 
Another possibility is to conserve the linking oxygen atom and substitute it with various 
chemical groups whose corresponding alcoholates should be good departing anions. As 
previously presented on Figure I.8, the coordination of two magnesium ions is thought to play 
an important role in the consensual nucleotide incorporation mechanism. As a consequence, it 
seems to be of utmost importance that the leaving group candidate possesses good 
coordinating capacity. Carboxylic acid, sulfonic acid, sulphonamide and aminophosphate are 
commonly used in drug design as the less bulky bioisosteres of the phosphate functional 
group. The rationale for the design of pyrophosphate mimics is summarized in Table I.2.  
 
Table I.2: Rational design of pyrophosphate mimics. 
 Lead compound Bioisosteres 
Linkage PPi-O-P RO-P, RNH-P, R2N-P, R-S-P 
Electronic status -PO32- 
-COO-, -SO32-, SO2-NH-,  
-PO2-NH- 
Coordination 
bond donor 
Non-bridging oxygen of 
PO32- 
All of the above 
Small O or N containing cycles 
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Some pyrophosphoric acid analogues like phosphonoformic acid (or foscarnet (Figure I.23)) 
(73) or other (reviewed in (74)) endowed with antiviral activity against viruses (e.g. herpes 
simplex virus) are thought to mimic pyrophosphate by coordinating specific divalent ions 
essentials for the functioning of many viral enzymes, exampling the possibility of other 
chemical functions to mimic pyrophosphate in this regard. 
P
HO
O
O
OH
OH
 
Figure I.23: Molecular structure of phosphonoformic acid (foscarnet). 
 
 The following issue in the replacement of pyrophosphate by an alternative leaving 
group is the fate of the released molecule in the biological system. Similarly to PPi, in order 
to promote advancement of the polymerization reaction and to prevent accumulation in the 
environment, an alternative leaving group should be preferably metabolized into simple 
fragments and/or possibly recycled for further biosynthesis. Importantly, the PPi mimic and 
corresponding metabolized fragments should bear little or no toxicity for the cellular/bacterial 
environment. If a chemical group meeting all previous requirements is developed, it could be 
possible to use it in order to orthogonalize the substrate recognition process. This in turn 
allows the segregation of natural deoxynucleoside triphosphates and avoids interference with 
natural genetic systems. 
 
It is essential to mention that such candidate leaving groups could be valuable in the search 
for new antiretroviral compounds. So far, most nucleoside-like polymerase inhibitors 
developed for anticancer or antiviral therapies are delivered in situ in their nucleoside or 
nucleoside monophosphate form and require further phosphorylation operated by cellular 
kinases (75-77). Cellular kinases unfortunately have greater substrate specificity and do not 
process some nucleoside analogues. For example, dideoxyuridine (ddU) is a very poor 
substrate for the host’s thymidine kinases (78). Yet, once triphosphorylated, this 
dideoxynucleoside is a potent antiviral compound as its administration leads to termination of 
viral DNA synthesis. Prodrug approaches involving the substitution of dNMP analogues with 
a chemical masking group have been developed in order to by-pass the first phosphorylation 
step and simultaneously allow the monophosphate species to enter the cell (79). Surprisingly, 
the mimicking of pyrophosphate by a structurally similar group has been little investigated for 
the purpose of by-passing the kinase pathway. The administration of a ddNMP analogue 
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substituted with a pyrophosphate mimic as masking group (and if necessary a lipophilic 
masking group for cellular uptake (80)), could allow the by-passing of the phosphorylation 
cascade (77), as shown in Figure I.24.  
dN(MP)
analogue
dNTP analogue
phosphorylation
cascade
incorporation
in viral DNA
by viral polymerase
DNA synthesis termination
or
dsDNA structure disruption
dNMP analogue
+ PPi mimic direct intraction
with target enzyme
 
Figure I.24: By-pass of phosphorylation cascade of deoxynucleotide analogues with the use 
of a deoxynucleotide monophosphate substituted with a pyrophosphate mimic. 
 
I.7 Aims of the study 
 
In enzymology the investigation of modified substrate recognition by enzymes is a great tool 
to gain valuable information about structure-activity relationships. In particular, the influence 
of the modification of a defined part of the substrate molecule on the polymerase function 
allows gaining insight on the polymerization mechanism. Efficient substrate mimics can be 
used in the development of antiviral strategies. On the other hand, modified oligonucleotides 
have numerous potential applications in therapeutics and diagnostics. Unfortunately, their 
chemical synthesis is laborious and costly, and the length of the products is limited. Therefore 
the pharmaceutical industry could benefit of alternative ways to produce modified 
oligonucleotides, such as the potential enzymatic synthesis presented in our study. 
The present study focuses on the modification of the pyrophosphate moiety of natural 
deoxynucleoside triphosphates and its influence on DNA polymerization efficiency.  In 
chapter two, various structural candidates, which represent potential mimics for PPi in the 
polymerization reaction, are synthetically coupled to natural deoxynucleotides. The capacity 
of the resulting dNTP mimics to act as substrates for a polymerase is investigated. The 
influence of the coordinating potential of the PPi mimic on the polymerization outcome is 
explored and insights on the influence of the phosphodiester or phosphoramidate linkage 
between dNMP and PPi mimic are gained. The third chapter presents the comparison of an 
amino acid dAMP phosphoramidate and its phosphodiester congener as dATP mimics. The 
influence of the PPi mimic’s structure on dAMP single and multiple incorporation efficiency 
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into DNA by HIV-1 RT is investigated. In chapter four the enzymatic incorporation of 
deoxyadenosine monophosphate into DNA is described when pyrophosphate is replaced by 
iminodiacetic acid. Modelling studies show the fitting of the modified leaving group in the 
active site of HIV-1 reverse transcriptase and  the issue of DNA synthesis pausing and 
termination is discussed. The fifth chapter is dedicated to the development of an 
iminodiacetic acid-specific biosynthesis of alternative DNA precursors. Therefore, the 
question whether iminodiacetic acid can also mimic pyrophosphate during enzymatic 
phosphorylation will be discussed. 
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II. Chapter two: Phosphodiester substrates for 
incorporation of deoxynucleotides in DNA using HIV-1 
reverse transcriptase  
 
The results reported in this chapter were published in ChemBioChem in 2009 under the title 
‘Phosphodiester substrates for incorporation of deoxynucleotides in DNA using HIV-1 
reverse transcriptase’. Giraut, A., Dyubankova, N., Xiaoping, S., Herdewijn, P., (2009) 
ChemBioChem 10, 2246-2252. 
 
II.1 Introduction 
 
The enzymatic synthesis of nucleic acids makes use of nucleoside triphosphates as substrates 
and this process is driven by the release and hydrolysis of pyrophosphate. The search for 
mimics of the pyrophosphate leaving group, and thus for mimics of nucleoside triphosphates, 
was initially directed towards the discovery of polymerase inhibitors. The emergence of 
synthetic biology as a new research field has intensified the search for new substrates with 
alternative leaving groups for the polymerase-catalyzed DNA synthesis. Two important 
reasons for this are the dissection of nucleic acid synthesis from the 
energetic/metabolic/signaling systems of a cell (which also makes use of nucleoside 
triphosphates) and to by-pass the kinase pathway (in case sugar or base modified nucleotides 
are used for nucleic acid synthesis). Here we have studied different potential new leaving 
groups for their ability to support HIV-1 RT polymerase catalyzed DNA synthesis.   
The pyrophosphate moiety has bridging (P-O-P) and non-bridging (P=O and P-OH) 
oxygen atoms. As it was previously assumed that the non-bridging oxygen atoms are 
important for the binding of the nucleoside triphosphate to the enzyme (directly and via metal 
coordination) and for efficient enzymatic polymerization of DNA, most research was 
concentrated on replacing the bridging oxygen with other atoms or groups.  
Recently, it was demonstrated that DNA polymerases such as HIV-1 reverse transcriptase, 
Taq DNA polymerase and Vent (exo-) DNA polymerase, are able to process selected 
substrates like L-amino acid dAMP phosphoramidates (81;82). In this case the pyrophosphate 
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leaving group is replaced by a completely different molecule with potential coordinating 
properties. In particular, the L-aspartic acid phosphoramidates of deoxyadenosine (L-Asp-
dAMP, Formula II.1) deoxyguanosine, deoxycytidine and thymidine monophosphates (83) 
demonstrated incorporation and elongation properties. The L-histidine phosphoramidate of 
deoxyadenosine monophosphate (L-His-dAMP) was also processed as a substrate. While L-
His-dAMP is a less good substrate for HIV-1 RT than the L-Asp congener, chain elongation 
seems to work slightly better with L-His-dAMP. The most remarkable observation is that this 
error-prone polymerase is able to catalyze P-N bond cleavage.  It was also demonstrated that 
the phosphate groups of the pyrophosphate moiety can be substituted with carboxylic acids 
and imidazole moieties. Furthermore it was proven that, using the L-Asp leaving group, 
selectivity was conserved among the four nucleobases (83). 
H
N
O OH
P NO
N
N
OH
N
NH2
O
HO O O
OH
 
Formula II.1. Chemical structure of L-aspartic acid-dAMP. 
Although these new building blocks are not able to compete with the natural substrates, as 
their substrate efficiency is lowered by a factor of 103 when compared to dATP, they proved 
to possess the necessary structural features, size, binding properties, flexibility, and leaving 
group capacity to function in enzymatic DNA synthesis. 
 
Based on the X-ray structure of a ternary complex between enzyme, template-primer duplex 
and substrate, a model was postulated which could explain the mechanism by which the 
incoming dNTP is activated by the polymerase for incorporation in the growing DNA chain 
(12). This model remains consensual up till now and suggests notably that one of the metal 
ions binds to the β- and γ-phosphates and facilitates the leaving of the pyrophosphate moiety. 
Garforth et al. could show that the interaction between a lysine residue of HIV-1 RT (Lys65) 
and one of the non-bridging oxygen atoms of the γ-phosphate is not necessary for the 
enzymatic reaction to be performed, enabling enzyme processing when only two potential 
chelating moieties are present (84). In this context, good ability to coordinate a magnesium 
cation appears to be a major requirement for a leaving group.  
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The main challenge of this project is to select a leaving group which possesses a good 
balance between satisfying leaving group properties, synthetic accessibility and sufficient 
chemical stability. Here we tested a series of new potential leaving groups in order to further 
explore this structure-substrate specificity. Examples of potential leaving groups with an 
aromatic character are given in Formula II.2. In isophtalic- (iPA, 1, 2) and phtalic- (3) dAMP 
the two carboxylic acids on the aromatic ring increase the polarity of the bond between 
leaving group and nucleotide and introduce the possibility to coordinate metal ions (moieties). 
P
O
NO
N
N
OH
N
NH2
O
OH
X
HOOC
HOOC
P
O
NO
N
N
OH
N
NH2
O
OH
OHOOC
HOOC
31: X=O
2: X=NH
 
Formula II.2. Molecular structure of 5′-(isophtalic acid)-dAMP 1 and 2, 5′-(phtalic acid)-
dAMP 3. 
The influence of the replacement of the P-N linkage by a P-O linkage can be evaluated 
while comparing the leaving group capacity of compounds 1 and 2, while differences 
observed between compounds 1 and 3 could show the influence of the position of carboxylic 
acid groups.  
In an attempt to further simplify the structure of the leaving group, we investigated the 
pyrophosphate mimicking ability of a group carrying only one carboxylic acid function, for 
both phosphodiester and phosphoramidate analogues (Formula 3). The glycine analogue has 
been evaluated previously and found to be inactive as leaving group (81). Here we evaluated 
the oxygen analogue (5) of this compound, as well as the β-alanine analogue (compound 4) 
and its hydroxyl counterpart, γ-hydroxypropionic acid 6. In addition, the study of compounds 
4 and 6 will allow us to estimate the role of the γ-carboxylic acid in the mechanism.   
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Formula II.3. Molecular structure of β-ala-dAMP 4, glycolic acid-dAMP 5 and γ-
hydroxypropionic acid-dAMP 6. 
II.2 Results 
II.2.1 Synthesis of phosphoramidates and phosphodiesters 
The synthesis of the methyl or benzyl esters of the protected nucleotides analogues (L-Asp-
dAMP, 1, 2, 3, 4 and 6) was accomplished according to the method described by Wagner and 
colleagues  starting from the nucleoside monophosphate (77). 
 Deprotection of the methyl esters was carried out with sodium hydroxide or potassium 
carbonate in methanol-water solution. Scheme II.1 shows a representative example of such a 
synthetic scheme using the β-Ala-dAMP analogue as prototype. Deprotection of the 
benzylated γ-hydroxypropionic acid-dAMP was easily achieved by hydrogenation. 
NH2P
O
NO
N
N
OH
N
NH2
O
OH
HO + NH
P
O
NO
N
N
OH
N
NH2
O
OH
O
RO
-O
O
a, b, c
4
Et3N+
R=Me, Bn
 
Scheme II.1. Reaction scheme for dicyclohexylcarbodiimide assisted coupling and methyl 
ester deprotection: a) DCC, tertbutanol, water, reflux, 6-8 hrs; b) R=Me: sodium hydroxide, 
methanol, water (1M), rt, 1h; R=Bn: H2 Pd-C, methanol; c) TEAB 1M, 4°C. 
 
For the synthesis of glycolic acid- dAMP 5 and hydroxypropionic acid dAMP 6, we resorted 
to a method based on divalent cation assisted coupling (represented for the synthesis of 5 in 
Scheme II.2), as previously published by Sawai (85). In this approach, the carboxyl acid 
moiety does not need to be protected, as it is proposed to possibly serve as ligand for the 
divalent metal-ion during the nucleotidyl transfer, thus reducing the number of synthetic steps 
to one. The starting material is the activated (deoxy)nucleotide dAMP imidazolide 
(ImdAMP), synthesized by adapting the method of Lohrman and Orgel (29), via a 
Mukayiama oxidation-reduction condensation (Scheme II.3) (31;86).  
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Scheme II.2: Reaction scheme for divalent cation mediated coupling of glycolic acid and 
dAMP: a) zinc chloride, N-ethyl morpholine buffer pH 7.5, rt, 2-4 days. 
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Scheme II.3: Synthesis of ImdAMP by oxidation-reduction condensation: a) 
Triphenylphosphine, imidazole, dipyridyl disulfide, triethylamine, DMSO, rt, 30 min. 
 
In this mechanism the divalent metal ion is thought to be activating the phosphate group by 
chelation and also chelating the carboxylic acid function, therefore bringing the nucleophilic 
hydroxyl group in proximity for in-line attack of the phosphorous, as shown in Scheme II.4.  
P
O
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N
N
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N
NH2
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Scheme II.4: Mechanism of divalent cation assisted coupling as proposed by Sawai (85). 
 
31P-NMR monitoring of two to four day-reaction showed disappearance of the ImdAMP peak 
(-8 ppm) and formation of the phosphodiester (1.4 ppm), concomitant with the appearance of 
an additional peak at -11 ppm. This side product of the reaction was purified and 
characterized as bis(2′-nucleoside) 5′,5′-diphosphate (dAppdA). Indeed, the yield of this 
coupling reaction is limited by the simultaneous dimerization of ImdAMP to the 
pyrophosphate dimer dAppdA. It is possible that two imidazolide molecules, bound in a 
single Zn2+ complex, react together to form an inter-nucleotide bond (30), as shown in 
Scheme II.5. Such dimerization in concentrated solutions of phosphoimidazolide nucleotide 
was also observed in the presence of magnesium ions.  
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Scheme II.5: Possible mechanism for the formation of dAppdA starting from ImpdA. 
 
The ratio between desired phosphodiester and side product dAppdA depends on the metal 
species, as shown in Figure II.1. In the presence of zinc, the reaction yields 80-90 % of the 
desired product. Presence of divalent magnesium ion promotes dAppdA formation and only 
yields about 40 % of phosphodiester. 
 
    
Figure II.1: Reverse phase HPLC purification profiles of GA-dAMP synthesis in presence of 
A) zinc chloride, B) magnesium chloride after 24 h reaction. 
II.2.2 Single incorporation experiments 
Previous experiments carried out with the L-aspartic acid phosphoramidate of dAMP 
demonstrated that this amino acid was an acceptable leaving group for the polymerase in the 
nucleotidyl insertion process. Incorporation results were lower when using the enantiomeric 
D-aspartic acid leaving group.  
In the present study, we evaluated the capacity to incorporate a deoxyadenosine nucleotide in 
the primer-template complex P1:T1 (Table II.1) using HIV-1 RT and the above mentioned 
dATP analogues as substrates. The initial screening was carried out using a template with an 
overhang of one thymidine nucleotide followed by three deoxycytidine nucleotides. 
Incorporation efficiency was analyzed by the polyacrylamide gel-based single nucleotide 
incorporation assay (87;88).  
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Table II.1. Primer-template complex used in the incorporation assay with HIV-1 RT DNA 
polymerase. Bold letters indicate the template overhang in the hybridized primer-template 
duplex. 
Oligonucleotide Sequence 
P1 
T1 
5'-CAGGAAACAGCTATGAC-3' 
3'-GTCCTTTGTCGATACTGTCCC-5' 
 
The isophtalic acid phosphodiester  analogue 1 is recognised by HIV-1 RT and efficiently 
incorporated into a growing primer strand with a conversion to a (P+1) strand in 90-92 % 
yield over a period of 2 hours at 1mM concentration (figure II.2). The corresponding aniline 
analogue 2 is less well recognized as substrate (67% (P+1) product). Finally, little 
incorporation (13% (P+1) product after 2 hours) was observed using the phtalic acid dAMP 
derivative 3.  
 
Figure II.2: Profiles of incorporation of dAMP into P1:T1 by HIV-1 reverse transcriptase 
using 1 (5-OH-iPA)-, 2 (5-NH-iPA)-, and 3 (4-OH-PA)-dAMP as substrates. Aliquots were 
drawn at 5, 10, 20, 30, 60 and 120 minutes (for dATP: 5, 30, 60, 120 min). 
 
A few interesting observations can be made from this first panel. Despite the geometric 
constraint brought by the aromatic ring, dicarboxylic acid substituted phenols and aniline can 
still function as leaving group in the polymerase catalyzed reaction. As expected, a phenolate 
is a better leaving group than the amide ion since it is a better ‘base’ although it is not clear if 
protonation at the nitrogen atom of the aniline group is involved in the catalytic mechanism. It 
has been shown recently that protonation of the pyrophosphate leaving group is important and 
occurs thanks to the presence of a neighbouring acid residue of the active site (89).  
Among the two phenol moieties, the one carrying both substituents in meta-position (1) is the 
most successful PPi mimic. This could indicate that the orientation of both carboxyl functions 
is important, which might be attributed to steric hindrance in the active site of the polymerase, 
or to a more stable complex. Compound 1 was further evaluated at different concentrations 
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(Figure II.3). At 500 µM it displayed a maximum of 75% of (P+1) formation, which 
represents 88% of the yield obtained with L-Asp-dAMP as a substrate (81).  
 
Figure II.3: Profiles of incorporation of dAMP into P1:T1 with dAMP by HIV-1 reverse 
transcriptase using 5-OH-iPA-dAMP 1 as substrate. Aliquots were drawn at 5, 10, 20, 30, 60 
and 120 minutes (for dATP: 5, 10, 20, 30, 60 min). 
 
These leaving groups could also only serve as activating groups in the reaction medium and 
be incorporated in a polymerase independent manner, as dAMP imidazolide (Im-dAMP) is 
incorporated into an appropriate primer:template duplex in a polymerase-independent reaction 
(90). Therefore, a control was made in the absence of polymerase, and we could observe that  
no primer elongation takes place in these conditions. 
 
Using the oxygen analogue of glycine, i.e. glycolic acid deoxyadenosine monophosphate 
phosphodiester 5 (GA-dAMP), the incorporation efficiency is better than with glycine itself. 
The compound possesses a reduced chelating capacity when compared with L-Asp, which 
apparently did not prevent incorporation of one nucleotide unit. The incorporation yield is 
moderate, as (P+1) formation was observed up to 68% at a concentration of 500 µM (Figure 
II.4). A large difference between the glycine phosphoramidate analogue (13.8 % (P+1) 
formation) and its phosphodiester counterpart could be observed, showing the better leaving 
group properties of the phosphodiester candidate. 
 
Figure II.4: Profile of incorporation of dAMP into P1:T1 with dAMP by HIV-1 reverse 
transcriptase using GA-dAMP 5 into P1:T1 as substrate. Aliquots were drawn at 5, 10, 20, 30 
and 60 minutes. 
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Interestingly, dAppdA (side product from the synthesis of GA-dAMP) also serves a substrate 
for HIV-1 RT. This bulky substrate is recognized by HIV-1 RT and dAMP is incorporated 
into dsDNA, resulting in up to 95% of extended primer (Figure II.5). Possible contamination 
of the GA-dAMP solution by the dimer was therefore carefully monitored by available 
spectroscopic methods. 
 
 
Figure II.5: Profile of incorporation of dAMP into P1:T1 with dAMP by HIV-1 reverse 
transcriptase using dAppdA as substrate. Aliquots were drawn at 5, 10, 20, 30 and 60 minutes. 
 
The phosphoramidate analogue aminopropionic acid dAMP 4, whose alkyl chain contains one 
additional methylene group, is not a substrate for HIV-1 RT, as no (P+1) product formation 
was observed at four concentrations ranging from 1 mM to 100 µM. On the contrary, the 
phosphodiester counterpart hydroxypropionic acid dAMP 6 serves as substrate, albeit poorly; 
(P+1) product formation was observed up to 11% at 500 µM concentration. Table II.2 gives 
an overview of the yield of dAMP incorporation (%) into DNA (at 60 minutes incubation 
time) using substrates 1, 2, 4-6. 
 
Table II.2. Percentage of incorporation of dAMP in function of the leaving 
group moiety and concentration (60 min incubation time, P1:T1, HIV-1 RT). 
 iPA -CH2-COOH -CH2-CH2-COOH 
 
O-P 
(1) 
N-P 
(2) 
O-P 
(5) 
N-P 
O-P 
(6) 
N-P 
(4) 
100 µM 24 nd 41 nd 0 0 
200 µM 47 nd 78 nd 0 0 
500 µM 75 nd 67 20 5 0 
1 mM 87 13 nd nd 11 0 
[a] % of the total amount of radioemitting oligonucleotides  in the mixture 
 
From Table II.2 we can conclude that a phosphodiester (P-O) bond is cleaved easier than a 
phosphoramidate (P-N) bond. Surprisingly, in the case of a phosphodiester bond between the 
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nucleoside monophosphate and the leaving group, one carboxylic acid function on the leaving 
group is sufficient to enable the nucleotidyl transfer reaction. This is not the case when 
considering the phosphoramidate linkage. Incorporation studies with aminopropionic acid 
dAMP and Gly-dAMP demonstrate that phosphoramidate bond (of an aliphatic leaving group) 
can only be cleaved when two carboxylate groups are present. In addition, the difference in 
incorporation yield between 5 and 6 suggest that the closer the carboxylic acid is, the better 
the group mimics pyrophosphate. 
 
II.3 Discussion 
 
The propagation of new information systems in vivo for synthetic biology purposes requires 
that the system is orthogonal to the existing natural informational systems (DNA and RNA). 
Only in this case, it can be avoided that the natural system will become infiltrated by 
information from outside. This also applies to the precursors for the enzymatic synthesis of 
artificial nucleic acids, which means that modified building blocks used for the in vivo 
synthesis of artificial nucleic acids should not enter the cellular metabolic pathways, since it 
may lead to toxicity. One way to realize this is to develop an independent metabolic route for 
chemically modified polymerase substrates. This might be based on the selection of new 
leaving groups for polymerase-catalyzed nucleic acid synthesis. Preferentially, this leaving 
group is metabolically available and can be recycled after the reaction.  
Deoxyadenosine triphosphate analogues where the pyrophosphate moiety is replaced by L-
aspartic acid had previously shown to act as substrates for DNA polymerization catalyzed by 
HIV-1 RT. In the presence of only one carboxylic acid in the leaving group, incorporation is 
observed when a phosphodiester linkage is cleaved during the reaction and not when a 
phosphoramidate bond has to be cleaved. In this case the better leaving group capacity of an 
oxygen linked moiety could compensate for the loss in electrostatic effects. This observation 
is confirmed when using leaving groups with an aromatic character. The difference between 
phtalic acid and isophtalic acid is interesting, and is most probably related to a different way 
that these molecules can be accommodated in the active site of the polymerase. Although the 
results do not surpass those found for L-Asp-dAMP, they contribute to the study of the 
structure-substrate relationship of HIV-1 RT and demonstrate that a variety of leaving groups 
can be used to synthesize DNA in an enzymatic way in place of pyrophosphate.  
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II.4 Experimental section 
II.4.1. General methods 
NMR spectral analyses were carried out on Brucker AvanceTM II 300 MHz or 500 MHz with 
PAXTI probe and recorded at 25°C, unless otherwise specified. The Bruker TopspinTM 2.1 
software was used to process spectra. Chemical shifts are expressed in parts per million (ppm) 
by frequency. 1H- and 13C- NMR chemical shifts are referenced to an internal TMS signal (δ 
= 0.00 ppm), 31P NMR chemical shifts are referenced to an external 85 % H3PO4 standard (δ 
= 0.00 ppm). Standard mass spectra were measured with a Finnigan LCQ DuO (Thermo 
Fischer Scientific) using the electrospray ionization technique (ESI); data were acquired with 
the LAC/E32 system (Waters). Exact mass spectra were obtained with a Q-Tof 2TM 
(Micromass Ltd.) coupled to a CapLCTM system (Waters). Chemicals of analytical or 
synthetic grade were obtained from commercial sources and were used as received 
(deoxyadenosine monophosphate: Sigma Aldrich; palladium on carbon: Aldrich; DCC, 
glycolic acid and zinc chloride: Fluka; N-ethylmorpholine, phtalic acids, tert-butanol, thionyl 
chloride and triethylamine: Acros). Dimethyl or benzyl ester of dicarboxylic acids and were 
either obtained form commercial sources or prepared by methylation after thionyl chloride 
activation. Technical solvents were obtained from Brenntag (Deerlijk, Belgium). Acetonitrile 
HPLC Grade was purchased from Fisher Scientific. Flash silica chromatography was 
performed on Davisil® silica gel 60, 0.040–0.063 mm (Grace Davison). Thin Layer 
Chromatography was performed on Alugram® silica gel UV254 mesh 60, 0.20 mm 
(Macherey-Nagel). Celite® 545 was purchased at VWR international. 
 
II.4.2 General procedure for the synthesis of the ester intermediates  
Synthesis of compounds 1 - 4 
 The example described is for 2'-deoxyadenosine-5'-(5-amino-isophtalic acid dimethyl ester) 
phosphoramidate (intermediate for 2). In a two-neck flask, 2'-deoxyadenosine-5'-O-
monophosphoric acid hydrate (50 mg, 0.14 mmoles), 5-amino-isophtalic acid dimethyl ester 
hydrochloride (245 mg, 1 mmoles, 7 equiv.) and  dicyclohexylcarbodiimide (DCC) (147 mg, 
1 mmol, 7 equiv.) were dissolved under argon in a mixture of tert-butanol (3mL) and H2O 
(1mL). A few drops of triethylamine (Et3N) were added to the solution as hydrochloric acid 
scavenger. The reaction mixture was refluxed for 6 hours while stirring under argon. The 
progress of the reaction was monitored by TLC (iPrOH:H2O:NH3 7:2:1). The reaction mixture 
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was cooled and the solvent was removed by rotary evaporation (37°C). The product was 
isolated by silica column chromatography eluting with CHCl3:MeOH:H2O gradient (5:1:0, 
5:2:0.25, 5:3:0.5) affording the product as a white solid (35  mg, 47% yield). 1H NMR (300 
MHz, D2O): δ 7.97 (s, 1H, H8), 7.94 (s, 1H, HiPA), 7.61 (s, 1H, H2), 7.44 (s, 2H, HiPA), 6.25 
(apparent t, 3JH1'-H2' = 6.6 Hz, 1H, H1'), 4.67 (m, 1H, H3'), 4.32 (m, 1H, H4'), 4.08 (m, 2H, H5'), 
3.9 (s, 6H, CH3), 2.85 (m, 1H, H2'), 2.53 (m, 1H, H2'') ppm. 13C NMR (75 MHz, D2O): δ 
167.8, 154.6, 151 .8, 147.9, 142.4, 139.7, 129.6, 121.7, 121.6, 121.1, 86.1, 83.9, 71.1, 
65.2, 58.8, 52.7, 46.6, 38.2 ppm. 31P NMR (121 MHz, D2O): δ -3.50 ppm. MS (ESI, negative 
ion mode): m/z calculated for C20H23N6O9P: 522.4, found 521.8. 
 
Deprotection of the ester intermediate. The example described is for the synthesis of 2'-
deoxyadenosine-5'-(5-aminoisophtalic acid) phosphoramidate (2). 
A solution (1 mL) of 1.3 M potassium carbonate (K2CO3) in MeOH:H2O 2:1 was added to 2'-
deoxyadenine-5'-(5-aminoisophtalic acid dimethyl ester) phosphoramidate (35 mg, 67 
µmoles) and the reaction was carried out at room temperature while stirring under argon for 4 
hours. The course of the reaction was monitored by TLC iPrOH:H2O:NH3 7:2:1). Once the 
starting material has disappeared, the reaction mixture was neutralized by addition of 2M 
triethylammonium bicarbonate. The solvent was removed under reduced pressure and the 
resulting residue was dried by lyophilisation. The desired product was purified by silica 
column chromatography eluting with (iPrOH:H2O:NH3) gradient. The product was isolated 
and concentrated by lyophilisation to provide a white solid (20 mg, 60%). 1H NMR (300 
MHz, D2O): δ 8.08 (s, 1H, H8), 8.00 (s, 1H, H2), 7.59 (s, 1H, HiPA), 7.31 (s, 2H, HiPA), 6.29 
(apparent t, 3JH1'-H2' = 6.6 Hz, 1H, H1'), 4.55 (m, 1H, H3'), 4.22 (m, 1H, H4'), 4.00 (m, 2H, H5'),  
2.80 (m, 1H, H2'), 2.45 (m, 1H, H2'') ppm. 13C NMR (75 MHz, D2O): δ 172.7, 153.7, 150.4, 
148.0, 141.4, 140.0, 135.1, 121.0, 120.0, 119.9,  85.9, 84.0, 71.0, 64.3, 38.4 ppm. 31P NMR 
(121 MHz, D2O): δ - 0.83 ppm. High res. MS (ESI, negative ion mode): m/z calculated for 
C18H19N6O9P: 494.09511, found: 493.08740. Stability in D2O at r.t.: superior as 24h. 
 
2′-deoxyadenosine-5′-(5-hydroxy-isophtalic acid dimethyl ester) phosphodiester 
(intermediate for 1) 
Yield: 62 mg (79%). 1H NMR (300 MHz, D2O): δ 8.23 (s, 1H, H8), 8.06 (s, 1H, H2), 8.00 (s, 
1H, HiPA)  7.68 (s, 2H, HiPA),  6.40 (apparent t, 3JH1'-H2' = 6.7 Hz, 1H, H1′), 4.4 (m, 1H, H3′), 
4.27 (m, 1H, H4′), 4.00 (m, 2H, H5′), 3.9 (s, 3H, CH3), 3.8 (s, 3H, CH3), 2.90 (m, 1H, H2′), 
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2.56 (m, 1H, H2′) ppm. 13C NMR (75 MHz, D2O): δ 166.9, 151.8, 151.6, 151.6, 139.9, 139.4, 
130.6, 125.4, 125.3, 118.8, 85.9, 83.9, 71.2, 65.9, 52.9, 38.2 ppm. 31P NMR (121 MHz, D2O): 
δ - 5.05 ppm. MS (ESI negative ion mode): m/z calculated for C20H22N5O10P: 523.11043, 
found: 522.1035. 
 
2′-deoxyadenosine-5′-(5-hydroxy-isophtalic acid) phosphodiester (1) 
 Yield: 25 mg (66 %). 1H NMR (300 MHz, D2O): δ 8.23 (s, 1H, H8), 8.1 (s, 1H, H2), 7.7 (s, 
1H, HiPA), 7.6 (s, 2H, HiPA), 6.46 (apparent t, 3JH1'-H2' = 6.7 Hz, 1H, H1′), 4.65 (m, 1H, H3′), 
4.32 (m, 1H, H4′), 4.19 (t, 2H, H5′),  2.84 (m, 1H, H2′), 2.56 (m, 1H, H2′) ppm. 13C NMR (75 
MHz, D2O): δ 173.7, 155.0, 152.0, 151.8, 149.0, 140.6, 137.5, 125.3, 123.4, 119.0, 96.5, 84.7, 
71.8, 66.1, 38.8 ppm. 31P NMR (121 MHz, D2O): δ  - 4.4 ppm. High res. MS (ESI, negative 
ion mode): m/z calculated for C18H19N5O10P: 495.07913 found: 494.0716. Stability in D2O at 
r.t.: superior as 24h. 
 
2′-deoxyadenosine-5′-(4-hydroxy-phtalic acid dimethyl ester) phosphodiester (intermediate 
for 3) 
 Yield: 70 mg (93%). 1H NMR (300 MHz, D2O): δ 8.12 (s, 1H, H8), 8.09, (s, 1H, H2), 7.48 (d, 
1H, HPA), 7.16 (d, 1H, HPA), 7.13 (s, 1H, HPA), 6.4 (apparent t, 3JH1'-H2' = 6.8 Hz, 1H, H1′), 
4.70 (m, 1H, H3′), 4.31 (m, 1H, H4′), 4.21 (m, 2H, H5′), 3.9 (s, 3H, CH3), 3.8 (s, 3H, CH3), 
2.81 (m, 1H, H2′), 2.54 (m, 1H, H2′) ppm. 13C NMR (75 MHz, D2O): δ 169.4, 168.5, 154.3, 
154.2, 150.4, 148.2, 140.2, 133.1, 130.8, 124.7, 122.6, 119.9, 118.4, 85.9, 84.0, 71.0, 65.8, 
53.3, 53.1, 38.5 ppm. 31P NMR (121 MHz, D2O): δ -5.42 ppm. MS (ESI negative ion mode): 
m/z calculated for C20H22N5O10P: 523.4, found 522.3. 
 
2′-deoxyadenosine-5′-(4-hydroxy-phtalic acid) phosphodiester (3) 
 Yield: 25 mg (66%). 1H NMR (300 MHz, D2O): δ 8.32 (s, 1H, H8), 8.21 (s, 1H, H2), 7.33 (d, 
1H, HPA), 7.12 (s, 1H, HPA), 6.92 (d, 1H, HPA), 6.49 (apparent t, 3JH1'-H2' = 6.7 Hz, 1H, H1′), 
4.68 (m, 1H, H3′), 4.30 (m, 1H, H4′), 4.17 (m, 2H, H5′),  2.88 (m, 1H, H2′), 2.61 (m, 1H, H2′) 
ppm. 13C NMR (125 MHz, D2O): δ 181.3, 178.3, 175.8, 175.2, 155.0, 152.1, 151.8, 148.4, 
139.5, 131.5, 129.2, 119.2, 118.3, 85.6, 83.9, 71.2, 65.7, 38.6 ppm. 31P NMR (121 MHz, 
D2O): δ -4.6 ppm. High res. MS (ESI positive ion mode): m/z calculated for C18H19N6O9P: 
496.0864, found: 496.8296. Stability in D2O at r.t.: superior as 24h. 
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2′-deoxyadenosine-5′- β-alanine phosphoramidate methyl ester (intermediate for 4) 
 Yield: 172 mg (81%). 1H NMR (500 MHz, CD3OD): δ 8.5 (s, 1H, H8); 8.2 (s, 1H, H2); 6.5 
(apparent t, 3JH1'-H2' = 7.0 Hz, 1H, H1′); 4.7 (m, 1H, H3′); 4.2 (m, 1H, H4′); 4.08-3.98 (m, 2H, 
H5′); 3.64 (s, 3H, -O-CH3); 3.14-3.10 (m, 2H, CH2β); 2.84-2.80 (m, 1H, H2′); 2.47-2.45 (m, 
3H, H2′, CH2α) ppm. 13C NMR (125 MHz, CD3OD): δ 173.3, 155.9, 152.4, 149.0, 139.7, 
118.7, 86.6, 83.9, 71.7, 64.1, 50.6, 39.9, 37.2, 35.9 ppm.  31P NMR (202 MHz, CD3OD): δ 
7.53 ppm.  High res. MS (ESI negative ion mode): m/z calculated for C14H21N6O7P: 
416.1209, found: 415.1127. 
 
2′-deoxyadenosine-5′- β-alanine phosphoramidate (4) 
 Yield: 15 mg (87%). 1H NMR (500 MHz, D2O): δ 8.2 (s, 1H, H8), 7.8 (s, 1H, H2), 6.2 
(apparent t, 3JH1'-H2' = 6.7 Hz, 1H, H1′), 4.6 (m, 1H, H3′), 4.1 (m, 1H, H4′), 3.8 (m, 2H, H5′), 2.8 
(m, 2H, CH2β), 2.7 (m, 1H, H2′), 2.5 (m, 1H, H2′), 2.1 (t, JHα-Hβ = 6.0 Hz, 2H, CH2α) ppm. 13C 
NMR (125 MHz, D2O): δ 178.1, 154.3, 151.0, 148.3, 140.0, 118.7, 85.7, 83.5, 70.9, 63.6, 38.5 
(2C), 37.1 ppm. 31P NMR (202 MHz, D2O): δ 8.75 ppm. High res. MS (ESI negative ion 
mode): m/z calculated for C13H19N6O7P: 402.10528, found: 401.0977. Stability in D2O at r.t.: 
superior as 24h. 
 
2′-deoxyadenosine-5′-O-monophosphate imidazolate 
A mixture of dAMP (100 mg, 0.3 mmoles), dithiopyridine (211 mg, 0.96 mmoles 3.2 eq.), 
triphenylphosphine (327 mg, 0.96 mmoles, 3.2 eq.) and imidazole (327 mg, 4.8 mmoles, 16 
eq.) was dried under high vacuum for 30 minutes. Subsequent dissolution in anhydrous 
DMSO (3.5 mL) under argon atmosphere afforded a clear yellow solution. Triethylamine (95 
µL, 0.7 mmoles, 2.3 eq.) was added via a syringe and the resulting solution stirred at room 
temperature for 4 hours. It was then dropped in a -20°C 0.1M sodium iodide solution in dry 
acetone and allowed to precipitate for 15 minutes. Filtration of the resulting suspension and 
repeated washing thereof with cold dry acetone afforded a white solid. Further drying on 
POCl3 under HV afforded quantitative yield of dAMP-imidazolide (110 mg, 96%). 
1H NMR (300 MHz, D2O, 5°C): δ 8.21 (s, 1H, H8), 8.20 (s, 1H, H2), 7.7 (s, 1H, HIm), 7.0 (s, 
1H, HIm), 6.8 (s, 1H, HIm), 6.4 (apparent t, 3JH1'-H2' = 6.41 Hz, 1H, H1′), 4.6 (m, 1H, H3′), 4.2 
(m, 1H, H4′), 4.0 (m, 2H, H5′), 2.9 (m, 1H, H2′), 2.6 (m, 1H, H2′) ppm. 31P NMR (121 MHz, 
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D2O): δ -8.01 ppm. High res. MS (ESI negative ion mode): calculated for C13H16N7O5P: 
381.0951, found: 380.0869. Stability in D2O at r.t.: 10% hydrolysis after 12h. 
 
 2'-deoxyadenosine-5'-(glycolic acid) phosphodiester (5) 
A solution of 2’-deoxyadenosine-5’-O-monophosphate imidazolate (20 mg, 50 µmoles), 
hydroxyacetic acid (7.6 mg, 100 µmole, 2 equiv.), zinc chloride (7 mg, 50 µmoles, 1 equiv.) 
in N-ethylmorpholine aqueous buffer 0.2 M (2 mL, pH 7.5) was stirred under argon at room 
temperature for 1 day. The reaction was monitored by TLC (iPrOH:H2O:NH3 7:2:1),  
quenched with an EDTA (ethylenediaminetetraacetic acid) 0.25 M solution in order to break-
down the nucleotide-metal complex, and finally lyophilized affording a white solid (42%).  
The product was isolated after HPLC purification on a PLRP-S column (100 Å 8 µm, 300x7.5 
mm, Polymer Laboratories) running a gradient of acetonitrile in 50 mM triethylammonium 
acetate buffer. Yield 41% (from HPLC purification profile). 1H NMR (300 MHz, D2O, 5°C): 
δ 8.4 (s, 1H, H8), 8.1 (s, 1H, H2), 6.4 (apparent t, 3JH1'-H2' = 6.8 Hz, 1H, H1′), 4.5 (m, 1H, H3′), 
4.2 (m, 1H, H4′), 4.1 (s, 2H, CH2), 3.9 (m, 2H, H5’), 2.8 (m, 2H, CH2α), 2.7 (m, 1H, H2′), 2.5 
(m, 1H, H2′) ppm. 13C NMR (125 MHz, D2O): δ 180.3, 155.8, 152.8, 148.93, 140.22, 118.8, 
86.5, 84.0, 71.8, 64.6, 54.1, 39.5 ppm. 31P NMR (121 MHz, D2O): δ 1.44 ppm. High res. MS 
(ESI negative ion mode): m/z calculated for C12H16N5O8P: 389.07365, found: 388.0652. 
Stability in D2O at r.t.: 12h. Unstable in RTRB. 
 
5′,5′-Diphosphate-2′,2′-dideoxyadenosine (dAppdA) 
Purified on C18 HPLC (Alltima® C18 column (5µm, 250x10mm, GRACE) eluted at 25% 
TEAA 50mm. 1H NMR (300 MHz, D2O, 25°C): δ 8.07 (s, 1H, H8), 7.92 (s, 1H, H2), 6.20 
(apparent t, 3JH1'-H2' = 6.21 Hz, 1H, H1′), 4.55 (m, 1H, H3′), 4.13 (m, 3H, H4′&H5′), 2.50 (m, 
1H, H2′), 2.43 (m, 1H, H2′) ppm. 13C NMR (125 MHz, D2O): δ 155.06, 152.64, 148.36, 
140.06, 118.40, 86.52, 84.35, 71.24, 66.00, 40.04 ppm. 31P NMR (121 MHz, D2O): δ -11.23 
ppm. HRMS (ESI, negative ion mode): m/z calculated for C20H25N10O11P2-: 643.1185, found: 
643.1183. Stable in D2O at r.t. 
 
2′-deoxyadenosine-5′-(γ-hydroxypropionic acid benzyl ester) phosphodiester (intermediate 
for 6) 
 Yield: 94 mg (68%). 1H NMR (300 MHz, D2O): δ 8.21 (s, 1H, H8), 8.02 (s, 1H, H2), 7.12 (m, 
5H, Ph), 6.29 (m, 1H, H1'), 4.91 (s, 2H, PhCH2), 4.55 (m, 1H, H3'), 4.12 (m, 1H, H4'), 4.95 (m, 
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2H, H5'), 3.87 (m, 2H, γ-CH2), 2.55 (m, 3H, H2'a and  β-CH2), 2.44 (m, 1H, H2'b). 13C NMR 
(75 MHz, D2O): δ 173.22, 155.32, 152.48, 148.41, 139.48, 135.13, 128.40 (2C), 128.03, 
127.27 (2C), 118.52, 85.68, 83.69, 71.05, 66.69, 65.05, 61.43, 39.11, 35.42 ppm. 31P NMR 
(121 MHz, D2O): δ 0.029 ppm. High res. MS (ESI, negative ion mode): m/z calculated for 
C20H24N5O8P: 493.1363, found: 492.1281. 
 
2′-deoxyadenosine-5′-(γ-hydroxypropionic acid) phosphodiester (6) 
A mixture of 2′-deoxyadenosine-5’-(3-hydroxypropionic acid benzyl ester) phosphodiester 
(40 mg, 0.0811 mmoles) and 10% palladium on activated carbon (35 mg, 0.0331 mmoles) in 
methanol (10 mL) was stirred under hydrogen atmosphere at room temperature for 1.5h. The 
progress of the reaction was monitored by TLC (iPrOH:H2O:NH3 7:1:2). The catalyst was 
filtered off on Celite® and the filtrate was concentrated to dryness in vacuum. The residue 
was redissolved in H2O, and lyophilized affording the product as a white solid (29 mg, 89% 
yield). 1H NMR (300 MHz, D2O): δ 8.34 (s, 1H), 8.15 (s, 1H), 6.42 (apparent t, 1H, 3JH1'-H2' = 
6.78Hz, H1'), 4.64 (m, 1H, H3'), 4.19 (m, 1H, H4'), 3.94 (m, 2H, H5'), 3.86 (dd, 2H, 3Jγ-β = 
6.4Hz, 2Jγ1-γ2 = 12.78Hz, γ-CH2O), 2.75 (m, 1H, H2'a), 2.53 (m, 1H, H2'b), 2.32 (apparent t, 2H, 
3Jγ-β = 6.4Hz, β-CH2) ppm. 13C NMR (75 MHz, D2O): δ 179.29, 155.22, 152.34, 148.40, 
139.39, 118.27, 85.43, 83.31, 70.81, 64.52, 62.80, 38.56, 38.16 ppm. 31P NMR (121 MHz, 
D2O): δ 0.271 ppm. High res. MS (ESI, negative ion mode): m/z calculated for C13H18N5O8P: 
403.0893 Found: 402.0817. Stability in D2O at r.t.: superior as 24h. Unstable in RTRB. 
II.4.3 Enzymatic reactions 
DNA duplexes Oligodeoxyribonucleotides P1 and T1 were purchased from Sigma Genosys. 
The concentrations were determined with a Varian Cary-300-Bio UV Spectrophotometer. The 
lyophilized oligonucleotides were dissolved in diethylpyrocarbonate (DEPC)-treated water 
and stored at -20°C. The primer oligonucleotides were 5'-33P-labeled with 5’-[γ33P]-ATP 
(Perkin Elmer) using T4 polynucleotide kinase (New England Biolabs) according to the 
procedure provided by the supplier. The labeled oligonucleotide was further purified using 
IllustraTM MicrospinTM G-25 columns (GE Healthcare). 
 
DNA polymerase reactions: All incorporation and elongation reactions reported in this 
manuscript were duplicated, unless otherwise specified; tripliquets were realized in case of 
conflicting results and in order to assess the reproducibility of the results. For the 
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incorporation of 1, 2, 3, 4, 5 and 6, a series of batch reactions (20 µL) was performed with the 
enzyme HIV-1 RT (Ambion, 10 U/µL stock solution, specific activity 8.095 U/mg, 
concentration 1.2 mg/mL). The final mixture contained 125 nM primer template complex, RT 
buffer (250 mM Tris.HCl, 250 mM KCl, 50 mM MgCl2, 2.5 mM spermidine, 50 mM 
dithiothreitol; pH 8.3), 0.025 U/µL HIV-1 RT , and different concentrations of 
phosphoramidate or phosphodiester building blocks (1 mM, 500 µM, 200 µM and 100 µM). 
In the case of the aromatic analogues 1 and 3, 1 mM was the only concentration tested. In the 
control reaction with the natural nucleotide, a 10 µM dATP concentration was used. The 
mixture was incubated at 37°C and aliquots (2.5 µL) were quenched after 5, 10, 20, 30 and 60 
min. 
 
Steady-state kinetics of single nucleotide incorporation: The steady-state kinetics of single 
nucleotide incorporation of the iminodiacetate phosphoramidate 1 (IDA-dAMP) and of a 
natural nucleoside triphosphate (dATP) was determined by gel-based polymerase assay. All 
kinetic reactions reported in this manuscript were carried out at least five times in order to 
obtain satisfying reproducibility (for discussion of the reproducibility of the results, see 
chapter VI). In all the experiments, the template T1 and the primer P1 were used. The primer 
and template in 1:2 molar ratio were hybridised in a buffer containing 20 mM Tris.HCl, 10 
mM KCl, 2 mM MgSO4, 0.1% Triton X-100, pH 8.3 and used in an amount to provide 125 
nM concentration of the primer in each reaction (20 µL). The range of concentrations for 
iminodiacetate dAMP was optimized according to a KM value for the incorporation of an 
individual nucleotide. In the case of HIV-1 RT (Ambion, 10 U/µL), reaction mixtures 
containing the enzyme in 0.025 U/µL concentration and appropriate substrate concentration to 
attain 5-25 % conversion (nucleoside phosphoramidate or natural  dATP) were incubated at 
37°C and run for 8 different time intervals. The reaction aliquots were quenched as described 
in chapter II. 
 
II.4.4 Polyacrylamide gel electrophoresis 
All polymerase reaction aliquots (2.5 µL) were quenched by the addition of loading buffer (10 
µL, 90% formamide, 0.05% bromophenol blue, 0.05% xylene cyanol and 50 mM EDTA). 
Samples were heated at 85°C for 3-4 minutes prior to analysis by electrophoresis for 2.5 h at 
2000 V on a  30 cm x 40 cm x 0.4 mm 20% (19:1 mono:bis) denaturing gel in the presence of 
a 100 mM Tris-borate, 2.5 mM EDTA buffer (pH 8.3). Products were visualized by 
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phosphorimaging. The amount of radioactivity in the bands corresponding to the products of 
enzymatic reactions was determined by using the imaging device Cyclone® and the 
associated Optiquant® image analysis software (Perkin Elmer). 
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III. Chapter three: Influence of the linkage between leaving 
group and nucleoside on incorporation efficiency  
 
Part of the results reported in this chapter was published in ChemBioChem in 2010 under the 
title ‘Influence of the linkage between leaving group and nucleoside on incorporation 
efficiency in DNA catalyzed by reverse transcriptase’: Giraut A., Herdewijn P. (2010), 
Chembiochem 11, 1399-1403. 
 
III.1. Introduction 
 
Deoxynucleotide incorporation catalyzed by polymerases is a complex event where chemical 
reactions rates (91), protein conformation dynamics (92), and stability of successive 
complexes between dsDNA, enzyme and substrate  are some of the most important features 
(17;93).  In order to study the mechanism of polymerization, several approaches are possible 
(3;12). One of them consists in introducing modifications in the natural substrates of 
polymerases (deox)nucleoside triphosphates ((d)NTP) and analysing their effect on the 
deoxynucleotide incorporation efficiency (17;84;94). Sucato et al. have investigated the 
influence of the bridging oxygen of the leaving group on nucleotide incorporation by DNA 
polymerase β (70;71). The bridging oxygen of pyrophosphate (PPi) was replaced by a halogen 
substituted methylene. The replacement of pyrophosphate by such biphosphonic acids 
affected the catalytic efficiency and fidelity of nucleotide incorporation by this polymerase. 
We propose to study the effect of replacing pyrophosphate by structurally different mimics. 
In the previous chapter, the qualitative observation was made that the outcome of single 
nucleotide incorporation reaction by HIV-1 RT is improved when a phosphoramidate linkage 
is replaced by a phosphodiester linkage. In view of a synthetic biology project to develop 
orthogonal chemistry for the synthesis of artificial nucleic acids, the pyrophosphate leaving 
group has been replaced by a completely different molecule. For example, as previously 
observed, L-aspartic acid-dAMP (1) and L-histidine-dAMP (2) (Figure III.1) are recognized 
by HIV-1 RT for nucleotide incorporation: L-Asp-dAMP and L-His-dAMP incorporation 
results in the formation of 80-90% and 50-60%, respectively, of primer+1 (P+1) product at 
0.5 mM substrate concentration and 120 min reaction time. With both substrates however, 
templated strand elongation of up to 6 nucleotides was only moderately successful (82). 
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Pausing and 90% of termination of DNA synthesis were observed after incorporation of two 
or three nucleotides for both L-His- and L-Asp-dAMP.  The study presented in chapter two 
performed with non-amino-acid-based analogues showed that a phosphodiester linkage was 
easier to cleave by the enzyme than its phosphoramidate counterpart. Therefore we proposed 
to synthesize the corresponding phosphodiesters, i.e. L-malic acid- and L-β-imidazole lactic 
acid- deoxyadenosine monophosphates (L-MA-dAMP 3 and L-ILA-dAMP 4, resp., Figure 
III.1). 
P
O
NO
N
N
OH
N
NH2
O
OH
X
O
OH
NHN
P
O
NO
N
N
OH
N
NH2
O
OH
X
O
OH
O
OH
P
O
NO
N
N
OH
N
NH2
O
OH
X=NH L-aspartic acid dAMP (1)
X=O L-malic acid dAMP (3) X=NH L-histidine dAMP (2)X=O L-β-imidazole lactic acid dAMP (4)
Deoxyadenosine triphosphate
OPOPHO
O
OH
O
OH
 
Figure III.1: Chemical structures of dATP, L-Asp-dAMP 1, L-malic acid dAMP 3, L-
histidine-dAMP 2 and L-β-imidazole-lactic acid dAMP 4. 
 
III.2. Results 
III.2.1 Synthesis of the phosphoramidate analogue 
The synthesis of the phosphoramidate L-His-dAMP was performed as described by 
Adelfinskaya et al. following a dicyclohexylcarbodiimide coupling procedure and subsequent 
deprotection of the carboxylic acid function in basic conditions (81).  
 
III.2.2 Synthesis of the phosphodiester analogues 
Diverse phosphate coupling methods were investigated for this purpose, starting with the 
straightforward and good yielding phosphite triester or phosphoramidite method (95). This 
methodology mostly makes use of cyanoethyl as protecting group for the phosphate (96;97), 
final phosphate deprotection being carried out in concentrated ammonia. In order to be able to 
carry out the final deprotection in mild conditions we opted for benzyl as phosphate 
protecting group. In a preliminary approach carried out by a former member of the laboratory 
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(shown in scheme III.1), deoxyadenosine was phosphorylated with a diisopropylamino 
substituted, benzyl protected phosphorous chloride in the presence of DIPEA(98), resulting in 
the formation of a phosphoramidite (intermediate 5). Activation of the phosphate by tetrazole 
allowed nucleophilic attack by the hydroxyl group of malic acid, oxidation with iodine in the 
presence of water and pyridine yielded the desired phosphotriester 6. 
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Scheme III.1: Synthesis of malic acid dAMP via benzyl protected phosphoramidite approach: 
a) benzyloxydiisopropylamino chlorophosphite, DIPEA, anh. acetonitrile; b) tetrazole, 
dimethyl ester L-malic acid ; acetonitrile anh.; c) iodine solution in pyridine, THF, water ; d) 
potassium bicarbonate, methanol, water ; e) palladium on carbon, activated, methanol. 
 
Mild basic treatment of 6 to remove of the carboxylate protecting methyl esters resulted in 
complete hydrolysis of the compound. As a consequence, we chose to protect the dicarboxylic 
acid with benzyl moieties, allowing a milder final deprotection reaction. Unfortunately, 
confronted to the bulky dibenzylated malic acid, 5 proved unable to serve as electrophilic 
centre, probably due to steric hindrance. The more reactive diethylamino phosphorous 
chloride or the stronger activation reagent, pyridinium trifluoroacetate were employed to 
enhance the electrophilicity of the phosphorous in the first or the second step, respectively; no 
evidence of coupling was found. The steric hindrance of the phosphate protecting benzyl 
group was probably a reason for this lack of success, since cyanoethyl protected 
phosphoramidite chemistry was successful in yielding the phosphotriester (results not shown).  
 
Hence, we decided to prepare the phosphoramidite reagent from benzylated malic acid and 
react it with the more nucleophilic 5′-hydroxyl of deoxyadenosine, as shown in scheme III.2. 
The benzyloxycarbonyl group (Cbz), cleavable by hydrogenation, was chosen to protect the 
3′-hydroxyl group (99). Transient tert-butylsilyl protection of the 5′-OH of deoxyadenosine 
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(compound 10) followed by benzyloxycarbonylation of the 3′-OH (compound 11) and final 
fluoride deprotection of the 5′-OH was adapted from published procedures (99), affording 3′-
O-Cbz-2′-deoxyadenosine 12. Hereto, malic acid was benzylated under acidic conditions 
(compound 8). The phosphorous chloride specie 7 was prepared in a one-pot synthesis, during 
which substitution of one chloride by benzyl alcohol group was followed by the substitution 
of the second chloride with a diisopropylamino group. Key step phosphorous coupling to 8 
was done in dry acetonitrile in the presence of diisopropylethylamine (DIPEA) to afford 
phosphoramidate 9. 31P NMR showed the expected doublet signal around 150 ppm, indicating 
the presence of a phosphoramidite species. Subsequent nucleophilic attack of the 5’ hydroxyl 
group of 3ʹ-Cbz-dA afforded the desired phosphittriester. Standard iodine oxidation in 
presence of pyridine only led to isolation of the benzyl protected monophosphate of Cbz-dA, 
suggesting that the phosphittriester or the phosphotriester species was formed and further 
degraded. Tert-butylperoxide oxidation carried out in a mixture of decane and 
dichloromethane as developed by Hayakawa (21) could prevent this rapid degradation  and 
afforded the desired phosphotriester 13 in small amounts. 31P NMR analysis showed a typical 
diastereoisomeric mixture profile (doublet with approx. -2 ppm shift). Hydrogenation in 
presence of palladium on carbon afforded the desired phosphodiester 3. Unfortunately the 
time spent in solution for characterization purposes led to phosphodiester cleavage. 
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Scheme III.2: Synthesis of 3 via phosphite triester approach: a) Benzyl alcohol, p-
TsOH, toluene, reflux; b) DIPA, diethylether, anhydrous, 0°C; c) benzyl alcohol, anhydrous; 
d) DIPEA, 8, acetronitrile, anhydrous, 0°C; e) tert-butyldimethylsilyl chloride, pyridine anh., 
rt; f) benzylchloroformate, pyridine, anh g) triethylammonium hydrogen fluoride, N-methyl 
pyrrolidone, triethylamine, rt; h) tetrazole 8, dichloromethane, distilled, rt; i) ter-BuOOH, 
decane, dichloromethane, 0°C ; j) hydrogen, palladium on carbon, activated, ethanol, rt. 
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Simultaneously and in the hope for a more successful coupling between benzylated 
malic acid phosphate and deoxyadenosine, the H-phosphonate coupling strategy was explored 
and is described in scheme III.3.  The H-phosphonate of alcohol 8, compound 14, was 
obtained via pivaloyl chloride activation in the presence of pyridine, adapting the approach 
developed by the Stawinski group (100). An additional equivalent of pivaloyl chloride 
promoted the coupling to deoxyadenosine (101). Presence of the benzyl and 
benzyloxycarbonyl protected compound 15 was witnessed by 31P and mass spectrometry. 
Unfortunately, numerous precautions in order to prevent product degradation were 
unsuccessful before or after hydrogenation of the benzyl groups. 
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Scheme III.3: H-phosphonate chemistry starting with dibenzylated malic acid: a) phosphonic 
acid, pivaloyl chloride, pyridine, anhydrous, 0°C; b) triethylammonium carbonate solution 
1M, r.t.; c) 12, pivaloyl chloride, pyridine, anhydrous, 0°C; d) tert-butyl peroxide in decane 
6.0 M, 0°C; e) hydrogen, Patm, palladium on carbon, activated, ethanol, r.t.. Bn = benzyl Cbz = 
benzyloxycarbonyl. 
 
Stability studies carried out on amino acid dAMP phosphoramidates by Dr. 
Dyubankova in the laboratory for medicinal chemistry showed that thymidine analogues 
presented with higher half life in solution (Herdewijn, unpublished results). The thymidine 
analogue malic acid dTMP (20) was therefore synthesized resorting to an identical H-
phosphonate synthetic route (Scheme III.4). Rapid degradation of 20 (towards the benzyl 
phosphodiester of dTMP) occurred during and/or after the final hydrogenolysis step. In 
summary, the phosphodiester linkage involving malic acid proved to undergo hydrolysis too 
rapidly and could therefore not be used for in vitro testing. 
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Scheme III.4: Synthesis of the thymidine analogue via phosphite triester approach : a) 
tertbutyldimethylsilyl chloride, pyridine anhydrous ; b) benzylchloroformate, pyridine, 
anhydrous c) triethylammonium hydrogen fluoride, THF ; d) tetrazole, 8, dichloromethane 
distilled; e) hydrogen, palladium on carbon activated, ethanol. 
 
Since L-β-imidazole lactic acid-dAMP 4 features an imidazole group in place of a carboxylic 
acid function in β position of the linking atom, it was reasoned that it could be potentially 
more stable than L-malic acid dAMP 3 towards hydrolysis. The divalent cation assisted 
coupling proposed by Sawai was used to synthesize the new candidate (Scheme III.5) (85). 
Starting reagent dAMP imidazolate 16 was prepared as described in chapter II. Due to the 
additional formation of a diphosphate species and simultaneous solvolysis, the desired 
product could be obtained only in moderate yield (50%) after ion exchange chromatography. 
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Scheme III.5:  Synthesis of L-β-imidazole-lactic acid dAMP: a) zinc chloride, N-ethyl 
morpholine buffer pH 7.5. 
 
III.2.3 Single incorporation experiments 
As for the series of analogues presented in chapter two, we evaluated 2 and 4 as substrates of 
HIV-1 reverse transcriptase for nucleotide incorporation into a dsDNA duplex. Previous 
experiments carried out with the L-aspartic acid and L-histidine phosphoramidates of dAMP 
demonstrated that these amino acids were acceptable leaving groups for the polymerase in the 
nucleotidyl insertion process.  
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Here we evaluated the capacity of HIV-1 RT to recognize and incorporate a deoxyadenosine 
nucleotide into the primer-template duplex P1:T1 (Table 1) when the pyrophosphate group is 
replaced by L-β-imidazole-lactic acid as compared to L-His- and natural PPi. Incorporation 
efficiency was analyzed by the polyacrylamide gel-based single nucleotide incorporation 
assay (87;88).  
 
Table III.1. Overview of the primer-template duplexes used in the DNA polymerase 
reactions. Bold letters indicate the template overhang in the hybridized primer-
template duplex. 
Single nucleotide incorporation and kinetic experiments 
P1 
T1 
5'-CAGGAAACAGCTATGAC-3' 
3'-GTCCTTTGTCGATACTGTCCC-5' 
Elongation experiments 
T2 3'-GTCCTTTGTCGATACTGTTTTTTTGGAC-5' 
 
Replacement of the nitrogen (in L-His-dAMP 2) by an oxygen atom (in L-ILA-dAMP 4) 
resulted in improved single incorporation. Using L-ILA-dAMP as a substrate we observed up 
to 60% of extended primer at 0.5 mM, whereas with L-His-dAMP the incorporation only 
yielded 50% of extended primer (Figure III.3). Surprisingly, for 4 we observed better 
incorporation at 5- and 10-fold lower concentrations (at a 100 µM deoxynucleotide 
concentration, conversion of a primer to a (P+1) strand ranged from 80% to completion in 20 
min (Figure III.4) (102).  
 
Figure III.3: Profile of incorporation of dAMP into P1:T1 by HIV-1 reverse transcriptase 
using L-ILA-dAMP 4 (500 µM), L-His-dAMP 2 (500 µM) and dATP (10 µM) as substrates. 
Aliquots were drawn between 10 and 120 minutes. 
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Figure III.4: Profile of incorporation of dAMP into P1:T1 by HIV-1 reverse transcriptase 
using ILA-dAMP 4 as substrate at 500 and 1000 µM (left panel) and at 50 and 100 µM (right 
panel) concentrations. Aliquots were drawn between 10 and 60 minutes. 
 
These results suggested that the reaction could be inhibited by the substrate L-ILA-
dAMP. Incorporation efficiency was plotted in function of substrate concentration for two 
different enzyme concentrations (0.025 U/µL, graphic III.1A and 0.0063 U/µL, III.B). All 
profiles showed a decrease in incorporation efficiency for substrate concentrations above 200 
µM, supporting a substrate inhibition eventuality. An accurate determination of inhibition 
parameters could be done to confirm this hypothesis by plotting KM in function of the 
substrate concentration, but such fundamental investigation is not the purpose of our study. 
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Graphic III.1: Incorporation efficiency (as % of elongated primer) measured at 5 and 60 min 
reaction time in function of substrate concentration for 4 A) 0.025 U/µL and B) 0.0063 U/µL 
HIV-1 RT (Ambion, specific activity 11.700 U/mg). 
 
Therefore, we compared both substrates at lower concentrations, to fall out of the range of 
possible substrate inhibition concentrations (approximately 0.25 mM). At 125 and 250 µM 
(Figure III.5), incorporation with 4 was more efficient (40% (P+1)) than with L-His-dAMP 
(17% (P+1)). 
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Figure III.5: (From l. to r.) incorporation of L-ILA-dAMP 4 (250 and 125 µM), L-His-dAMP 
2 (250 and 125 µM) and dATP (10 µM) into P1T1 by HIV-1 reverse transcriptase. Aliquots 
were drawn between 10 and 120 minutes. 
 
III.2.4 Elongation experiments 
Afterwards, we evaluated L-His-dAMP and L-ILA-dAMP as substrates for primer elongation 
using the primer-template duplex P1:T2 (Table III.1). Elongation efficiency was somewhat 
better with L-ILA-dAMP as substrate (Figure III.6). Nevertheless, complete strand elongation 
could not be obtained for either triphosphate mimic at 0.1 mM substrate concentration, nor 
could it at 0.5 mM substrate concentration (picture not shown). 
 
Figure III.6: Elongation of duplex P1:T2 with L-His-dAMP and L-ILA-dAMP at 100 µM 
concentration and reference compound dATP at 10 µM by HIV-1 RT (Ambion, specific 
activity 11.700 U.mg-1). Aliquots were drawn at 30, 60, 90 and 120 minutes. 
 
The premature termination of DNA synthesis can have many causes. Since stalling of HIV-1 
RT is observed for both L-His- and L-ILA-dAMP, it cannot be attributed to the nature of the 
linkage. It is more likely due to the properties of the leaving group. Elongation tests involving 
a different leaving group, such as iminodiacetic acid, linked via a P-N bond to dAMP (IDA-
dAMP, figure III.7. See corresponding study in chapter IV) resulted in a reduced stalling of 
the polymerase. With IDA-dAMP as substrate the full-length oligonucleotide could be 
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obtained as one of the major products, supporting a leaving group induced pausing hypothesis 
(see Chapter IV). 
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Figure III.7: Molecular structure of iminodiacetic acid dAMP 
 
DNA synthesis termination could also be inherent to the nucleotide sequence. Several 
polymerases are known for pausing and strand termination when encountering hairpin 
structures (for example HIV-1 RT (103)), or sequences such as pyrimidine-GC motifs (T7 
DNA polymerase (104)), repeated trinucleotides sequences (Pol I) (105;106) and 
poly(T)/poly(dA) sequences (HIV-1 RT (107)). The use of a poly(T) template for evaluation 
of poly(A) incorporation could therefore account for the decrease in elongation efficiency 
when using unusual substrates like L-ILA-, L-His- and L-Asp-dAMP. This hypothesis could 
be challenged by confronting this incorporation system with upstream and downstream 
differing dsDNA duplexes. 
On the other hand, the polymerization reaction is generally thought to be driven forward by 
the hydrolysis of the PPi leaving group (3;93). Yin and Steitz suggested that the absence of 
the energetically rewarding hydrolysis of PPi might be responsible for less efficient and less 
selective nucleotide incorporation by T7 RNA polymerase (108). Using a non hydrolysable β-
imidazole lactic acid instead of PPi could therefore be another cause for the decreased 
catalytic efficiency of HIV-1 RT. In other terms, the absence of released PPi and associated 
'cellular energy’ in the mechanism might account for the loss of processivity and/or efficiency 
of reverse transcriptase. In order to explore this lead, additional elongation experiments were 
performed. Temperature modulation was excluded since experimentation temperature is fixed 
as the optimal working temperature of the enzyme, in our case 37°C.  Therefore, elongation 
reactions were performed in the presence an ‘external’ source of pyrophosphate (PPi, ATP or 
dATP) in various micromolar concentrations. Introduction of PPi or ATP at time zero or after 
60 minutes reaction did not allow DNA synthesis to resume. If their presence promoted the 
reverse reaction (pyrophosphorolysis of the preceding 3’ nucleotide), the corresponding 
kinetic equilibrium was too rapid to be visible with our imaging method. When the natural 
substrate of the enzyme dATP was introduced after 60 minutes reaction with the modified 
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substrate, chain elongation resumed, proving that reverse transcriptase retained the ability to 
elongate a primer strand in standard conditions.  
III.2.5 Kinetic experiments 
Maximum velocity of the reaction (Vmax), affinity (KM) and efficiency (VMax/KM) of the 
triphosphate analogues as substrates for HIV-1 RT were determined on the basis of the single 
completed hit model and are presented in Table III.2. P1 and T1 were used respectively as 
primer and template DNA strands (Table III.1).  
 
Table III.1. Kinetic parameters of the incorporation of dAMP into P1T1 by HIV-1 RT 
DNA polymerase at 0.0063 U/µL (dATP and ILA-dAMP) or 0.025 U/µL (L-His-dAMP) 
 linkage 
KM 
[µM] 
Vmax 
[pmol.U-1.min-1] 
Vmax/KM 
Substrate efficiency 
dATP ref 0.48 ± 0.13 5.114 ± 0.397 10.65 
L-His-dAMP  P-N  505.0 ± 114.8 0.330 ± 0.033 0.0007 
ILA-dAMP  P-O 204.7 ± 30.8 2.746 ± 0.144 0.013 
 
Both dNTP analogues were processed by HIV-1 RT and displayed a Michaelis-Menten 
kinetic profile. In the case of structurally identical side chains, the replacement of the linking 
nitrogen by an oxygen atom appeared to have two beneficial effects: substrate affinity was 
doubled and maximum velocity was increased by a factor 10. In other terms, during 
incorporation a phosphodiester linkage is being more efficiently cleaved by HIV-1 RT than a 
phosphoramidate linkage. This is consistent with the incorporation results obtained with the 
series of non-amino-acid-like candidates (Chapter II). Changing the nature of this linkage is 
therefore a way to modulate the kinetic parameters of the leaving group release reaction and 
can be taken in account for the design of other alternative leaving group candidates. However, 
implementation of this concept on pre-existing successful phosphoramidate analogues is 
likely to be limited by stability issues, as observed for the L-malic acid dAMP, 
phosphodiester analogue of L-aspartic acid dAMP. 
III.2.6 Exploration of other possible linkages 
 
As mentioned in table I.2, other chemical entities such as sulphur (in C-S-P) and 
methylamine (in C-N(CH3)-P) are isosteric to NH in the linkage between phosphorous atom 
and carbon atom. The methyl amino analogue of L-Asp-dAMP (figure III.8) was previously 
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synthesized and tested for enzymatic incorporation by HIV-1 RT (83). Unfortunately, this 
deoxynucleoside triphosphate analogue was not processed by the enzyme in the usual test 
conditions.  
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Figure III.8: Chemical structure of N-Methyl-(L-) aspartic acid dAMP phosphoramidate. 
 
The sulphur analogues of β-Ala-dAMP (Chapter II, compound 4), glycolic acid-dAMP 
(ibid., compound 5) and L-Asp-dAMP are presented in figure III.9.  
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Figure III.9: Chemical structures of: (from left to right) DL-thiomalic acid, analogue of 
DL-Asp-dAMP; thiopropionic acid-dAMP (analogue of 4) and thioacetic acid-dAMP 
(analogue of 5). 
 
Attempts to synthesize these dAMP phosphorothioates were made resorting to both 
DCC coupling and divalent cation assisted coupling procedures, with commercially available 
thiol compounds. With both procedures presence of the dimer dAppdA was immediately 
witnessed (Figure III.10), and no evidence of formation of the phosphorothioate analogues 
was found by the usual analytic methods. This absence could be explained by rapid 
dimerization of dAMP imidazolide, as already observed during the synthesis of GA-dAMP 5 
(see scheme II.5). It is also possible that the phosphorothioate species is formed as an instable 
intermediate and functions as an activated dAMP. In other words, the thiolate groups seem to 
be to good leaving groups to allow isolation of the corresponding dAMP phosphorothioate 
analogues. 
 
III.3 Discussion 
 
In order to evaluate the influence of the nature of the leaving group connecting atom on the 
kinetics of deoxyadenosine monophosphate incorporation by DNA polymerases, the 
III. Chapter three: Influence of the linkage between leaving group and nucleoside on 
incorporation efficiency   
  55 
phosphoramidate L-His-dAMP and its phosphodiester counterpart L-ILA-dAMP were 
synthesized and evaluated as substrates for HIV-1 reverse transcriptase. Both dATP analogues 
were used by the enzyme to obtain 50-60 % (L-His-) to 80-100 % (L-ILA-) of an extended 
primer after 60 min reaction. In other terms both alternative structures were able to mimic the 
pyrophosphate moiety as leaving group in the polymerization reaction. The difference in 
incorporation efficiency between the analogues seems to be due to an increase in both the 
apparent affinity and the maximum velocity when the phosphoramidate linkage is replaced by 
a phosphodiester linkage. This is consistent with preliminary results obtained with various 
non-amino-acid-like leaving groups. Full-length elongation templated by seven 
complementary bases could not be obtained with either of the dATP analogues. Therefore, 
premature DNA synthesis termination cannot be attributed to the nature of the linkage 
between leaving group and deoxynucleoside. The influence of the leaving group’s linkage on 
the kinetics of the incorporation reaction could be used to increase or slow down the rate of 
leaving group release and help understanding the chemical steps of DNA polymerization. Full 
understanding of the characteristics and influence of the leaving group in DNA 
polymerization could help designing new antiviral compounds, or be used in the context of 
nucleic acid synthesis orthogonalization. The instability of phosphorothioate analogues of 
both amino acid-dAMP did not allow the testing of a phosphorothioate linkage in this study. 
 
III.4 Experimental section 
III.3.1 General methods 
NMR spectral analyses were carried out and processed as described in Chapter II. Chemical 
shifts are expressed in parts per million (ppm) by frequency. 1H chemical shifts are referenced 
to an internal TMS signal (δ = 0.00 ppm), 31P NMR chemical shifts are referenced to an 
external 85 % H3PO4 standard (δ = 0.00 ppm). Standard and exact mass spectra were 
measured as described in Chapter II. Chemicals of analytical or synthetic grade were obtained 
from commercial sources and were used as received unless otherwise specified 
(Dimethylaminopyridine, L-malic acid, para-toluene sulfonic acid sodium salt, tert-butanol, 
N-ethyl morpholine, triethylamine, N-ethylmorpholine, tert-butyl dimethyl chlorosilane, 
benzylchloroformate, N-methyl pyrrolidone: Acros; sodium hydroxide, phosphorous 
trichloride, DIPEA, diisopropylamine, benzyl alcohol, triethylammonium hydrogen fluoride, 
tert-butyl peroxide in decane 6.0 M, 10% wt. palladium on activated carbon Degussa type 
III. Chapter three: Influence of the linkage between leaving group and nucleoside on 
incorporation efficiency   
  56 
E101 NE/W, phosphonic acid: Aldrich;  L-histidine methyl ester hydrochloride, Alfa Aesar; 
imidazole, triphenylphosphine, zinc chloride, ethylene diamine tetraacetate disodium salt and 
dicyclohexylcarbodiimide: Fluka; pivaloyl chloride: Janssen Chimica; deoxyadenosine 
monophosphate and β-imidazole lactic acid: Sigma Aldrich; Celite® 545: VWR Int.). 
Technical solvents were obtained from Brenntag (Deerlijk, Belgium).  
 
DNA duplexes preparation and polyacrylamide gel-based electrophoresis were carried 
out as described in Chapter II.  
 
III.3.2 Synthesis 
L-malic acid dibenzyl ester (8) 
To a suspension of L-malic acid (8g, 59.7 mmol) and benzyl alcohol (12 mL, 119.4 mmol, 2 
eq.) in anhydrous toluene (distilled over sodium) was added paratoluene sulfonic acid sodium 
salt (1.159 g, 5.97 mmol, 0.1 eq.). The reaction mixture was heated at reflux (140°C) for 6 
hours. Water was separated and collected. Solvents were evaporated and the mixture was 
dissolved in dichloromethane and washed with a saturated solution of sodium 
hydrogencarbonate. Organic phases were evaporated under reduced pressure, affording 8 in 
quantitative yield. Rf (CHCl3/CH3OH:6/1) = 0.82. 1H NMR (300 MHz, CDCl3): δ 7.36 (m, 
10H, Ph), 5.16 (2s, 2H, CH2-Ph), 5.11 (s, 2H, CH2-Ph), 3.89 (dd, 1H, CHα), 3.2 (d, 1H, OH'), 
2.85 (m, 2H, CH2β). 13C NMR (125 MHz, CDCl3): δ 174.02 (CO), 170.95 (CO), 135.56 (Cp-
Ph), 128.62-128.24 (C-Ph), 67.11, 66.65 (CH2-Ph), 51.34(CHα), 38.98 (CH2β). MS (ESI) m/z 
calculated for C18H18O5 314.33, found 314.0.  
 
Benzyl alcohol diisopropylamino chlorophosphite (7) 
Phosphoroustrichloride (20 mL, 0.23 mol) was mixed with dried acetonitrile (10 mL) in a two 
neck 50 mL flask under argon atmosphere, and dried benzyl alcohol (3.5 mL) was added over 
10 min via syringe. The resulting mixture was stirred for 30 min at room temperature. Solvent 
and excess of PCl3 was distilled off. 1H NMR (300 MHz, CDCl3 mol. sieves 3Å): δ 7.40 (m, 
5H, Ph), 5.29 (s, 1H, CH2), 5.27 (s, 1H, CH2) ppm. 13C NMR (125 MHZ, CDCl3 mol. sieves 3 
Å): δ 128.78-128.42 (Ph), 69.80 (2JC-P= 9.64 Hz, CH2-Ph) ppm. 31P NMR (121 MHz, CDCl3 
mol. sieves 3 Å): δ 177.09 ppm.  
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Diethylether (10 mL) was added to the resulting white mixture under argon atmosphere and 
this solution was cooled down to 0°C and a solution of diisopropylamino (7.6 mL) in 
diethylether (10 mL) was added dropwise under vigorous stirring.  The reaction mixture was 
let to warm up to r.t and stirred overnight. The white precipitate of diisopropylamonium 
chloride was filtered off under argon. Diethylether was then evaporated under reduced 
pressure at 40°C for 4 hours affording 7 in quantitative yield.  1H NMR (300 MHz, CDCl3 
mol. siev. 3Å): δ 7.36 (m, 5H, Ph), 4.92 (s, 1H, CH2), 4.89 (s, 1H, CH2), 3.84 (sept., 2H, CH-
(CH3)3), 1.27 (m, 12H, CH-(CH3)3) ppm. 13C NMR (125 MHZ, CDCl3 mol. siev. 3 Å): δ 
128.86-127.27 (Ph), 67.30 (2JC-P =18.18 Hz, P-CH2), 46.12 (1JC-P =12.95 Hz, P-CH) 23.62 
(CH-(CH3)3) ppm. 31P NMR (121 MHz, CDCl3 mol. siev. 3 Å): δ 181.53 ppm. 
 
 (L-malic acid dibenzyl ester) benzyl diisopropylamino phosphoramidite (9) 
A solution of 7 (192 mg, 0.7 mmol) in anhydrous acetonitrile (5 mL) was cooled down to -
10°C under argon atmosphere. Upon cooling, diisopropylethylamine (236 µL, 1.5 mmol, 2 
eq.) was added via syringe, followed by 8. The resulting clear mixture was let to warm up to 
room temperature for 1.5 hour then solvents were evaporated under reduced pressure. The 
resulting oil was dissolved in ethyl acetate and washed with water. Organic phases were 
gathered and evaporated, and the residue was subjected to flash silica chromatography eluting 
a gradient of ethyl acetate in hexane containing 0.1 % triethylamine. Corresponding fractions 
were collected and evaporated, yielding 110 mg of colourless oil (0.20 mmol, 20% yield) 
which was stored in anhydrous dichloromethane and under argon. 1H NMR (300 MHz , 
CDCl3): δ 7.33-7.30 (m, 15H, Ph), 5.14 (s, 2H, CH2-Ph), 5.10 (s, 2H, CH2-Ph), 5.13 (s, 2H, 
CH2-Ph), 5.06 (s, 2H, C(O)-CH2-Ph), 4.61 (m, 1H, CHα), 3.63 (sept, 2H, CH-(CH3), 22.91 (m, 
2H, CH2β), 1.16 (2s, 12H, CH-(CH3)2. 31P NMR (121 MHz, CDCl3): δ 150.88, 150.69 (Rp and 
Sp). HRMS (positive ion mode): m/z calculated for C31H38NO6P 551.24367, found 552.2512. 
 
5′-tertbutylsilyl-2′-deoxyadenosine (10) 
2′-deoxyadenosine (2.0 g, 8.0 mmoles) was co-evaporated three times with freshly distilled 
pyridine to remove traces of water. It was redissolved in pyridine (20 mL) and tert-
butylchlorosilane (1.32 g, 8.8 mmoles, 1.1 eq.) was added in one portion. The resulting 
mixture was stirred overnight at r.t. under argon atmosphere. Solvent was evaporated and 
coevaporated three times with toluene. The crude mixture was redissolved in chloroform, and 
extracted with water. The organic phase was collected and dried over sodium sulfate. After 
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filtration and evaporation, a white solid was obtained (2.56 g, 7 mmoles, 88 % yield). The 
crude was used as such for the next step. Rf(CHCl3/CH3OH/Et3N:6/1/0.1) = 0.5. 1H NMR 
(300 MHz, CDCl3): δ 8.35 (s, 1H2), 8.18 (s, 1H, H8), 6.53 (apparent t, 3JH1'-H2' = 6.47 Hz, 1H, 
H1'), 5.88 (bs, 2H, NH2), 4.70  (m, 1H, H3'), 4.12 (m, 1H, H4′), 3.89 (m, 2H, H5'), 2.71 (m, 1H, 
H2'), 2.60 (m, 1H, H2′′), 0.92 (s, 9H, C-(CH3)3), 0.11 (s, 6H, Si-CH3) ppm. 13C NMR (125 
MHz, CDCl3): δ 155.4 (C6), 153.0 (C2), 149.5 (C4), 138.9 (C8), 119.9 (C5), 87.1 (C4′), 84.1 
(C1′), 72.1 (C3′), 63.4 (C5′), 41.3 (C2′), 26.0 (C-(CH3)3), 18.4 (Si-C-(CH3)3), -5.40 (Si-CH3) 
ppm. 
 
3ʹ-benzyloxycarbonyl-5ʹ-tertbutylsilyl-2ʹ-deoxyadenosine (11) 
After 10 (1.46 g, 4 mmoles) was dissolved in freshly distilled dichloromethane (25 mL), 
benzylchloroformate (0.85 mL, 6 mmoles, 1.5 eq.) and dimethylaminopyridine (1.5 g, 12 
mmoles, 3 eq.) and the resulting mixture was stirred at r.t. for 4 days. The mixture was diluted 
with dichloromethane and extracted with 2M hydrogen chloride solution. The organic phase 
was collected, dried with sodium sulfate. Finally, the solvent was evaporated after filtration. 
The crude mixture was purified by silica chromatography using a gradient of methanol (0 to 
2.5 %) in dichloromethane. 11 was obtained as a white solid (1.43 g, 2.8 mmoles, 72% yield). 
TLC CHCl3/CH3OH 0.75. 1H NMR (300 MHz, CDCl3): δ 8.37 (s, 1H2), 8.20 (s, 1H, H8),7.40 
(bs, Haro Cbz), 6.52 (apparent t, 3JH1'-H2' = 6.68 Hz, 1H, H1'), 6.02 (bs, 2H, NH2), 5.36 (m, 1H, 
H3'), 5.21 (s, 2H, CH2 Cbz), 4.31 (m, 1H, H4′), 3.93 (m, 2H, H5'), 2.73 (m, 2H, H2'), 0.92 (s, 
9H, C-(CH3)3), 0.11 (s, 6H, Si-CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 155.30 (C6), 
154.41 (Ph),  153.00 (C2), 149.74 (C4), 138.59 (C8), 134.79 (Ph), 128.71-128.38 (Ph), 120.30 
(C5), 85.24 (C4’), 84.17 (C1’), 78.93 (C3’), 70.10 (CH2), 63.57 (C5’), 38.95 (C2’), 25.93 (C-
(CH3)3), 18.36 (Si-C-(CH3)3), -5.48 (Si-CH3) ppm.  
 
3'- benzyloxycarbonyl -2'-deoxyadenosine (12) 
The product 11 (400 mg, 0.8 mmoles) was dissolved in N-methylpyrolidone (2 mL) under 
argon atmosphere and triethylamine (1mL), then triethylammonium hydrogen fluoride (1.34 
mL) were added via syringe to obtain a clear yellow solution. After stirring at r.t. fro 30 min, 
the mixture was diluted with 50 mL ethyl acetate, washed twice with 25 mL water. The 
organic phases were gathered, dried with Na2SO4 and evaporated. Product 12 was obtained as 
a white powder (520 mg, 1.35 mmol, 67% yield). TLC (CHCl3:CH3OH/6:1) Rf=0.53. 
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1H NMR (300 MHz, DMSO d6): δ 8.37 (s, 1H, H2), 8.17 (s, 1H, H8),7.40 (bs, Haro Cbz), 7.54 
(bs, 2H, NH2), 6.36 (apparent t, 3JH1'-H2' = 5.87 Hz, 1H, H1'), 5.34 (m, 1H, H3'), 5.21 (s, 2H, 
CH2 Cbz), 4.16 (bs, 1H, H4’), 3.64 (m, 2H, H5'), 3.01 (m, 1H, H2′), 2.73 (m, 2H, H2′) ppm. 13C 
NMR (125 MHz, DMSO-d6): δ 156.06 (C6), 154.25 (Ph), 152.18 (C2), 149.22 (C4), 140.37 
(C8), 135.75 (Ph), 129.00-128.74 (Ph), 119.75 (C5), 85.58 (C4′), 84.59 (C1′), 79.54 (C3′), 69.72 
(CH2-Ph), 62.17 (C5′’), 38.88 (C2′) ppm. MS (ESI positive ion mode): m/z calculated for 
C18H19N2O5 385.37, found 386.1. 
 
3'-benzyloxycarbonyl-2'-deoxyadenosine-5'-(malic acid dibenzyl ester)-benzyl 
phosphotriester (13) 
To a solution of 12 (77 mg, 0.2 mmol, 1 eq) in anhydrous dichloromethane (2 mL) kept under 
argon atmosphere was added a solution of 9 (165 mg, 0.3 mmol, 1.5 eq) in anhydrous 
dichloromethane (1 mL). A solution of tetrazole in acetonitrile (0.1 M, 4 eq.) was added via 
syringe and the resulting mixture was stirred for 2 hours at room temperature. After 
completion of the reaction was assessed by TLC (hexane/acetone/TEA: 50/50/1), an oxidizing 
solution of tert-butanol peroxide in decane (6.0 M, 0.3 mL, 1 eq.) was added via syringe and 
the mixture was further stirred for 20 min. The mixture was then partitioned between 
dichloromethane and a saturated sodium chloride solution. Organic phase were gathered, 
evaporated and co-evaporated with dichloromethane 3 times. The yellow oily residue was 
purified by flash chromatography eluting with a gradient of methanol in dichloromethane and 
affording 13 in small amount (10 mg, 0.012 mmol, 5% yield). 1H NMR (300 MHz , CDCl3): δ 
8.34 (s, 1H, H2), 8.13 (s, 1H, H8), 7.32-7.28 (m, 20H, Ph), 6.46 (dd, 3JH1'-H2' = 5.64 & 8.73 Hz, 
1H, H1'), 5.63 (bs, 2H, NH2), 5.20-5.0 (m, 10H, 4xCH2-Ph, CHα, H3'), 4.32 (m, 2H, H5'), 4.25 
(m, 1H, H4′), 2.93 (m, 2H, CH2β), 2.73 (m, 1H, H2'), 2.60 (m, 1H, H2’) ppm. 13C NMR (125 
MHz, CDCl3): δ 168.7 (CO malic acid), 155.4 (C6), 154.2 (CO Cbz) 153.1 (C2), 149.8 (C4), 
138.7 (C8), 135.4-135.2 (Ph), 119.8 (C5), 84.1 (C1'′, 82.8 (C4), 78.5 (C3), 72.1 (C5 or CH2 
malic acid), 70.1 (C5 or CH2 malic acid), 67.9, 67.1, 67.0 (CH2Ph), 37.7 (C2) ppm. 31P NMR 
(121 MHz, CDCl3): δ -1.97, -2.11 ppm (Rp and Sp). HRMS (ESI, positive ionization mode): 
m/z calculated for C43H42N2O12P+: 852.2682, found: 852.2647. 
 
2'-deoxyadenosine-5'-(malic acid)-phosphodiester (3) 
Phosphotriester 13 (100 mg, 0.12 mmol) was dissolved in absolute ethanol or ethyl acetate (2 
mL), palladium on carbon 10% (Degussa® type, 38.3 mg, 0.036 mmol, 0.3 eq) was added and 
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the resulting suspension was stirred for 24 hours under hydrogen atmosphere (atmospheric 
pressure) while monitoring by TLC (CHCl3/CH3OH/H2O:5/3/0.5). Upon completion (TLC 
shows quantitative yield), the suspension was filtered on Celite® 545, and washed several 
times with ethanol. This solution was lyophilized, affording 3 as a white residue. 31P NMR 
(121 MHz): δ (major peak) -1.15 ppm. MS (ESI negative mode): m/z calculated for 
C14H18N5O10P 447.07, found (major peak) 446.2. Stability in D2O is inferior to 15 minutes.  
 
Synthesis of (L-malic acid dibenzyl ester) H-phosphonate TEA salt (14) 
Compound 8 (250 mg, 0.8 mmol) and phosphorous acid (655 mg, 8.0 mmol, 8 eq) were co-
evaporated 2 times with anhydrous pyridine, separately. 8 was redissolved in anhydrous 
pyridine (10 mL) and added to previously lyophilized phosphorous acid. After cooling down 
the mixture to 0°C, pivaloyl chloride (0.5 mL, 4.0 mmol, 5 eq) was added via a glass syringe. 
The reaction was let to warm up to r.t. After overnight stirring, the mixture was quenched 
with TEAB 2M, then was partitioned solvents between dichloromethane and TEAB 0.5 M. 
Organic phases were gathered, dried on sodium sulfate, evaporated and finally co-evaporated 
with toluene to yield 14 as a triethylamonium salt (366 mg, 96 % yield). Rf
 
(CHCl3/CH3OH:6:1) = 0.23. 1H NMR (300 MHz, DMSO-d6): δ 7.68 (s, 0.5 H, 1JP-H = 608.54 
Hz, H-P), 7.32 (m, 10H, Ph), 5.65 (s, 0.5H, 1JP-H= 608.54 Hz, H-P), 5.07 (s, 2H, CH2-Ph), 
5.13 (s, 2H, CH2-Ph), 4.88 (dd, 1H, CHα), 2.99 (q, 6H, CH2(Et3NH+)'), 2.83 (1H, 2H, CH2β), 
1.12 (t, 9H, CH3(Et3NH+)) ppm. 13C NMR (125 MHz, DMSO-d6): δ 168.7 (C(O) malic acid), 
155.4 (C6), 170.95 (C(O)α), 169.80, (C(O)β), 136.30 (Ph), 128.85-128.27 (Ph), 69.09 (CHα), 
45.82 (CH2(Et3NH+)), 27.47 (CH3Ph), 8.91 (CH3(Et3NH+)) ppm. 31P NMR (121 MHz, 
DMSO-d6): δ 0.64 ppm. MS (ESI, negative ion mode): m/z calculated for C18H19O7P 
378.31, found 377.0. 
 
3'-benzyloxycarbonyl-2'-deoxyadenosine-5'-(malic acid dibenzyl ester) phosphodiester 
triethylammonium salt (15) 
Compound 14 (87 mg, 0.18 mmol) was dissolved in anhydrous pyridine (1 mL). After cooling 
down the mixture to 0°C, pivaloyl chloride (25 µL, 0.2 mol, 1.1 eq) was added dropwise and 
the resulting mixture was stirred for 20 minutes. A solution of 12 (55 mg, 0.2 mmol, 1.1 eq) 
in pyridine (2 mL) was added dropwise. After stirring at r.t. for 2 hours TLC showed 
completion of the reaction. Tert-butyl peroxide (1 eq.) in decane or dichloromethane was 
added and the mixture was let to react for 20 minutes before evaporating all solvents. The 
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resulting oil was dissolved in dichloromethane and washed with water. Organic phases were 
gathered, dried on sodium sulfate and evaporated. The crude was subjected to silica column 
chromatography eluting with a gradient of methanol in chloroform containing 0.1 % 
triethylamine. Product fractions were collected and evaporated, affording 15 as a white solid 
(32 mg, 22%, 29% yield). Rf (CHCl3/CH3Cl/H2O: 5:3:0.5)=0.76. 1H NMR (300 MHz , 
CDCl3): δ 8.61 (s, 1H, H2), 8.31 (s, 1H, H8), 7.32 (m, 5H, PhCbz), 7.30 (m, 10H, PhBn), 6.57 
(dd, 3JH1'-H2'= 5.8 & 8.9 Hz, 1H, H1'), 6.36 (bs, 2H, NH2), 5.42 (d, H, H3'), 5.19 (s, 2H, 
CH2Ph), 5.18 (m, 1H, CHα), 5.06 (s, 2H, CH2Ph), 5.06 (s, 2H, CH2Cbz), 4.32 (m, 1H, H4′), 
4.15 (m, 2H, H5'), 2.98 (m, 7H, CH2(Et3NH+) & CH2β), 2.84 (m, 1H, H2'), 2.60 (m, 1H, H2′), 
1.23 (t, 9H, CH3(Et3N) ppm. 31P NMR (121 MHz, CDCl3): δ -1.68 ppm. MS (ESI, negative 
ion mode): m/z calculated for C36H36N5O12P: 761.7, found: 760.4. 
 
2'-deoxyadenosine-5'-(malic acid) phosphodiester (3) 
Phosphodiester 15 (30 mg, 0.04 mmol) was dissolved in absolute ethanol (2 mL), palladium 
on activated carbon 10% (Degussa® type, 5 mg, 0.012 mmol, 0.3 eq.) was added and the 
resulting suspension was stirred for 2 days under hydrogen atmosphere (atmospheric pressure) 
while monitoring by TLC. Upon completion (TLC indicates quantitative yield) the suspension 
was filtrated on Celite® 545, and washed several times with ethanol. The solvent was 
evaporated, affording 3 as a white residue. Rf (CHCl3/CH3Cl/H2O: 5:3:0.5)=0.51. 31P NMR 
(121 MHz, D2O) of the crude mixture showed multiple signals around δ 0 ppm (degradation 
products) and a peak at δ -1.14 ppm, which had disappeared within the 30 min of the NMR 
experiment. 
 
5′-tertbutylsilyl-2′-deoxythymidine (17) 
2′-deoxythymidine (2.0 g, 8.2 mmoles) was co-evaporated three times with freshly distilled 
pyridine to remove traces of water. It was redissolved in pyridine (40 mL) and tert-
butylchlorosilane (1.36 g, 9.02 mmoles, 1.1 eq.) was added in one portion. The resulting clear 
mixture was stirred for 2 days at r.t. under argon atmosphere. Solvent was evaporated and the 
mixture co-evaporated three times with toluene. The crude mixture was redissolved in 
chloroform and extracted with water and the organic phases were collected, co-evaporated 
with toluene then dichloromethane and dried over sodium sulfate. 17 was obtained as a white 
solid (3.06 g, 8.2 mmoles, quantitative yield). The crude was used as such for the next step. 
Rf(CHCl3/CH3OH/Et3N:6/1/0.1) = 0.68. 1H NMR (300 MHz, CDCl3): δ 8.38 (s, NH-T), 7.26 
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(s, 1H, 4JH5′-H6′=1.24Hz, H6), 6.39 (dd, 3JH1'-H2' = 6.93 Hz, 1H, H1'), 4.49 (m, 1H, H3'), 4.06 
(m, 1H, H4′), 3.88 (dd, 2H, H5'), 2.13 (m, 2H, H2'), 1.94 (s, 1H, 4JH5′-H6′= 1.17 Hz, CH3), 0.95 
(s, 9H, C-(CH3)3), 0.14 (s, 6H, Si-CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 163.5 (C4), 
150.16 (C2), 138.0 (C6), 110.9 (C5), 87.03 (C4′), 84.90 (C1′), 72.60 (C3′), 63.55 (C5′), 41.13 
(C2′), 25.92 (C-(CH3)3), 18.36 (Si-C-(CH3)3), 12.54 (CH3-T), -5.38 (Si-CH3) ppm. HRMS 
(ESI, positive ion mode): calculated for C16H29N2O5Si+ 357.18408, found 357.1870. 
 
3’-benzyloxycarbonyl-5’-tertbutylsilyl-2’-deoxythymidine (18) 
 After 17 (2.92 g, 8.2 mmoles) was dissolved in freshly distilled dichloromethane (40 mL), 
benzylchloroformate (2.33 mL, 16.4 mmoles, 2.0 eq.) and dimethylaminopyridine (4.01 g, 
32.8 mmoles, 4 eq.) and the resulting clear mixture was stirred at r.t. for 3 days. It was then 
diluted with dichloromethane (50 mL) and extracted with 2M hydrogen chloride solution. The 
organic phase was collected, dried with sodium sulfate, filtrated, and volatiles were 
evaporated. The crude mixture was purified by silica chromatography using a gradient of 
methanol (0 to 2.5 %) in dichloromethane. 18 was obtained as a thick yellow foam (3.01 g, 
6.14 mmoles, 75% yield). TLC CHCl3/CH3OH 0.84. 1H NMR (300 MHz, CDCl3): δ 8.33 (s, 1 
NH), 7.54 (s, 1H, 4JH5′-H6′=1.20 H6),7.40 (bs, Haro Cbz), 6.37 (dd, 3JH1'-H2' = 7.44 Hz, 1H, 
H1'), 5.20 (s, 3H, H3', CH2-Ph), 4.21 (bs, 1H, H4′), 3.93 (m, 2H, H5'), 2.53 (m, 1H, H2'), 2.15 
(m, 1H, H2'), 1.94 (s, 1H, 4JH5′-H6′= 1.14, CH3), 0.95 (s, 9H, C-(CH3)3), 0.15 (s, 6H, Si-CH3) 
ppm. 13C NMR (125 MHz, CDCl3): δ 163.39 (C4), 155.48 (C(O)-Cbz), 150.04 (C2), 134.98 
(C-CPh), 128.72-128.128.38 (C-CPh), 111.11 (C5), 85.01 (C4′), 84.68 (C1′), 78.85 (C3′), 70.07 
(CH2), 63.64 (C5′), 38.12 (C2′), 25.91 (C-(CH3)3), 18.32 (Si-C-(CH3)3), -5.46 (Si-CH3) ppm. 
HRMS (ESI, positive ion mode): calculated for C24H35N2O7Si+ 491.2208, found 491.2224. 
 
3'- benzyloxycarbonyl -2'-deoxythymidine (19) 
Product 18 (2.99 g, 6.1 mmoles) was dissolved in tetrahydrofurane (25 mL) under argon 
atmosphere and the mixture was cooled down to 0°C. Triethylammonium hydrogen fluoride 
(3.93 mg, 24.4 mmoles, 4 eq.) was added via syringe to obtain a clear yellow solution. After 
stirring at r.t. for 24 h, the mixture was diluted with 50 mL ethyl acetate then washed twice 
with a saturated solution of sodium hydrogenocarbonate. The organic phases were gathered, 
dried with Na2SO4 and evaporated to a yellow oil. Final co-evaporation afforded 19 as a white 
powder (2.15 g, 5.7 mmol, 94% yield). TLC (CHCl3:CH3OH/6:1) Rf=0.63. 1H NMR (300 
MHz, DMSO d6): δ 7.72 (s, 1H, 4JH5′-H6′=1.14Hz, H6),7.40 (bs, Haro Cbz), 6.16 (apparent t, 
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3JH1'-H2' =7.293Hz, 1H, H1'), 5.23 (s, 3H, H3'), 5.17 (bs, 3H, CH2-Ph and NH), 4.04 (s, 1H, H4′), 
3.63 (m, 2H, H5'), 2.34-2.31 (m, 2H, H2'), 1.78 (s, 1H, 4JH5′-H6′= 0.87Hz,CH3) ppm. 13C NMR 
(125 MHz, CDCl3): δ 163.39 (C4), 155.48 (C(O)-Cbz), 150.04 (C2), 134.98 (C-CPh), 128.72-
128.128.38 (C-CPh), 111.11 (C5), 85.01 (C4′), 84.68 (C1′), 78.85 (C3′), 70.07 (CH2), 63.64 
(C5′), 38.12 (C2′), 25.91 (C-(CH3)3), 18.32 (Si-C-(CH3)3), -5.46 (Si-CH3) ppm. MS (ESI 
positive ion mode): m/z calculated for C18H20N2O5 376.1271, found 377.1258. 
 
3'-benzyloxycarbonyl-2'-deoxythymidine-5'-(malic acid dibenzyl ester)-benzyl 
phosphotriester (20) 
To a solution of 19 (94 mg, 0.25 mmol, 1 eq) in anhydrous dichloromethane (5 mL) kept 
under argon atmosphere was added a solution of 9 (202 mg, 0.38 mmol, 1.5 eq) in anhydrous 
dichloromethane (2 mL). A solution of tetrazole in acetonitrile (0.1 M, 2.2 mL, 4 eq.) was 
added via syringe and the resulting clear colourless mixture was stirred for 2.5 hour at room 
temperature. After completion of the reaction was assessed by TLC, an oxidizing solution of 
tert-butanol peroxide in decane (6.0 M, 0.2 mL, 1 eq.) was added via syringe and the mixture 
was further stirred for 20 min. The mixture was then partitioned between dichloromethane 
and a saturated solution of sodium chloride. Organic phase were gathered, dried on Na2SO4, 
evaporated and co-evaporated with dichloromethane 3 times. 245 mg of yellow oily residue 
were purified by flash chromatography eluting with a 0-2% gradient methanol in 
dichloromethane and afforded 20 in small amount (27 mg, 0.032 mmol, 8% yield). 
Rf(CH3Cl/CH3OH:6/1) = 0.90 ≈ Rf(CHCl3/CH3OH/H2O:5/3/0.5).  1H NMR (300 MHz , 
CDCl3): δ 8.53 (s, 1H, H6), 7.33 (m, 21H, HPh), 7.32-7.28 (m, 20H, Ph), 6.37 (dd, 3JH1'-H2' = 
8.88 Hz, 1H, H1'), 5.19-4.98 (m, 10H, 4xCH2-Ph, CHα, H3'), 4.40-4.13 (m, 3H, H4′ and H5'), 
3.01-2.93 (dd, 2H, CH2β), 2.35(m, 1H, H2'), 2.03 (m, 1H, H2′), 1.72 (s, 3H, CH3) ppm. 31P 
NMR (121 MHz, CDCl3): δ -1.86, -1.99 ppm. (Rp and Sp). HRMS (ESI): m/z calculated for 
C43H43N2O14P: 853.2524, found: 853.2543. 
 
2'-deoxythymidine-5'-(malic acid)-phosphodiester (21) 
Phosphotriester 20 (20 mg, 0.023 mmol) was dissolved in methanol (2 mL), palladium on 
carbon 10% (Degussa® type, 0.002 mmol, 0.3 eq) was added and the resulting suspension 
was stirred for 24 hours under hydrogen atmosphere (atmospheric pressure) while monitoring 
by TLC. Upon completion, the suspension was filtered on Celite® 545, and washed several 
times with methanol. The filtrate was evaporated and 11mg of resulting solid was lyophilized, 
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affording 3 as a white solid (10 mg, 0.023 mmol, quantitative yield). 
Rf(CHCl3/CH3OH/H2O:5/3/0.5)=0.35. MS (ESI negative mode): m/z calculated for 
C14H19N2O12P 438.28, found 438.6. Stability in D2O: 15 minutes. 
 
 Synthesis of 2'-deoxyadenosine-5'-methylhistidyl phosphoramidate 
In a two neck flask, 2'-deoxyadenosine-5'-monophosphoric acid hydrate (200 mg, 0.572 
mmoles) and L-histidine methyl ester hydrochloride (979 mg, mmoles, 7 equiv.) were 
dissolved in a mixture of tert-butanol (9 ml) and H2O (2ml). A few drops of triethylamine 
(Et3N) were added to facilitate dissolution. An appropriate amount of N,N'-
dicyclohexylcarbodiimide (DCC) (826 mg, 4 mmoles, 7 equiv.) was dissolved under argon in 
1 ml of tert-butanol and was added dropwise to the reaction mixture. The reaction mixture 
was refluxed carefully for 3-4 hours while stirring under argon. The progress of the reaction 
was monitored by TLC (iPrOH:NH3:H2O). Upon completion, the reaction mixture was cooled 
down and the solvent was removed by rotary evaporation. The product was isolated by silica 
column chromatography eluting with CHCl3:MeOH:H2O gradient and affording the product 
as a white solid (138 mg, 50% yield). 1H NMR (300 MHz , DMSO-d6): δ 8.40 (s, 1H), 8.17 
(s, 1H), 8.13 (s, 1H), 7.26 (s, 2H, NH2), 7.05 (s, 1H), 6.35 (apparent t, 3JH1'-H2' = 6.6 Hz, 1H, 
H1'), 4.41 (m, 1H, H3'), 4.16 (s, 1H, H4'), 3.94 - 3.92 (m, 1H, CHCOOCH3), 3.83-3.65 (m, 2H, 
CH2), 3.53 (s, 3H, COOCH3), 2.89 (m, 2H, H5'), 2.75 -2.61 (m, 1H, H2'), 2.33-2.19 (m, 1H, 
H2'). 31P NMR (121 MHz, DMSO-d6): δ 3.77 ppm. MS (ESI positive ion mode): m/z 
calculated for C17H23N8O7P 482.39, found 483.0. 
 
2'-deoxyadenosine-5'-histidyl phosphoramidate (2) 
The DCC coupling procedure described for with starting material 2 ′-deoxyadenosine (100 
mg, 0.3 mmol), L-histidine dimethyl ester hydrochloride (363 mg, 1.5 mmoles, 5 eq.) and 
DCC (414 mg, 1.76 mmoles, 7 eq.) afforded 2 as a white solid (85 mg, 0.18 mmol, 61%).  
1H NMR (300 MHz , D2O): δ 8.30 (d, 1H, 4JHImo-CH2 = 1.5Hz, HIm), 8.29 (s, 1H, H2), 8.03 (s, 
1H8), 6.95 (s, 1HIm), 6.33 (t, 3JH1'-H2' = 6.9 Hz, 1H, H1'), 4.57 (bs, 1H, H3'), 4.14 (s, 1H, H4'), 
3.94-3.78 (m, 2H, H5'), 3.71-3.59 (m, 1H, CHCOOH), 2.85-2.64 (m, 3H, H2', CH2), 2.55-2.42 
(m, 1H, H2'). 13C (125 MHz, DMSO-d6): δ 178.29, 155.02, 152.32, 148.42, 139.55, 132.34, 
129.21, 118.14, 116.12, 85.67, 83.26, 70.93, 63.59, 55.86, 38.32, 29.34, 23.52 ppm. 31P NMR 
(121 MHz, D2O): δ 6.44 ppm. HRMS (ESI): m/z calculated for C16H21N8O7P 467.1193, found 
467.1182. Stable in D2O at r.t. 
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Phosphate activation strategy: 
Synthesis of 2'-deoxyadenosine-5'-(β-imidazole lactic acid)-monophosphate (4) 
The imidazolate of 2’-deoxyadenosine-5’-O-monophosphate 16 was synthesized as described 
in Chapter II. A solution of 16 (20 mg, 50 µmoles), β-imidazole lactic acid (15.6 mg, 100 
µmoles, 2 equiv.), zinc chloride (7 mg, 50 µmoles, 1 equiv.) in N-ethylmorpholine aqueous 
buffer 0.2 M (2 mL, pH 7.5) was let standing at room temperature for 5-20 hours. The 
reaction was monitored by 31P NMR spectroscopy or ion exchange HPLC, quenched with a 
0.25M EDTA (ethylenediaminetetraacetic acid) solution in order to break-down the 
nucleotide-metal complex.  The product was isolated after HPLC purification on an ion 
exchange column (Source 15Q, Amersham Biosciences) by running a gradient of 
triethylammonium bicarbonate (TEAB) 1M in Millipore water. Corresponding fractions were 
analyzed by ESI-MS prior to lyophilisation. Removal of the triethylammonium salt was 
completed by two additional lyophilisation steps, affording 4 as a white solid. 1H NMR (300 
MHz, D2O, 25°C): δ 8.4 (s, 1H, H8), 8.3 (s, 1H, HIm), 8.1 (s, 1H, H2), 7.0 (s, 1H, HIm), 6.4 
(apparent t, 3JH1'-H2' = 6.8 Hz, 1H, H1′), 4.5 (m, 1H, H3′), 4.2 (m, 1H, H4′), 4.1 (s, 2H, CH2β), 
3.9 (m, 2H, H5′), 2.8 (m, 1H, CHα), 2.7 (m, 1H, H2′), 2.5 (m, 1H, H2′) ppm. 13C NMR (125 
MHz, D2O): δ168.5, 155.8, 152.8, 148.9, 140.2, 133.9, 125.8, 118.8, 86.5, 84.0, 71.8, 64.6, 
54.3, 52.6, 39.5 ppm. 31P NMR (121 MHz, D2O): δ -0.89 ppm. HRMS (ESI, negative ion 
mode): m/z calculated for C16H19N7O8P-: 468.1038, found 468.1030. Stability in D2O: 20% 
hydrolysis after 12h. Stability in RTRB: 30 minutes. 
 
III.4.3 Enzymatic reactions 
DNA polymerase reactions: All reactions were duplicated; tripliquets were realized in case 
of conflicting results and in order to verify the reproducibility of the results. End-labeled 
primer was annealed to the suited template by combining primer and template in a 1:2 molar 
ratio and heating the mixture at 70°C for 10 min followed by slow cooling to room 
temperature over a period of 1.5 h. Since a risk of early departure of the leaving group was 
experimentally observed in the presence of a divalent cation with malic acid-dAMP, the 
sample preparation protocol for single nucleotide incorporation assay and for steady-state 
kinetic studies was modified in order to preserve the triphosphate mimic from being 
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prematurely degraded by the magnesium ions present in the Reverse Transcriptase Reaction 
Buffer (RTRB). 
A solution of substrate was pre-incubated at 37°C for 1 minute and mixed with a 37°C-
preincubated mixture of enzyme, appropriate primer template hybrid and RTRB (10 µL 
reaction volume). For the incorporation a series of 10 µL-batch reactions was performed with 
the enzyme HIV-1 RT (Ambion, 10 U/µL stock solution, specific activity 11.700 U/mg, 
concentration 0.85 mg/mL). The final mixture contained 125 nM primer template complex, 
RTRB (250 mM Tris.HCl, 250 mM KCl, 50 mM MgCl2, 2.5 mM spermidine, 50 mM 
dithiothreitol (DTT); pH 8.3), 0.025 U/µL (32.1 nM) HIV-1 RT , and different concentrations 
of phosphoramidate or phosphodiester building blocks (0.1-1 mM). In the control reaction 
with the natural nucleotide, a 10 µM dATP concentration was used. The mixture was 
incubated at 37°C and aliquots were quenched after 5, 10, 20, 30 and 60 min. For elongation 
experiments, the same mixture with appropriate primer:template hybrid was incubated at 
37°C and aliquots were drawn after 30, 60 90 and 120 min. In the control reaction, 50 µM 
dATP was used. Aliquots (1.5 µL) were drawn at 5 time points and quenched for 8 min at 
85°C in formamide buffer (6µL). 
 
Steady-state kinetics of single nucleotide incorporation: The steady-state kinetics of single 
nucleotide incorporation of L-His-dAMP 1 and ILA-dAMP 2 and of the natural nucleoside 
triphosphate (dATP) was determined by gel-based polymerase assay. In all the experiments, 
the template T1 and the primer P1 were used. The primer and template in 1:2 molar ratio were 
hybridised in a buffer containing 20 mM Tris.HCl, 10 mM KCl, 2 mM MgSO4, 0.1% Triton 
X-100, pH 8.3 and used in an amount to provide 125 nM concentration of the primer in each 
10 µL reaction. The range of concentrations for substrate was optimized according to a KM 
value for the incorporation of an individual nucleotide (0.02 mM - 1 mM for 1 and 2, 0.01 to 
0.1 mM for dATP). Reaction mixtures containing the HIV-1 RT enzyme (Ambion, 10 U/µL) 
in appropriate concentration to attain 5-20 % conversion (0.0063 U/µL for 1 and dATP, 0.025 
U/µL for 2) were incubated at 37°C and aliquot were drawn at 1, 2, 3, 30 and 60 minutes. The 
reactions were quenched by addition of the buffer 80% formamide, 2 mM EDTA, 1X TBE 
buffer. The analysis of polymerase reaction was performed by polyacrylamide gel 
electrophoresis. The initial incorporation rates (V0) were calculated based on the percentage 
of the extension production (P+1 band). The kinetic parameters (VMax and KM were 
determined by plotting V0 (nM/min-1) versus substrate concentration (mM) and fitting the data 
to a non-linear Michaelis-Menten regression using GraphPad Prism Software (Version 5.0). 
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IV. Chapter four: Iminodiacetic-phosphoramidates as 
metabolic prototypes for diversifying nucleic acid 
polymerization in vivo 
 
The results reported in this chapter were published in Nucleic Acid Research in 2010 under 
the title ‘Iminodiacetic-phosphoramidates as metabolic prototypes for diversifying nucleic 
acid polymerization in vivo’. Giraut, A., Xiaoping, S., Froeyen, M., Marlière, P., Herdewijn, 
P., Nucleic Acid Res., 38, 2541-2550. 
 
IV.1 Introduction 
 
The aim of our project is to develop and introduce additional types of nucleic acids in living 
cells. As a long term objective, these nucleic acids could be used to avert genetic pollution by 
preventing dissemination of artificial hereditary messages in natural ecosystems, including the 
human body (56). In formal terms, this project amounts to the systematic search of the 
chemical space in order to identify an assortment of activated monomers carrying a set of 
complementary bases. Another aspect of this project is to discover nucleic acid enzymes that 
would use activated monomers as substrates in polymerization, ligation or recombination. The 
result of this interplay would be templated-reproduction of polymers which would convey 
additional genetic information but not interfere with RNA and DNA metabolism or function. 
 
Base and backbone variants of DNA and RNA are the topic of intense research in several 
laboratories, auguring well for the feasibility of xenonucleic acid (XNA) reproduction in vivo 
(60;68). It is our strong belief that unnatural leaving groups used for activation of XNA are 
crucial propagating additional types of nucleic acids in living cells. Indeed, the chemical 
structure of the leaving group can be elaborated leading to segregation polymerization of 
XNA polymers from that of indigenous DNA and RNA monomers and establishing an 
informational enclave. Another result, as a consequence, is disentangling the XNA 
polymerization from the phosphoanhydride economy of the cell and thus establishing an 
energetic enclave as well. The dual role of nucleoside triphosphates as both energetic 
currency and precursors for the informational polymers RNA and DNA, drastically limits the 
range of metabolic and genetic reprogramming that can be accomplished in living cells. The 
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judicious implementation of novel leaving groups in metabolism could overcome the need for 
physical compartmentalization of unnatural information transfers and enable the launching 
and sustaining of autonomous hereditary procedures in vivo. 
 
In the aim of broadening our search of the chemical space, we addressed the synthesis and 
enzymatic assay of the deoxyadenylate adduct of iminodiacetate. Although this isomer of 
aspartate is not commonly found in living cells, its biosynthesis and recycling from glycine 
and glyoxylate could be readily implemented in metabolism. Formation of the prototype 
metabolite triphospho-imino-diacetate (TPI) and its reaction with nucleosides can also be 
experimentally studied to investigate novel energetic and informational metabolism and its 
potential implementation in bacterial cells. 
The enzymatic synthesis of nucleic acids makes use of nucleoside triphosphates as substrates 
and this process is driven by the release and hydrolysis of pyrophosphate. The selection of 
new leaving groups for the enzymatic synthesis of nucleic acids should be accompanied by a 
selection of appropriate polymerases which can use the modified nucleotides as building 
blocks for gene synthesis, independent of the cellular gene-synthesis machinery (56). Since 
HIV-1 RT shows broad substrate specificity, this enzyme was chosen as a primary 
polymerase for selection of potential leaving groups to activate nucleoside triphosphate 
mimics.   
Despite the fact that many polymerases as HIV-1 reverse transcriptase, Taq DNA polymerase, 
Vent (exo-) DNA polymerase , are able to process selected substrates like amino acid dAMP 
phosphoramidates (82), HIV-1 RT was chosen as the preferred enzyme. In our study the 
pyrophosphate leaving group (linked to a deoxynucleotide in Figure IV.1a) is replaced by a 
completely different molecule with potential chelating properties. It has been indicated that 
the L-aspartic acid derivatives of dATP (Figure IV.1b), dGTP, dCTP and dTTP demonstrated 
conserved single nucleotide incorporation and limited elongation properties (83). However 
incorporation of L-His-dAMP by HIV-1 RT proceeded with lower efficiency. In contrast to 
its congener L-Asp-dAMP, primer chain elongation was slightly improved when L-His-
dAMP was used (82). It is important to note that regardless of which amino acid was used, 
DNA synthesis dramatically slowed down after incorporation of two nucleotides. 
Understanding and resolving this stalling issue is a prerequisite for the future use of such 
modified nucleotides for enzyme-catalyzed DNA synthesis in vivo.  
A model postulated by Steitz explains the way by which the incoming deoxynucleotide 
triphosphate (dNTP) is bound in the active site of the polymerase for incorporation in the 
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growing DNA chain (12). This model takes into account the importance of the chelation of 
two divalent magnesium ions required in the polymerization mechanism which are thought to 
bring the free 3’-OH group of the primer for in-line attack the α-phosphate group of dNTP. 
More recently, Garforth et al. suggested that enzyme processing could occur when only two 
potential chelating moieties are present, since in their studies a deoxynucleoside diphosphate 
served as substrate for HIV-RT and resulted in DNA strand elongation (84).  
In the case of phosphoramidate substrates, the necessity of the leaving group to carry two 
potential chelating moieties has been acknowledged in chapter II. To broaden the chemical 
space and get further insight in the structure-activity relationship, we altered the substitution 
pattern of the nitrogen atom of the phosphoramidate moiety, while a) taking care of potential 
chelating properties and b) focusing on potential metabolic accessibility of the new leaving 
group. Enhanced coordination of the magnesium ion by the leaving group moiety of the 
modified nucleotide might influence incorporation kinetics and efficiency of the chain 
elongation reaction. In addition, iminodiacetic acid (Figure IV.1c) can be considered as 
potentially metabolically accessible and potentially prone to catabolism into non-toxic cellular 
constituents (i.e. glycine and a two-carbon atom fragment glyoxalic acid). As a consequence, 
this degradation reaction may have a driving effect on the equilibrium of the nucleotide 
incorporation reaction.  
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Figure IV.1: Molecular structures of deoxyadenosine (a) -triphosphate, (b) -aspartic acid 
phosphoramidate, (c) –iminodiacetic acid phosphoramidate. 
 
The iminodiacetate dAMP phosphoramidate (IDA-dAMP, Figure 1c) possesses no chiral 
centre, ensuring less stereochemical constraint than for the chiral L-aspartic acid. 
Furthermore, the diacetic acid substituted amine is present in the molecular structure of 
ethylenede diamine tetraacetic acid (EDTA), known for its great chelating properties towards 
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a diversity of metal ions. Finally, it has been shown recently that protonation of the 
pyrophosphate leaving group is important and facilitated by a neighbouring general acidic 
residue in the active site (often a lysine residue) in all four classes of nucleic acid polymerases 
(89). A departing amide ion is a very strong base as illustrated by the high pKa of sodium 
amide (pKa in ammonia solution >30) (109) and should therefore undergo extremely rapid 
protonation.  
 
IV.2. Results and discussion 
IV.2.1 Synthesis of Iminodiacetate dAMP phosphoramidate (IDA-dAMP) 
The synthesis of the methyl ester of IDA-dAMP was accomplished according to the method 
described by Wagner and colleagues starting from the corresponding nucleoside 
monophosphate (75).  Deprotection of the methyl ester was carried out with sodium 
hydroxide in methanol-water solution. Scheme IV.1 shows the synthetic route, which is an 
easy-to-perform two-step reaction.  
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Scheme IV.1: Preparation of iminodiacetic acid dAMP phosphoramidate: a) iminodiacetic 
acid, DCC, tert-butanol, water; b) sodium hydroxide, methanol, water (1M); c) TEAB 1M. 
 
IV.2.2 Single Nucleotide Incorporation 
HIV-1 reverse transcriptase serves as a catalyst in the HIV-1 viral replication process and uses 
deoxynucleotides as substrates. This polymerase is error-prone and thus possesses a high 
mutation rate (4;18). Previous experiments carried out with the L-aspartic acid 
phosphoramidate of dAMP demonstrated that this amino acid was an acceptable leaving 
group for the polymerase in the nucleotidyl incorporation process (81;82). In the present 
study, we evaluated the capacity of HIV-1 RT to incorporate IDA-dAMP as a substrate in the 
primer-template complex P1:T1. The initial experiments were carried out using a template 
with an overhang of one thymidine nucleotide followed by three non-thymidine bases (Table 
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IV.1). Incorporation efficiency was analyzed by the polyacrylamide gel-based single 
nucleotide incorporation assay (110).  
 
Table IV.1. Overview of the primer-template complexes used in the DNA polymerase 
reactions. Bold letters indicate the template overhang in the hybridised primer-template 
duplex.  
Single nucleotide incorporation and kinetic experiments 
P1 
T1 
5'-CAGGAAACAGCTATGAC-3' 
3'-GTCCTTTGTCGATACTGTCCC-5' 
Elongation experiments 
P1 
T2 
T3 
5'-CAGGAAACAGCTATGAC-3' 
3'-GTCCTTTGTCGATACTGTTTTTTT-5' 
3'-GTCCTTTGTCGATACTGTTTTTTTGGAC-5' 
 
The phosphoramidate analogue IDA-dAMP was correctly processed by HIV-1 RT converting 
a primer to a (P+1) strand with a yield up to 86% in 60 min, at 500 µM deoxynucleotide 
concentration (Figure IV.2). So as for L-Asp-dAMP (50% P+1 product at 100 µM), efficient 
substrate incorporation was also detected with a 5-fold lower substrate concentration (40% 
P+1 product at 100 µM). 
Figure IV.2: Profile of incorporation of dAMP into P1:T1 by HIV-1 reverse transcriptase 
using IDA-dAMP as substrate. Aliquots were drawn at 10, 20 30, 60 and 120 minutes. 
 
IV.2.3 Elongation experiments 
Previous studies carried out with L-Asp-dAMP and HIV-1 RT showed its ability to serve as a 
substrate for template dependent incorporation of more than one phosphoramidate nucleotide.  
Primer elongation of up to 6 nucleotides was observed only to a limited extent, and with 
prevalence of the (P+2) and (P+3) products. Such a stalling represents a significant hindrance 
for a future use of phosphoramidate nucleotides for enzymatic DNA synthesis in vivo. For the 
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evaluation of the strand elongation capacity of IDA-dAMP using the same enzyme, the 
primer-template duplexes P1:T2 and P1:T3 were used (Table IV.1).  
 
A range of concentrations of IDA-dAMP was incubated at the appropriate temperature with 
the primer-template complex and 0.025 U/µL of enzyme. Reaction aliquots were drawn 
between 30 and 120 minutes time points and analyzed by 20% polyacrylamide gel 
electrophoresis. In the P1:T2 experiment, the template possesses an overhang of seven 
thymidine nucleotides. Using IDA-dAMP as a substrate, we observed a prevalence of the 
(P+6) product, indicating an excellent elongation capacity (Figure IV.3). The initial stalling at 
the (P+2) and (P+3) products disappears over time and is not so pronounced as with L-Asp as 
a leaving group (Numerical data are gathered in Table IV.2). However, we did not observe 
formation of a P+7 when P1:T2 system was used.  
 
 
Figure IV.3: Profile of elongation of P1:T2 with dAMP by HIV-1 RT using IDA-dAMP as 
substrate. Aliquots were drawn at 10, 20 30, 60 and 120 minutes. 
 
The major product of L-Asp-dAMP incorporation is the (P+2) resulting oligonucleotide, 
whereas the (P+6) product is only present in trace amounts and barely quantifiable. In 
contrast, IDA-dAMP incorporation results mostly in formation of the (P+6) oligonucleotide 
(Table IV.2). 
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Table IV.2. L-Asp-dAMP versus IDA-dAMP in the elongation of P1 
directed by template T2: % of P+n product after 120 min reaction 
product 
% substrate[a] 
L-Asp-dAMP 
%  substrate[a]  
IDA-dAMP 
P+6 Traces 40 
P+5 Traces 19 
P+4 Traces 3 
P+3 34  14 
P+2 64  12 
[a] % of the total amount of radioemitting oligonucleotides  in the mixture 
 
In the subsequent P1:T3 experiment using a P1:T3 duplex, where the seven thymidine 
overhang of the template was flanked by four non-thymidine units, the primer extension 
resulted in formation of a (P+7) product (Figure IV.4). 
 
 
Figure IV.4: Profile of elongation of P1:T3 with dAMP by HIV-1 RT using IDA-dAMP as 
substrate. Aliquots were drawn at 10, 20 30, 60 and 120 minutes. 
 
The observed full-length elongation obtained when using the purine-elongated template T3, 
could be due to the increased affinity of the longer template overhang for the enzyme and the 
formation of a more stable tertiary complex. It has been shown by Kohlstaedt in 1992 that the 
template strand binds to the fingers subdomain of the polymerase active site (91). This was 
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confirmed in the crystal structures observed by Huang for HIV-1 RT and by Doublié for T7 
DNA polymerase (14;17). In addition, the binding affinity of RT with DNA duplexes as 
template is increased when template overhang was extended to 6 additional bases (111). 
According to models based on crystal structures of the complex (111;112),  the β3-β4 loop 
situated in this finger domain contacts the template three nucleotides upstream from the 
primer terminus (near or at Leu74). Kew et al. postulated that a stronger complex between the 
fingers subdomain of a HIV-RT and the template overhang may be responsible for higher 
processivity by the enzyme (113). Although it seems that binding and incorporation of a 
natural triphosphate substrate dATP is not dependent on the length of the template overhang 
(as observed in Figure IV.3 and 4 and in (112), it appears to be the case with the triphosphate 
mimic IDA-dAMP. The presence of a four base 5’-overhang could favour a more stable 
dsDNA-protein complex. The template length also seems to influence the ability of HIV-1 RT 
to recognise and incorporate an incoming dNTP carrying a modified leaving group. 
 
The superior substrate properties of IDA-dAMP as compared to L-Asp-dAMP might also be 
arising from the better chelating ability of the N-diacetate group of IDA-dAMP, from 
structural differences of the transition state, or from modified conformational changes of the 
enzyme. In the case of T7 RNA polymerase, Yin and Steitz proposed a model where cross-
linking between the DNA helix and the enzyme depends on the presence of pyrophosphate. 
They demonstrated that the nature of the electrostatic interactions of this complex undergo 
changes between the pre- and post-translocation state of nucleotide incorporation (108). In a 
previous model postulated by Steitz, one magnesium ion is indeed coordinated by the 3′-end 
of the primer and the α-phosphate, while the second magnesium ion is thought to facilitate the 
leaving group properties of the pyrophosphate moiety by forming interactions with the β- and 
γ-phosphates of the nucleotide (12). It can be hypothetized that the better stability of the 
tertiary complex compensates for the loss of stability induces by the replacement of PPi. 
 
IV.2.4 Kinetic experiments 
Further investigation of IDA-dAMP was focused on kinetics of incorporation. Kinetic 
parameters for the incorporation of both the natural and the modified substrate by HIV-1 RT 
were determined on the basis of the single completed hit model (88;114). In the study, P1 and 
T1 (Table IV.1) were used as the primer and template DNA strands, respectively. The steady-
state kinetic values KM and VMax corresponding to the substrate efficiency of the nucleotide 
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triphosphate analogues are reported in Table IV.3. Along with showing a similar single 
incorporation after 60 minutes and far better elongation results, IDA-dAMP also demonstrates 
better incorporation kinetics than L-Asp-dAMP for HIV-1 RT. The measured VMax/KM ratio 
towards HIV-1 RT is only one order of magnitude lower than that of dATP. In comparison, 
this ratio was for L-Asp-dAMP 103 fold lower than the one of the natural substrate. Similarly 
to the L-Asp phosphoramidate analogue, the KM of IDA-dAMP is much higher than for the 
natural substrate, whereas the VMax is 1.3 fold lower. The increased capacity for chain 
elongation is paralleled by a similar increase in incorporation efficiency. It is clear that 
enzyme evolution should focus on the selection of a polymerase enhancing KM rather than 
VMax, which is easier to achieve than the inverse. 
 
Table IV.3. Determination of the kinetic parameters of the incorporation of dAMP with 
the natural pyrophosphate leaving group (dATP) and the iminodiacetate leaving group 
(IDA-dAMP) into P1T1 by HIV-1 RT DNA polymerase at 0.025 U/µL.  
 
KM 
[µM] 
Vmax 
[nM.min-1] 
Vmax/KM 
[min-1] 
dATP 29 ± 5 65.7 ± 4.3 2.26x10-3 
IDA-dAMP 312.5 ± 70.5 49.0 ± 4.5 0.16x10-3 
 
IV.2.5 Model of IDA-dAMP bound to HIV-1 reverse transcriptase 
With the IDA-dAMP molecule bound to reverse transcriptase, stable molecular dynamics 
(MD) trajectories were obtained. In the calculated ground state complex (Figure 5b), the 
spatial arrangement of two Mg2+ ions is comparable to their situation in the original TTP 
complex (Figure 5a) (17). Although in the ground state the carboxylate groups of IDA-dAMP 
(mimicking the β and γ phosphate groups) are not yet involved in an ionic bond with the Mg2+ 
ions, they are stabilised by ionic interactions with Lys65A, Arg72A and Gln151A. The 
difference in the binding affinity between PPi and IDA could also contribute to a difference in 
kinetics or to the lower processivity of the enzyme when challenged with IDA-dAMP in place 
of dATP (92). In the ground state crystal structure obtained with dTTP, Gln151 only contacts 
the leaving group of the dTTP, without forming an actual ionic bond.  
The divalent magnesium ions are located in a very strong network of ionic bonds which 
involves the non-bridging oxygen of the phosphoramidate group and the three aspartate 
residues Asp185A, Asp110A and Asp186A, which are highly conserved in the polymerase 
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family (111;115). The ionic bond interactions observed between the divalent cation and 
residue Asp186A in the ground state is specifically noted in the complex of HIV-1 RT with 
both IDA-dAMP and Asp-dAMP (82;93).  
 
 
Figure IV.5: A) The thymidine triphosphate (TTP) in the RT dNTP pocket (X-ray structure 
from Huang 1998 (17)).  The primer strand is shown as a green ribbon; the template strand is 
in blue. The stabilizing interactions of the TTP within the complex are shown. Hydrogen bond 
distances between the bases are indicated in Å. The ligation of the 2 Mg2+ ions to the complex 
is also visualized by dashes and distances in Å. B) Average structure of IDA-dAMP in the RT 
dNTP binding pocket. This figure was generated using Bobscript, Molscript and Raster3d 
(116-118). 
 
IV.2.6 Metabolic accessibility 
In order to investigate the metabolic accessibility and recycling potential of a novel 
triphosphate mimic, we synthesized triphospho-iminodiacetate (TPI) and tested the possibility 
of displacement of the pyrophosphate moiety by deoxyadenosine (Scheme IV.2). The 
triphosphate was formed by reacting trimetaphosphate with iminodiacetic acid, adapting a 
method described by Feldmann et al. (119). However, the pyrophosphate displacement 
reaction with deoxyadenosine in the presence of magnesium ions with release of 
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pyrophosphate was not successful due to poor nucleophilicity of the 5′-hydroxyl group of 
deoxyadenosine and solubility problems. On the other hand, cleavage of cyclic 
trimetaphosphate by adenosine in presence of MgCl2 in neutral conditions was previously 
observed by Yamagata (120). The presence of a divalent cation which would facilitate the 
pyrophosphate displacement implies the use of a non-nucleophilic polar solvent. Therefore, 
further experiments are needed to circumvent solubility problems. Another approach to solve 
the aforementioned difficulty with pyrophosphate displacement consists in developing 
biochemical agents capable of catalyzing the reaction.  
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Scheme IV.2: Potential metabolic availability of IDA-dAMP using 1) enzymatic 
condensation of simple carbon fragments by a dehydrogenase (EC.1.5), 2) 
cyclotrimetaphosphate as triphosphate precursor and 3) pyrophosphate displacement by 
deoxyadenosine. 
 
IV.3 Conclusion 
 
Deoxyadenosine triphosphate analogues in which the pyrophosphate moiety is replaced by L-
aspartic acid had previously been shown to act as substrates for DNA synthesis catalyzed by 
HIV-1 RT. The use of iminodiacetate dAMP as a potential substrate improved both 
incorporation and elongation results. The contribution of the pyrophosphate leaving group to 
DNA synthesis, in terms of catalytic efficiency and fidelity of DNA polymerase β, was 
studied recently (70). These data suggest a leaving-group-induced change at the rate limiting 
step due to stabilisation of the pyrophosphate group release. It is clear that the substitution of 
pyrophosphate by L-Asp and IDA moieties would be likely to have a major impact on this 
process. Furthermore, chemical modification of the leaving group influences active-site 
structural differences between correct and incorrect base-paired transition state (71).  
Elongation results with IDA-dAMP allowed us to confirm the positive influence of a longer 
template overhang for the recognition and incorporation of several successive building blocks 
carrying a modified leaving group. Therefore, our results validated the importance of 
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interactions between finger subdomain residues and template’s upstream nucleotides during 
the HIV-1 RT directed DNA synthesis. 
 
Modelling experiments showed us that in the ground state the carboxylate groups are most 
likely to be bound to an intricate network of amino acid residues, Lys65, Arg72 and Gln151, 
located in the enzyme’s active site via divalent cations. Our study suggests that in the ground 
state the magnesium ion could also form an ionic bond with Asp110, Asp185 and Asp186. 
The last interaction mentioned (Asp186) is observed only in the case of IDA-dAMP and L-
Asp-dAMP. Therefore this model implies that in the ground state the stabilisation of IDA-
dAMP is enhanced and involves 6 amino acid residues instead of 4 with the natural substrate 
and 5 with Asp-dAMP (82). This increase in amino acids interactions observed in the 
complex formation with IDA-dAMP is reflected in a change in KM. The electrostatic 
involvement of residues Gln155A and Asp186A has not been observed in previous studies. 
The difference in binding affinity between pyrophosphate and iminodiacetic acid is likely to 
contribute to a difference in kinetics (92). In addition, the difference in intrinsic energy of the 
released leaving group could be a possible “brake” for further conformational changes of the 
enzyme (92;108). 
 
The nucleoside phosphoramidates developed in this study lend themselves to metabolic 
implementation, as described in Scheme IV.2. With the help of the divalent magnesium 
cation, a further nucleophilic attack of the α-phosphate by the 5ʹ-hydroxyl group of adenosine 
should form the phosphoramidate IDA-dAMP with the energetically favoured release of a 
pyrophosphate. The biosynthesis would start from the two common metabolites glycine and 
glyoxylate, which is its corresponding 2-oxo-acid. A specific transaminase, namely serine-
glyoxylate aminotransferase) performs interconversion of glycine and glyoxylate in certain 
methylotrophic bacteria (121). Reductive condensation of glycine with glyoxylate resulting in 
iminodiacetate is reminiscent of octopin biosynthesis. Enzymes directing the production of 
these nutrient shuttles could therefore be harnessed for our purpose (122;123). Furthermore, 
ammonia reacts in neutral aqueous media with cyclotriphosphate to yield triphosphoramidates 
and the equilibrium constant of this reaction is about 1.52 min-1 (119). We propose that this 
reaction could be readily observed in the case of the secondary amine IDA, spontaneously 
providing TPI in good yield (80 % yield after 24 hours at room temperature). Putative 
enzymes capable of accelerating this spontaneous reaction could possibly be found in the 
class of hydrolases that act on acid anhydrides, such as trimetaphosphatase (EC 3.6.1.2) (124). 
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Nevertheless, our study showed that further condensation of TPI with the 5'-hydroxyl of the 
nucleoside deoxyadenosine did not proceed spontaneously under the various conditions 
tested. Since this reaction features the nucleophilic attack of a phosphoanhydride by a primary 
alcohol as performed by many kinases, the systematic assay of such enzymes can unveil a 
biocatalyst marginally endowed with the desired activity. 
 
IV.4. Experimental section 
IV.4.1 General methods 
NMR spectral analyses were carried out and processed as described in Chapter II. Chemical 
shifts are expressed in parts per million (ppm) by frequency. 1H chemical shifts are referenced 
to an internal TMS signal (δ = 0.00 ppm), 31P NMR chemical shifts are referenced to an 
external 85 % H3PO4 standard (δ = 0.00 ppm). Standard and exact mass spectra were 
measured as described in Chapter II. Chemicals of analytical or synthetic grade were obtained 
from commercial sources and were used as received (deoxyadenosine monophosphate: Sigma 
Aldrich; DCC, dimethyl iminodiacetic acid hydrochloride: Fluka; tert-butanol and 
triethylamine: Acros). Technical solvents were obtained from Brenntag (Deerlijk, Belgium). 
Acetonitrile HPLC Grade was purchased from Fischer Scientific. Flash silica chromatography 
was performed on Davisil® silica gel 60, 0.040–0.063 mm (Grace Davison). Thin Layer 
Chromatography was performed on Alugram® silica gel UV254 mesh 60, 0.20 mm 
(Macherey-Nagel).  
DNA duplexes preparation and polyacrylamide gel-based electrophoresis were carried 
out as described in Chapter II.  
 
IV.4.2 Synthesis 
Synthesis of 2'-deoxyadenosine-5'-(dimethyl iminodiacetate) phosphoramidate 
(Intermediate for 10) 
In a two-neck flask, 2′-deoxyadenosine-5′-monophosphoric acid hydrate (100mg, 0.286 
mmoles) and dimethyl iminodiacetate hydrochloride (283 mg, 1.430 mmoles, 5 equiv.) were 
suspended in a mixture of 1, 4-dioxane (9ml) and N,N-dimethylformamide (1ml). A few drops 
of triethylamine were added to the solution to facilitate dissolution. Then, a solution of DCC 
(414 mg, 2.004 mmoles, 7 equiv.) in 1,4-dioxane (1 ml) was added and the reaction mixture 
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was heated for 3 hours while stirring under nitrogen atmosphere. The progress of the reaction 
was monitored by TLC (CHCl3:CH3OH:H2O 5:3:0.5). Upon completion, the reaction mixture 
was cooled and the solvent was removed by rotary evaporation. The residue was resuspended 
in water (15 ml), extracted with diethyl ether (3×10 ml), and the aqueous phase was 
lyophilised. The resulting solid was subjected to column chromatography on silica gel using 
the following solvent gradient: CHCl3:CH3OH:H2O (5:1:0; 5:2:0.25; 5:3:0.25; 5:3:0.5). The 
product was obtained as a white solid (58mg, 43%). 
1H NMR (500 MHz, D2O): δ 8.46 (s, 1H, H8), 8.24 (s, 1H, H2), 6.50 (apparent t, 1H, 3JH1'-H2' = 
6.5Hz, H1'), 4.72 (m, 1H, H3'), 4.22 (m, 1H, H4'), 4.00 (m, 2H, H5'), 3.78 (s, 1H, 
CH2COOCH3), 3.69 (s, 1H, CH2COOCH3), 3.56 (s, 6H, CH3), 2.89 (m, 1H, H2'a), 2.61 (m, 
1H, H2'b) ppm. 13C NMR (125 MHz, D2O): δ 174.27, 156.07, 153.21, 149.36, 140.38, 119.14, 
86.63, 84.12, 72.13, 64.67, 52.62, 49.28, 39.25 ppm. 31P NMR (121 MHz, D2O): δ 6.67 ppm. 
HRMS (ESI): calculated for C16H22N6O9P 473.1186, found: 473.1180. 
 
Synthesis of 2'-deoxyadenosine-5'-iminodiacetate phosphoramidate (10) 
A solution of 2’-deoxyadenosine-5’-dimethyl iminodiacetate phosphoramidate (50mg, 0.105 
mmoles) in 0.4 M sodium hydroxide solution in MeOH:H2O (4:1) (2mL), was stirred at room 
temperature under nitrogen for 2 hours. The progress of the reaction was monitored by TLC 
(iPrOH:H2O:NH3 7:1:2). Upon completion, the reaction mixture was neutralised by addition 
of 1M triethylammonium bicarbonate. The solvent was removed under reduced pressure. The 
residue was purified by column chromatography and eluted with the following solvent 
gradient: CHCl3:CH3OH:H2O (5:1:0 to 5:4:1). The product was isolated and concentrated, 
affording a white solid (31mg, 65% yield). 
1H NMR (500 MHz, D2O): δ 8.46 (s, 1H, H8), 8.25 (s, 1H, H2), 6.50 (apparent t, 1H, 3JH1'-H2' = 
6.48Hz, H1'), 4.70 (m, 1H, H3'), 4.26 (m, 1H, H4'), 4.02 (m, 2H, H5'), 3.64 (m, 4H, 
CH2COOH), 2.83 (m, 1H, H2'a), 2.59 (m, 1H, H2'b) ppm. 13C NMR (125 MHz, D2O): δ 
171.96, 156.26, 153.35, 149.49, 140.68, 119.41, 86.62, 84.42, 71.87, 64.67, 49.67, 39.62 ppm. 
31P NMR (121 MHz, D2O): δ 8.34 ppm. HRMS (ESI negative ion mode): calculated for 
C14H19N6O9P 446.0951, found: 445.0864. Stability in D2O at r.t.: superior as 72h. 
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IV.4.3 Metabolic availability 
Trisodium trimetaphosphate (153 mg, 0.5 mmoles) and iminodiacetic acid disodium salt (979 
mg, 5 mmoles, 10 equiv.) were dissolved in double distilled water (6 mL) and the resulting 
clear mixture was let at r.t. for 1 day and monitored by 31P NMR (121 Hz, 90% H2O+10% 
D2O). Simultaneously with disappearance of the starting material (-20.79 ppm, s), formation 
of three news peaks (-0.39 ppm (d, JP-P = 20.06 Hz), -4.97 ppm (d, JP-P = 17.58 Hz), -19.65 
ppm (t, JP-P = 18.99 Hz)), assigned to iminodiacetic acid triphosphate (TPI), was observed 
(80% yield, from 31P peak integration). The mixture was lyophilised; solvent (DMF, DMSO, 
hexamethylphosphoramide, or mixture thereof with water) (1mL), deoxyadenosine (16 mg, 
0.0625 mmoles) and magnesium chloride (127 mg, 0. 625 mmoles) were added. The resulting 
mixture was stirred at r.t. for 1 hour and monitored by 31P NMR. Disappearance of TPI 
signals was simultaneous with appearance of two singlets (δ 0.38 ppm and -9.24 ppm), 
attributed respectively to iminodiacetic monophosphate and to inorganic pyrophosphate. 
 
IV.4.4 Enzymatic reactions 
DNA polymerase reactions using IDA-dAMP as substrate 
All reactions were duplicated; tripliquets were realized in case of conflicting results and in 
order to verify the reproducibility of the results. For the incorporation of IDA-dAMP a series 
of 20 µL-batch reactions was performed with the enzyme HIV-1 RT (Ambion, 10 U/µL stock 
solution, specific activity 8.095 U/mg). The final mixture contained appropriate 125 nM 
primer template complex, RT buffer (250 mM Tris.HCl, 250 mM KCl, 50 mM MgCl2, 2.5 
mM spermidine, 50 mM dithiothreitol (DTT); pH 8.3), 0.025 U/µL HIV-1 RT , and different 
concentrations of IDA-dAMP building blocks (1mM, 500 µM, 200 µM and 100 µM). In the 
control reaction with the natural nucleotide, a 10 µM dATP concentration was used. The 
mixture was incubated at 37°C and aliquots were quenched after 5, 10, 20, 30 and 60 min. For 
elongation experiments, the same mixture with appropriate primer:template hybrid (see Table 
IV.1) was incubated at 37°C and aliquots were quenched after 15, 30, 60, 90, 120 min. In the 
reaction with the natural nucleotide, a 50 µM dATP concentration was used. 
 
Steady-state kinetics of single nucleotide incorporation 
The template T1 and the primer P1 were used. The primer and template in a 1:2 molar ratio 
were hybridised in a buffer containing 20 mM Tris.HCl, 10 mM KCl, 2 mM MgSO4, 0.1% 
Triton X-100, pH 8.3 and used in an amount to provide 125 nM concentration of the primer in 
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each 20 µL reaction. A range of building block concentrations between 10 µM and 1mM for 
the phosphoramidate and between 0.1 µM and 10 µM for the natural building block was used. 
The final concentrations of primer-template complex and HIV-1 RT were 125 nM, and 0.0063 
U/µL, respectively. Reaction mixtures were incubated at 37°C and aliquots were drawn at 6 
different time intervals. Quenching of the reaction and polyacrylamide gel-based 
electrophoresis were carried out as previously described. The incorporation rates (V) were 
calculated based on the percentage of the extended oligonucleotide in the mixture (P+1 band). 
The kinetic parameters (VMax and KM were determined by plotting V (nM/min-1) versus 
substrate concentration (µM) and fitting the data to a non-linear Michaelis-Menten regression 
using GraphPad Prism Software version 5.0. 
 
IV.4.5 Molecular modelling 
Modelling of the iminodiacetate-dAMP in the HIV-1 RT active site was prepared and 
performed as previously described (116-118). Solvated Molecular Dynamics was used to 
verify the stability. The complex was solvated and simulated for 1 ns. The presence of the 
base pair hydrogen bonds between primer and template strand was taken as a valid indicator 
for the stability of the structures. Nearly all H-bonds were still present in the final dynamic 
structures. An average structure of the last 50 ps was generated and analyzed. 
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V. Chapter five: Proposition of biosynthesis, metabolization 
and biodegradation of XNA building blocks for diversifying 
nucleic acid synthesis in vivo 
V.1. Introduction 
 
In our efforts to diversify the synthesis of nucleic acids in vivo, we have identified 
iminodiacetic acid as a substitute for the pyrophosphate leaving group in the polymerization 
of DNA by HIV-1 reverse transcriptase (see chapter IV). In order to be used in artificial 
enzymatic DNA synthesis, alternative DNA precursors should be metabolically available and 
recyclable. As presented in chapter I, the deoxynucleoside triphosphates used as precursors in 
the natural DNA synthesis machinery are the products of successive phosphorylation 
reactions carried out by an assortment of phosphoryltransferases, or kinases. This succession 
of reactions, referred to as the ‘phosphorylation cascade’ (figure I.5), has drawn the attention 
of enzymologists over the past decades. Nucleoside kinases (NK) process nucleosides as 
substrates and are base-specific. Nucleotide kinases (NMK) phosphorylate nucleotides to 
afford nucleoside diphosphate, which are in turn phosphorylated by nucleoside diphosphate 
kinases (NDK). Kinases may vary in terms of amino acid sequence, tridimensional shape and 
or polymerization pattern (number of enzyme units in the catalytic complex and heterogeneity 
of this complex) depending on the organism and or nucleoside, but the mechanism of 
phosphoryl transfer remains universal. A functional domain accommodating the phosphate 
donor is found in all kinases. It is meant to accommodate polyanionic species featuring great 
intramolecular repulsion forces and is referred to as the ‘ATP binding pocket’ (125).  
The primary phosphorylation amounts to transfering the terminal phosphate group of a 
‘phosphate donor’ to the 5′ hydroxyl of a (deoxy)nucleoside. For instance, deoxycytidine 
kinase (dCK) assigns the gamma phosphate of adenosine triphosphate (ATP) to dC, dG and 
dA, as shown in scheme V.1. (126) While nucleoside specificity is well documented, 
specificity towards the phosphate donor has been less studied, ATP being more or less 
designated as optimal and universal donor. Depending on the kinases, dATP or UTP are also 
common phosphate donors. Other nucleoside triphosphates can serve for this function, albeit 
moderately. Interestingly, it has been recently demonstrated that CDK2, a typical wild type 
protein kinase, can use a series of γ-substituted ATP analogues for phosphorylation of the 
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p27kip1 acceptor substrate (127), resulting in the transfer of a substituted phosphate onto a 
protein. 
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Scheme V.1: The first phosphorylation step affording dAMP from dA, using ATP as 
phosphate donor is carried out by deoxycytidine kinase. 
 
The first tridimensional crystal structure of a kinase (T4dK) was published by 
Teplyakov (128). Eriksson listed the structural elucidation of three additional phosphorylases 
in his 2002 review and Sabini et al. published the high resolution crystal structure of dCK in 
2003 (129;130). A large cleft for binding of the phosphate donor seems to be a common 
feature of all nucleoside kinases. While the nucleoside binding is selective for A and U, the 
glycine-rich loop that binds to the phosphate moiety (P-loop) is a large anion pocket. The 
large size of the anion pocket, the flexibility of the P-loop and the induced-fit character of the 
binding mechanism might allow the binding of a triphosphate analogue where the gamma 
phosphate has been substituted with an amino-linked chemical group. Provided that the 
phosphoryl transfer will not be impaired by the presence of this modification, the catalysis by 
dCK could result in the transfer of a substituted γ-phosphate onto a chosen 
deoxyribonucleoside (dC, dG or dA, see scheme V.2). 
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Scheme V.2: Potential enzymatic transfer of substituted γ-phosphoryl group onto 
deoxycytidine by deoxycytidine kinase (dCK). 
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V.2. Results and discussion 
 
Since CDK2 could use a γ-substituted triphosphate as phosphoryl donor, in this study we 
chose to challenge deoxycytidine kinase (dCK) with a gamma-modified ATP as a phosphate 
donor for the phosphorylation of one of its natural acceptor substrate deoxycytidine (scheme 
V.4). ATP was substituted in gamma-position with the iminodiacetic acid (IDA) following a 
cyclohexylcarbodiimide (CDI) approach (Scheme V.5) adapted from Hoard and Ott (131) to 
obtain [γ-P]-iminodiacetate adenosine triphosphate (IDA-ATP). 
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Scheme V.4: Potential phosphorylation of deoxycytidine with IDA-ATP by deoxycytidine 
kinase. 
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Scheme V.5: Synthetic route for iminodiacetic acid adenosine triphosphate: a) CDI, 
dimethylformamide, anhydrous; b) methanol, 30 min; c) iminodiacetic acid dimethyl ester; d) 
Sodium hydroxide, 5% in water, 15 min. 
 
In the control phosphorylation reaction, ion exchange HPLC monitoring (Figure V.2) showed 
disappearance of the peak attributed to dC eluted at 11% B and of ATP at 74 % B. 
Disappearance of dC was simultaneous with the appearance of a small peak whose retention 
corresponded to that of pure dCMP (37 % B) and a bigger peak whose retention time matched 
that of pure ADP (57-58%). The identity of the peaks was confirmed by MS analysis of the 
corresponding fractions. 
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Figure V.1: Ion exchange HPLC profile of dC phosphorylation with ATP as phosphate donor 
after 16h reaction at room temperature. 
 
Attempts to transfer the IDA-phosphate moiety to dC were monitored by ion exchange HPLC 
and showed that disappearance of ATP-IDA was not simultaneous with the formation of 
dCMP-IDA (reference peak in figure V.2). Instead, dCMP was produced, suggesting in situ 
degradation of ATP-IDA towards ATP (observed only in the presence of divalent cation) for 
further use as phosphate donor. The comparison of peak areas suggests that phosphorylation 
took place only on a small amount of dC, involving an equimolar production of ADP. The 
substantial amount of ADP observed after reaction can therefore not only account for the by-
product of phosphorylation. This additionnal appearance of ADP can be explained by the 
concomitant degradation of ATP-IDA. As a matter of fact, stability of IDA-ATP in the 
reaction buffer was determined and ranged from 10-15 minutes at 37°C to a few hours at 
25°C.  
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Figure V.2: Ion exchange HPLC profile of A) IDA-dCMP, reference peak, from chemically 
synthesized compound and B) Attempt of dC phosphorylation with ATP-IDA as phosphate 
donor: no IDA-dCMP has formed after 16h reaction at room temperature.  
 
In addition, a recombinant human deoxycytidine kinase was used for this preliminary testing 
(i.e. the only commercially available deoxynucleoside kinase). Its human origin implies high 
substrate specificity. This restriction applies to the phosphate acceptor as well as for the 
phosphate donor. Testing of deoxynucleoside kinases offering broader substrate specificity, 
such as bacterial or archeon kinases, could allow a gamma phosphate-substituted ATP to be 
processed as phosphate donor towards deoxycytidine. 
In the previous chapters IDA could be regarded as the ‘equivalent’ of two phosphate groups 
during the catalytic process of polymerization involving divalent cations. Therefore, after 
introducing IDA onto a dN triphosphate moiety, the modified substrate could be regarded as 
carrying five phosphate equivalents, as represented on Figure V.3. Such a compound forms a 
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very large anionic moiety that might not fit anymore in the anionic pocket of the enzyme’s 
active site, impairing substrate recognition by deoxycytidine kinase. 
 
Figure V.3: ‘Phosphate equivalence’ of IDA leaving group. One group equivalent is 
represented as a disk. 
 
Attempts to promote this γ-P transfer using the iminodiacetic acid is in its dimethyl ester form 
proved that a reduction of the number of negative charges by 2 is insufficient to promote 
phosphorylation, as shown on figure V.4. 
 
Figure V.4: Ion exchange HPLC profile attempting dC phosphorylation with ATP-(IDA)Me2 
as γ-phosphate donor after 20h reaction at room temperature: both substrates are unreacted. 
 
All in all, the modification of the phosphate moiety of the phosphate donor species in 
enzymatic phosphorylation necessitates further study. It would first involve the identification 
of (deoxy)nucleoside kinases endowed with broader substrate specificity and then require the 
testing γ-P modified nucleoside triphosphates as phosphate donor substrate towards these 
candidate enzymes. 
As introduced in Chapter I, the prerequisites for the sustainment of an orthogonal system for 
the synthesis and propagation of artificial informational polymers (XNA) are numerous. A 
proposal for such a system (with deoxyadenosine as a base) is presented in Figure V.4. As a 
potential alternative to pyrophosphate in the polymerization of XNA, iminodiacetic acid has 
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the advantage of being catabolically available. Indeed, the enzyme alanopine dehydrogenase 
(EC1.5.1.17) is able to catalyze the condensation reaction between an amino acid and a keto 
acid to form an ‘opine’ (132). In this reaction, nicotinamide adenine dinucleotide (NADH) 
could be used as reducing agent. While L-alanine and pyruvate are the preferred substrates, is 
has been shown that glycine and glyoxylate can also be processed, allowing the biosynthesis 
of iminodiacetic acid (step a) (133). At the other end of the polymerization loop, in situ 
metabolic degradation of the leaving group can be achieved by EDTA monooxygenase, 
harvested from the EDTA-degrading bacterium BNC1 (122;134). This degradation could 
prevent accumulation of IDA in the active site or in the ‘nucleic acid factory’ and could also 
provide a driving force for the polymerization reaction. After synthesis or recovery of IDA, it 
could be part of what we call an ‘energetic enclave’. In this synthetic cycle, IDA replaces 
pyrophosphate as energetic currency. The in situ production of alternative building blocks is 
realised as presented in Chapter IV (Scheme IV.4) and involves cyclotriphosphate (a.k.a. 
trimetaphosphate) as a phosphate source and results in the formation of bis(iminodiacetic 
acid) phosphorodiamidate (IDA2P) (step b). As a matter of fact, along with orthophosphate 
cyclic triphosphate is thought to have possibly served as phosphate source under pre-biotic 
conditions (135).  The phosphoryl transfer reactions involved in steps c) and d) are not 
spontaneous and require to be catalytically performed. A different type of catalysis than the 
enzymatic one is prohibited since we aim at in vivo sustainment. The transfer of IDA-
phosphate reaction (possibly catalyzed by a kinase) of IDA2P onto adenosine diphosphate 
would result in γ-P iminodiacetic acid ATP (step c). Released IDA is either degraded or re-
enters the cycle (step f). Afterwards, alternative DNA building blocks carrying IDA as leaving 
groups would originate from the reaction between IDA-ATP and the corresponding 
nucleosides (step d), also potentially catalyzed by a kinase. At that point, the building block 
can enter what we call a ‘genetic enclave’, in which it is used by a leaving group-specific 
polymerase for the synthesis of the corresponding informational polymer (step e). 
The possibility of modified phosphoryl transfer could be investigated by testing 
kinases from different sources or by mutating a pool of available kinases. After a suitable 
catalytic system is identified, the envisioned orthogonal system presented below could be 
assembled and tested in vivo. 
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Figure V.4: Envisioned orthogonal system for the propagation of informational polymers 
using iminodiacetic acid as alternative leaving group: a) condensation of glyoxylate and 
glycine by an opine dehydrogenase, potentially using NADH as reducing agent; b) 
cyclotriphosphate opening by IDA generates alternative energetic currency; c and d) series of 
IDA-P transfers ‘IDA-phosphorylations’ yielding alternative nucleic acid precursors 
(exemplified for deoxyadenosine); side products IDA and ADP can re-enter the synthetic 
cycle and therefore promote auto-maintenance of the system; e) orthogonal synthesis of 
nucleic acids by specific DNA polymerase; f) possible degradation (by EDTA 
monooxygenase) and/or recycling (into step b) of the leaving group displaces the equilibrium 
in favour of nucleic acid synthesis.  
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V.4. Experimental section 
V.4.1 General methods 
NMR spectral analyses were carried out and processed as described in Chapter II. Chemical 
shifts are expressed in parts per million (ppm) by frequency. 1H chemical shifts are referenced 
to an internal TMS signal (δ = 0.00 ppm), 31P NMR chemical shifts are referenced to an 
external 85 % H3PO4 standard (δ = 0.00 ppm). Standard and exact mass spectra were 
measured as described in Chapter II. Chemicals of analytical or synthetic grade were obtained 
from commercial sources and were used as received unless otherwise specified 
(tributylamine, Acros; carbonyldiimidazole, Alfa Aesar; deoxyadenosine monophosphate: 
Sigma Aldrich; trimetaphosphate trisodium salt, Sigma; hexamethylphosphoramide, UCB 
stock). Acetonitrile HPLC Grade was purchased from Fischer Scientific. Thin Layer 
Chromatography was performed on Alugram® silica gel UV254 mesh 60, 0.20 mm 
(Macherey-Nagel). Ion exchange chromatography was performed on Source 15Q in a 
TricornTM column 200mmx10mm (both Pharmacia) using 2748 Dual Absorbance Detector, 
600 Controller, 600 Pump with Empower 2 as processing software (all: Waters). 
 
DNA duplexes preparation and polyacrylamide gel-based electrophoresis were carried 
out as described in Chapter II.  
 V.4.2 Synthesis 
Bis(n-tributylammonium) salt of 5'-adenosine triphosphate 
Adenosine triphosphate as a disodium salt was converted to its bis(n-tributylammonium) salt 
by applying it as an aqueous solution onto a Dowex 50WX8-200 (Acros) ion exchange 
column in its protonated form and subsequently washing the column with water. The resulting 
free acid was dropped into a cooled solution of n-tributylamine (1.1 equiv.) in ethanol (20 
mL) and further evaporation under reduced pressure afforded the product as a colourless 
solid. 
1H NMR (300 MHz) δ 8.38 (s, 2H, H2 & H8), 5.90 (d, 1H, 3JH1'-H2' = 5.49 Hz, H1′), 4.56 (m, 
1H, H3′), 4.38 (bs, 1H, H2′), 4.21 (bs, 1H, H4′), 4.11 (bs, 2H, H5′), 2.90 (bs, 12H, CH2-N), 1.45 
(bs, 12H, CH2-CH2-N), 1.14 (d, 12H, CH2-CH2-CH2-N), 0.73 (t, 18H, CH3-CH2-CH2-CH2-N) 
ppm. 31P NMR (121 MHz) δ -10.92 (d, γ-P, 2Jβ-γ=19.34 Hz), -11.56 (d, α-P, 2Jα-γ =19.76 Hz), -
23.21 (t, β-P, 2Jβ-γ ~2Jα-γ =19.59Hz) ppm. 
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γ-P-imidazolide-5'-adenosine triphosphate  (Im-ATP) 
Adenosine triphosphate as a bis(n-tributylammonium) salt (0.73 mmol, 460 mg) was dried 
overnight in vacuo over potassium oxychloride and was dissolved as a 0.1 M solution in DMF 
previously dried with freshly activated 0.4µm molecular sieves. Cyclohexylcarbodiimide (3.6 
mmoles, 592 mg, 5 eq.) was added to the solution stirred under argon atmosphere, resulting in 
a clear yellow solution. The reaction was monitored by analytical ion exchange HPLC 
(Source 15Q running a gradient of TEAB 1M in water) coupled to ESI MS. Im-ATP was 
eluted at 68 % B. After 48 hours, the solution was used as such for the next synthesis step.  
1H NMR (300 MHz): δ 8.39 (s, 1H, H8), 8.18 (s, 1H, H2), 7.84 (s, 1H, Im), 7.21(s, 1H, Im), 
6.18 (s, 1H, Im), 6.03 (d, 1H, 3JH1'-H2' = 6.03Hz, H1′), 4.38 (m, 1H, H3′), 4.29 (t, 1H, H2′), 4.25 
(m, 1H, H4′), 4.03 (m, 2H, H5′), 3.05 (m, CH3-CH2-NH+), 1.17 (t, CH3-CH2-NH+) ppm. 
31P NMR (121 MHz): δ –7.04 (d, P-γ, J=19.94 Hz), -11.54 (d, P-α, J=19.88 Hz), -22.49 (t, P-
β, J=20.13 Hz) ppm. HRMS (ESI negative ion mode): calculated for C13H18N7O12P3: 
557.0226, found: 556.0150. 
 
γ-P-(iminodiacetic acid dimethyl ester) 5'-adenosine triphosphate  (IDA-ATP) 
The hydrochloride salt of iminodiacetic acid dimethyl ester (5 eq., 720 mg) and n-
tributylamine (5 equiv., 850 µL) were added to the previous reaction mixture and the course 
of the reaction was monitored by ion exchange HPLC. Me2(IDA)-ATP was eluted at 50% B; 
Rf (iPrOH/H20/NH3:5.5/3.5/1)=0.50. After 24 hours the mixture was diluted 10 times in water 
(Millipore) and purified by ion exchange (Source 15Q, preparative). Corresponding fractions 
were collected and lyophilized, affording a white fluffy solid.  
1H NMR (300 MHz): δ 8.55 (s, 1H, H2), 8.26 (s, 1H, H8), 6.14 (d, 1H, 3JH1'-H2' = 5.97Hz, H1′), 
4.72 (m, 1H, H3′), 4.58 (t, 1H, H2′), 4.39 (m, 1H, H4′), 4.25 (m, 2H, H5′), 3.89 (s, 2H, MeOOC-
CH2-N), 3.85 (s, 2H, MeOOC-CH2-N), 3.67 (s, 6H, CH3-OC(O)-CH2-N), 3.1 (m, CH3-CH2-
NH+), 1.22 (t, CH3-CH2-NH+) ppm. 31P NMR (121 MHz, D2O): δ –3.85 (d, P-γ, 2Jβ-γ = 21.14 
Hz), -11.51 (d, P-α, 2Jα-γ =19.03 Hz), -22.98 (t, P-β, 2Jβ-γ ~ 2Jα-γ) =20.13 Hz) ppm. HRMS (ESI 
negative ion mode): calculated for C16H25N6O16P3: 650.0540, found: 649.0471. 
 
γ-P-(iminodiacetic acid) 5'-adenosine triphosphate 
The dimethyl ester of iminodiacetic acid ATP was dissolved in a 5% NaOH solution and left 
to react at room temperature. The course of the reaction was monitored by analytical ion 
exchange HPLC and TLC (iPrOH:H2O:NH3 5.5:3.5:1). Complete conversion to the free 
dicarboxylic acid (which was eluted at 82 % TEAB 1M) was observed after 30 min.; Rf 
V. Chapter five: Proposition of biosynthesis, metabolization and biodegradation of XNA 
building blocks for diversifying nucleic acid synthesis in vivo 
  93 
(iPrOH/H20/NH3:5.5/3.5/1)=0.21. The reaction mixture was purified by preparative ion 
exchange HPLC and the corresponding fractions were collected and lyophilized, affording a 
white fluffy solid.  
1H NMR (300 MHz): δ 8.46 (s, 1H, H8), 8.17 (s, 1H, H2), 6.05 (d, 1H, 3JH1'-H2' = 4.80Hz, H1′), 
4.55 (m, 1H, H3′), 4.28 (t, 1H, H2 ′), 4.18 (m, 1H, H4 ′), 4.11 (m, 2H, H5 ′), 3.63 (s, 2H, HOOC-
CH2-N), 3.60 (s, 2H, HOOC-CH2-N), 3.10 (m, CH3-CH2-NH+), 1.18 (t, CH3-CH2-NH+) ppm. 
31P NMR (121 MHz): δ –3.34 (d, P-γ), -11.46 (d, P-α, 2Jα-γ =18.9Hz), -22.79 (t, P-β) ppm. 
HRMS (ESI negative ion mode): calculated for C14H21N6O16P3: 622.0227, found: 621.0168. 
 
V.4.3 Enzymatic assays 
 
Transfer of γ-P-IDA onto 5’-OH of deoxyadenosine 
A solution of 0.5 mM ATP or IDA-ATP, 0.5 mM dCMP and 0.35 µM deoxycytidine kinase 
(Biaffin GmbH), in kinase buffer (50mM Tris.HCl, 100mM KCL, 5mM MgCl2, dithiothreitol 
1 mM), for a total reaction volume of 200 µL, was left at room temperature for 16 hours. The 
reaction mixture was then purified on an ion exchange column (Source 15Q) eluting with a 
gradient of TEAB 1M in water (0 to 100 % in 35 min). 
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VI. Conclusions and perspectives 
 
The polymerization of nucleotides into nucleic acids is catalyzed by polymerases and is the 
supporting process for the survival and reproduction of all living organisms. Four 
deoxynucleoside triphosphates (dATP, dCTP, dGTP and dTTP) are the traditional precursors 
of deoxyribonucleic acid (DNA). In recent decades numerous analogues of these precursors 
have been designed and synthesized in order to study the mechanism of their enzymatic 
polymerization. For this purpose, modifications were synthetically introduced on different 
parts of the molecule, mainly on the nucleobase or the sugar-phosphate backbone. Polymerase 
recognition of the corresponding deoxynucleoside triphosphate analogues can be 
characterized and inform us about the importance of enzyme-substrate binding interactions. In 
this context, modifications of pyrophosphate were not explored until very recently, since it is 
not part of the resulting biopolymer per se. Nevertheless, initial binding of the dNTP to active 
site residues play a key role on polymerization efficiency and replication fidelity. Therefore, 
enzyme recognition of dNTPs analogues where pyrophosphate is replaced by various leaving 
group candidates can instruct us about the role of pyrophosphate in the polymerization 
mechanism and its influence on different stages of this biochemical event.  
Deoxyadenosine triphosphate analogues where the pyrophosphate moiety is replaced by 
L-aspartic acid and few other amino acids were previously shown to act as substrates for 
DNA polymerization catalyzed by promiscuous polymerases such as HIV-1 reverse 
transcriptase (RT) or Vent exo- polymerase. It was suggested that the functional moieties of 
these alternative leaving groups (carboxylic acid and, or imidazole ring) could act as mimics 
of pyrophosphate in the enzyme’s active site. The aim of this thesis was to identify new 
leaving group candidates that are able to replace pyrophosphate during nucleic acid synthesis. 
For this purpose, structures similar to L-Asp and L-His in shape, size and coordination 
capacity are explored. 
 
In chapter two of this thesis it was demonstrated that a variety of other chemical groups 
with potential coordination capacity could also be processed as leaving groups during HIV-1 
RT catalyzed DNA synthesis. Coordination capacity, relative position of the potential 
coordinating groups, as well as the phosphoramidate or phosphodiester nature of the linkage 
between leaving group and nucleotide, seemed to affect the incorporation outcome.  
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Results presented in chapter three completed the evaluation of the influence of the 
linking atom in relation to the efficiency of nucleotide incorporation. For this purpose, 
phosphodiester analogues of the best performing amino acid dAMP phosphoramidates were 
synthesized. Regrettably, poor stability of malic acid dAMP (phosphodiester analogue of L-
Asp-dAMP) in polymerization media prevented any enzymatic tests. L-β-imidazole lactic 
acid dAMP (L-ILA dAMP, phosphodiester analogue of L-His-dAMP) proved to be just stable 
enough to allow its evaluation as a substrate for reverse transcriptase. As expected, L-ILA 
was able to mimic the pyrophosphate moiety as leaving group in the DNA polymerization 
reaction. Replacement of a phosphoramidate linkage by a phosphodiester linkage resulted in 
greater substrate affinity, higher maximum velocity and fairly better elongation capacity. 
Unfortunately full-length primer elongation opposite a template with a seven base overhang 
could not be obtained with either of the dATP analogues. Many reasons could explain 
premature DNA synthesis termination, such as the absence of energy, usually provided by 
pyrophosphate hydrolysis, and required by the enzyme for further conformational changes. 
DNA elongation could also be hampered by uncorrect binding of the substrate in the active 
site (leading to substrate inhibition of the enzyme), or strong binding of the product in or out 
the active site (leading to product inhibition). Probably due to instability of the 
phosphorothioate analogues of L-Asp-, β-Ala- and GA-dAMP, the compounds could not be 
isolated. The influence of replacing the linking oxygen by the other possible isostere sulphur 
could therefore not be investigated. 
As detailed in chapter four, great incorporation and elongation results were obtained 
when using iminodiacetic acid dAMP as substrate. When this analogue was used as the 
substrate, the full-length elongation product was partially obtained. Moreover, supplementary 
elongation results also demonstrated the positive influence of a longer template overhang for 
the recognition and incorporation of several successive units carrying a modified leaving 
group, thus validating the importance of interactions between finger subdomain residues and 
the template’s upstream nucleotides in the HIV-1 RT polymerization process. The calculated 
model of the ground state interactions for accommodation of IDA-dAMP in the active site of 
reverse transcriptase showed that similarly to pyrophosphate, iminodiacetic acid seems to be 
bound in a network of catalytical residues of the enzyme with the help of two catalytical metal 
ions. This molecular model supports the idea that IDA probably mimics pyrophosphate in this 
mechanism by coordinating essential features in the active site (catalytic ions and residues). 
Overall, comparison of the results obtained with our series of analogues points out that IDA-
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dAMP is the best analogue and hence IDA the best alternative leaving group for 
pyrophosphate in the enzymatic polymerization by HIV-1 reverse transcriptase.  
The synthetic work reported in this thesis is centred on phosphorous coupling chemistry. 
Many methods are available and allow the formation of P-O and P-N bonds, ranging from 
some requiring rigorous anhydrous conditions to some more user- and environment-friendly 
reactions carried out in water solution. Phosphorous coupling chemistry has enormously 
developed since the importance of ATP and that of the phosphodiester bond in the life cycle 
have been uncovered. Phosphorous reactivity remains a matter of investigation, since 
polyphosphates are now thought to be the molecular source of energy in prebiotic conditions 
on earth. The presence of one or more phosphate groups in test compounds confers them a 
very high polarity. Their purification requires in turn very specific and polar methods like ion 
exchange chromatography and the use of trialkylammonium salts to promote dissolution. 
Unfortunately for the chemist, this greatly reduces the yield of coupling reactions since much 
product is lost over numerous steps of HPLC purification and subsequent lyophilisation. 
Therefore, the search for innovative synthetic and purification strategies deserves to be 
encouraged. 
 
Studying a chemical group in a biochemical environment and the effects of its modification 
on a biochemical reaction is not a simple task. Biochemical actors such as proteins endowed 
with catalytic activity add a tremendous amount of uncertainty to in vitro experiments, whose 
results should therefore be interpreted with uttermost circumspection. On a practical point of 
view, so far only the crystallographic resolution of static structures is possible, which limits 
the observation to discrete steps of the process and complicates the examination of transition 
steps. In addition, working with enzymes greatly decreases the reproducibility of experimental 
results. As an illustration, standard errors of a remarkably high 30 % are considered as 
acceptable by standard textbooks (136).  Furthermore, inter-batch variations in specific 
activity (activity per mg enzyme) and a fortiori changes in enzyme manufacturer, shipping 
and storing conditions can interfere considerably with experimental reproducibility. 
Nevertheless, experimental results of in vitro enzymatic reactions provide valuable insights on 
their mechanism, helping the medicinal chemist to better understand structure activity 
relationships of potential tools for biotechnology or drug therapies. Conclusions drawn in the 
three first studies of this thesis are consistent with each other and converge towards various 
postulations. First, it is possible to replace pyrophosphate in the polymerization of DNA 
with various alternative leaving groups, albeit, until now, at the expense of incorporation 
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and elongation efficiency. Second, intrinsic physicochemical properties (size, coordinating 
capacity, spatial arrangement, and polarisability of the phosphorous linkage; pKa and stability 
of the released species) of the pyrophosphate mimic can differ drastically from that of the 
natural and so far optimal leaving group. Therefore this replacement is likely to have direct 
effects on the chemical step (equilibrium displacement, rate, yield and geometry of 
successive states). Interestingly, better incorporation efficiency does not correlate with a 
enhanced elongation capacity. Third, altering the phosphorous linkage and or the structure of 
the leaving group might also affect previous and following steps of the overall biochemical 
event.  
 
Among other characteristics of the leaving group, its affinity towards the duplex DNA-
enzyme complex during the second binding step is thought to influence substrate selectivity 
and polymerization kinetics (137). In this regard, modelling experiments provide indications 
on coordinating possibilities, but crystallization of HIV-1 RT liganded with dsDNA and IDA-
ddNMP remains the best method to study ground state interactions between alternative 
leaving group and active site’s residues.  
Downstream in the polymerization process, released pyrophosphate is suspected to have 
an important role in catalytic ion removal, DNA duplex translocation to the following 
incorporation site (108) or overall conformational changes of successive enzymatic 
complexes (92). The biochemical fate of a modified leaving group will certainly differ from 
that of pyrophosphate depending on its coordinating capacity and interaction with its 
environment. For instance, an explanation for premature DNA synthesis termination 
witnessed in chapter III could be that released imidazole lactic acid or L-histidine binds to 
reverse transcriptase, thereby inhibiting the enzyme. Since rates reported from gel bands in 
percent extension per minute are difficult to interpret precisely and therefore prohibit 
mechanistic insights. Doubtless determination of such a situation requires using analytical 
tools involving fluorescence detection of product formation and/or consumption  (138). As 
proposed by Götte, the absence of released PPi and corresponding free enthropy ‘cellular 
energy’ in the mechanism might account for the loss of processivity and or efficiency of 
reverse transcriptase observed in elongation experiments after incorporation of a few 
nucleotides (92). As stressed out by Johnson in a recent review (138), the role of 
pyrophosphate in the polymerization mechanism remains an area of active investigation. By 
reviewing the kinetics and the chemical mechanism of DNA polymerases, Johnson reminds us 
that the (free) energy source required for enzyme isomerisation remains undetermined. In this 
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regard, his team judiciously developed a sensitive technique allowing real time measurement 
of PPi release that could be used to further investigate the relationship between PPi release 
and DNA polymerization (139). Additional fundamental research should be done to gain more 
information on the role of other intrinsic properties of the leaving group as well as short and 
long term effect of its modifications on the polymerization mechanism. In particular, efforts 
should be put towards developing novel analytical tools allowing real time visualisation of 
biochemical complexes. 
 
The study of DNA polymerization helps understanding a key step of viral replication. New 
insights on its mechanism could help future design of powerful antiviral compounds. 
Nucleoside like reverse transcriptase inhibitors (NRTIs) are broadly used in antiviral drug 
regimens, but the development of drug resistant strains leads to a rapid decrease in therapeutic 
efficacy. There is therefore a constantly renewed need for novel antiviral compounds, and it is 
our strong belief that NRTI analogues containing a pyrophosphate mimic such as 
iminodiacetic acid could be used efficiently as therapeutic compounds. Conjugating an RT 
inhibitor which is not substrate for cellular kinases, with a pyrophosphate mimic via a 
phosphoramidate linkage, could allow by-passing of the phosphorylation cascade and promote 
the delivery of an already active dNTP analogue into targeted cells. McGuigan and co-
workers have been addressing the search for new antiviral compounds with an approach 
involving a lipophilic group and an amino acid phosphoramidate, but unfortunately no studies 
were carried out with potential pyrophosphate mimics so far. In this original approach, the 
alternative leaving group would serve both goals of masking the nucleoside monophosphate 
and by-passing the two remaining phosphorylation reactions for efficient inhibition of viral 
DNA replication. 
 
Meanwhile, the timeframe and efficacy constraints of the project for orthogonalization of 
nucleic acid synthesis demands that a leaving group be chosen out of the series of candidates. 
From our studies, which are limited to deoxyadenosine triphosphate analogues, the most 
promising alternative to pyrophosphate is undoubtedly iminodiacetic acid. It is superior to the 
other analogues by its stability and substrate efficiency for incorporation and elongation. 
Discrepancies in the results obtained by colleagues with T, C and G analogues showed that 
the efficiency of IDA at mimicking pyrophosphate strongly depends on the nucleobases, 
which prevents for now an accurate evaluation of polymerization selectivity and specificity. 
The reason for this nucleobase dependence is still a matter of investigation. Further evaluation 
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of IDA as the orthogonal leaving group candidate would also require challenging the 
polymerases for much longer elongation. In the search of better leaving group candidates, 
analogous dicarboxylic acids are being evaluated in the laboratory of medicinal chemistry. 
Among other tracks, the influence of the length of the alkyl chain connecting the nitrogen 
atom to the carboxylic acid functions is being investigated, since a dicarboxybutyl 
phosphoramidate analogue of dCTP showed surprising incorporation capacities (140). 
Besides, the possibility of replacing the moieties with coordinating potential by phosphonic 
acids is also being investigated. The near future of the project for DNA synthesis 
orthogonalization now depends on the ability of polymerases to evolve in such a way that they 
favour the modified leaving group over the natural one, and eventually to segregate fully 
modified XNA precursors (unnatural base pair linked to a modified sugar –phosphate 
backbone activated by a pyrophosphate mimic) from natural DNA precursors. 
 
Further development of an orthogonal genetic system requires that the leaving group 
candidate is metabolically available and degradable. Attempts for the chemical synthesis of 
IDA-dAMP from biological precursors were reported at the end of chapter four and the need 
for enzymatic catalysis was suggested. In chapter five we aimed at introducing an 
independent metabolic route for the biosynthesis of in vivo precursors of artificial nucleic 
acids. The search for broad substrate kinases able to transfer a phosphoro-iminodiacetic acid 
group onto a deoxynucleoside could be initiated by screening the numerous 
phosphoryltransferases that can be obtained from bacterial sources. Potential metabolization 
of DNA precursors carrying the selected alternative leaving group seems therefore reasonable. 
The possibility of iminodiacetic acid degradation (avoiding in situ accumulation and 
potentially providing a driving force for polymerization) already exists since EDTA 
monooxygenase has been identified as a bacterial enzyme endowed with appropriate activities 
and could be successfully cloned. Adaptation of existing enzymes to exogenous nucleic acid 
precursors is now in the hand of evolutionary biologists and, in this context we are expecting 
much of innovative methods for bacterial growth on modified substrates. The efforts 
developed nowadays in this direction, as well as the rapid expansion of synthetic biology 
augur well for the feasibility of an orthogonal XNA synthesis machinery. 
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